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“With a growing number of patients surviving critical illness, there is an urgent need 
to more fully address the long term consequences of intensive care for survivors and 
their families. This Society of Critical Care Medicine conference focused on improving 
these long term consequences and discussed three major issues in the field” one of 
which is “identifying barriers and solutions for comprehensive post-ICU 
rehabilitation”. (Needham, Davidson et al. 2012) pg 507-508 
The program of research in this thesis pre-dates this quote from 2012 by four years. 
The aim of the studies in this thesis was to evaluate an implementation of early 
mobilisation practices and record the barriers and work practices associated with 
early mobilisation at a local, national and international level. 
III 
Abstract 
Introduction 
Patients who are admitted to the intensive care unit (ICU) for the treatment of 
critical illness experience muscle loss greater than that experienced from bed rest 
alone. Muscle loss is thought to be due to a combination of factors involving 
inflammation, sedation and immobilisation. The exact pathophysiology is not yet 
understood. Mobilisation has been purported to slow or reverse the rate of muscle 
loss but as yet this has not been proven.  
The literature that focuses on mobilisation in ICU is limited in both number and 
scope. The studies focus primarily on efficacy of the treatment and are not able to 
be generalised due to the restricted study populations included. Many of the 
studies include less than 10% of patients admitted to that ICU. The definition in the 
literature of what constitutes ‘mobilisation’ and what is defined as ‘early’ is highly 
variable. To date there is poor documentation of the work practices and variation of 
these for ‘early’ mobilisation in ICU. No studies exist that examine more than two 
ICUs and therefore no benchmarks of mobilisation practice exist for local, national 
or international populations. 
The program of research undertaken in this thesis examines work practices 
associated with mobilisation in multiple ICUs. The three studies conducted analyse 
an introduction of systems change approach towards mobilisation practices as well 
as an examination of safety and barriers associated with mobilisation. This thesis 
forms the widest review of mobilisation practices in a local, national and 
international setting.  
Methods 
This thesis is comprised of three studies. The first study was conducted at a single, 
level III, tertiary ICU and utilised a before and after study design examining the 
ability to introduce an early mobilisation systems change in work practices. Adult 
patients admitted to ICU who received mechanical ventilation for three or more 
calendar days were included. The study had three timeframes: retrospective 
(n=500), current practice (n=102) and prospective (n=412). Auditing was 
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undertaken using a specific mobilisation form completed by ICU staff. The data was 
used to examine the influence of an early mobilisation program on the feasibility of 
implementation, safety and barriers to mobilisations within existing resources. 
Study Two was a physiotherapy point prevalence study and was nested within the 
larger point prevalence study conducted by ANZICS CTG in 2010.This study was a 
prospective, observational epidemiological study carried out at a single time point 
across ICUs in Australia and New Zealand. Mobilisation practices and barriers were 
recorded using a scale derived from Study One. 
Study Three aimed to evaluate baseline practice, safety and barriers to early 
mobilisation for adult patients who were mechanically ventilated during their stay 
in Australian and Scottish ICUs. This study was a series of prospective, observational 
bedside audits. The audits consisted of a four-week recruitment period and then a 
further four-week period of follow up auditing of those patients already recruited 
but not yet discharged from ICU. This was the first study to obtain full length of stay 
data for consecutive patients in an international setting.  
Results  
Study One: The proportion of patients who mobilised increased significantly after 
implementation of an early mobilisation program. Proportions rose from 53.9% to 
64.6% (p=.047) of all patients and from 63.3% to 79.9% (p=.002) for patients who 
had the opportunity to mobilise. Mobilisation rates for patients with endotracheal 
tubes and vasopressor infusions increased significantly after implementation. 
Mobilisation rates for patients with renal replacement therapy increased but did 
not reach significance. Adverse event rates did not increase and remained low at 
1.1% of episodes. Patients who mobilised were associated with better discharge 
destinations. The leading barrier to mobilisation was sedation.  
Study Two: In 86% (n=33) of all level III ICUs in Australia and New Zealand, 40% of 
the 498 patients admitted to ICUs on the point prevalence day were mobilised. No 
patient on mechanical ventilation was mobilised. Adverse event rates were low 
(6.4%). Haemodynamic instability and sedation were the top barriers to 
mobilisation identified on the study day. 
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Study three: Ten Australian and nine Scottish ICUs participated in the study 
incorporating a total of 665 patients. The percentage of patients who mobilised 
during their ICU stay was 68.8% in Australian and 42.5% in Scottish sites. The 
adverse event rate in the Australian cohort was 3.2% and 6.2% in the Scottish 
cohort. The leading barrier to mobilisation in both cohorts was sedation.  
Conclusions 
The three studies provided a review of mobilisation work practices in ICU in 
Australia, New Zealand and Scotland. Mobilisation of mechanically ventilated adults 
is both safe and feasible in a heterogeneous ICU patient population. It was 
demonstrated that mobilisation can be conducted without significant adverse 
events for patients with ETTs, RRT and / or vasopressor infusions. This was true for a 
diverse range of settings across Australia and Scotland. This forms the basis of 
evidence to influence clinical guidelines on barriers to mobilisation.  
The scope of these studies demonstrates that work practices vary greatly across all 
units and these are influenced by the admission diagnosis and the severity of illness 
of the patient. A systems change strategy (Study One) demonstrated that these 
practices and specifically the barriers to mobilisation can be modified.  
Across the majority of settings, the primary barrier to mobilisation was sedation.  
Implications  
This is the first study to examine a heterogeneous ICU patient population in a local 
(Western Australia), national and international setting. Standard nomenclature of 
‘early mobilisation in ICU’ should be adopted to establish a generalisable framework 
for future efficacy studies. Barriers to mobilisation are either modifiable or 
unavoidable. Modifiable barriers have been shown to have the capacity to be 
changed (Study One). The information gained in these studies can form the basis of 
future, more robust studies examining the influence of mobilisation on patient 
centred outcomes.  
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Chapter 1 Introduction 
1.1 Background 
There has been progressive improvement in patient mortality for people who suffer 
a critical illness (Hodgin, Nordon Craft et al. 2009; Herridge, Tansey et al. 2011; 
Moran and Solomon 2012). The advancements in patient morbidity have not kept 
pace with those seen in mortality (Eddleston, White et al. 2000; Hodgin, Nordon 
Craft et al. 2009; Vincent and Norrenberg 2009; Griffiths and Hall 2010; Corner, 
Wood et al. 2013). Weakness is a common side effect experienced by patients in 
the ICU (Bolton, Gilbert et al. 1984; Bloomfield 1997; Greenleaf 1997; De Jonghe, 
Cook et al. 1998; de Letter, Schmitz et al. 2001; DeJonghe, Sharshar et al. 2002; 
Hudson and Lee 2003; Robson 2003; Winkelman 2004; DeJonghe, Lacherade et al. 
2007; Johnson 2007; Stevens, Dowdy et al. 2007; Brower 2009; Chambers, Moylan 
et al. 2009; de Jonghe, Lacherade et al. 2009; Herridge 2009; Vincent and 
Norrenberg 2009; Griffiths and Hall 2010; Banerjee, Girard et al. 2011; Adler and 
Malone 2012; Bierbrauer, Koch et al. 2012). Muscle mass losses of between 2 and 
6% per day have been reported in the ICU patient population (Bloomfield 1997; 
Topp, Ditmyer et al. 2002; Brower 2009; Truong, Fan et al. 2009). This rate is greater 
than that experienced with immobilisation alone and is thought to be due to the 
combination of inflammation, sedation and immobilisation that frequently occurs in 
the ICU (Monk, Plank et al. 1996; De Jonghe, Cook et al. 1998; de Letter, Schmitz et 
al. 2001; DeJonghe, Sharshar et al. 2002; Hudson and Lee 2003; Winkelman 2004; 
DeJonghe, Lacherade et al. 2007; Johnson 2007; Winkelman 2007; de Jonghe, 
Lacherade et al. 2009; Vincent and Norrenberg 2009; Griffiths and Hall 2010). This 
weakness is typically more prevalent in proximal muscles used for functional tasks 
such as transfers. Loss of function secondary to this weakness can last for up to five 
years in some patient populations (Herridge, Cheung et al. 2003; Cheung, Tansey et 
al. 2006; Herridge, Tansey et al. 2011).  
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Mobilisation is an attractive candidate intervention that may ameliorate weakness 
experienced in the ICU. Comparatively, it is an inexpensive therapy that if shown to 
improve an outcome has the potential to decrease the health care burden.  
The term early mobilisation has been used loosely to describe a number of terms 
such as rehabilitation, passive and active range of movement ambulation and 
exercise. To date there has not been a clear definition of early mobilisation in 
reference to patients in intensive care. In order to progress this area of research a 
clear definition of the therapy is required. This thesis will endeavour to construct a 
definition from available literature and operationalise this definition in three 
studies.  
Limited studies exist that examine mobilisation as a therapy. Those that do examine 
a limited scope of patients, predominantly patients admitted for respiratory failure. 
No study has evaluated early mobilisation practices in a heterogeneous patient 
population. It has not been established if mobilisation is able to be safely 
implemented to patients of a variety of admission diagnoses. Feasibility of 
implementing a change in practice using existing resources is not conducive to a 
randomised controlled trial design. Therefore a before and after design approach 
was taken to implement and measure the changes in practice that occurred.  
Due to the ambiguity of the definition of what ‘early’ implies in reference to 
mobilisation practices in ICU, it is important to document current practice across a 
large sample of ICUs. It is proposed that this is necessary to progress this area of 
research (Needham, Davidson et al. 2012). This has subsequently (2012) been 
determined by the Society of Critical Care Medicine as a key priority for research in 
this area. Studies in this thesis pre-date this recommendation and have 
documented baseline practice around Australia and benchmarked this 
internationally with Scottish practices.  
1.2 Thesis structure and aims 
This thesis is comprised of three studies. These will be presented in chronological 
order as they were carried out. There are many common elements to the methods 
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of the studies. Therefore, a common methods chapter will precede the three 
studies with study specific methods included in the chapter outlining each study. 
Each study’s specific methods and results will be presented within a chapter with an 
epilogue explaining the link from one study to the next. The discussion chapter will 
be structured according to the aims of the thesis and cover all three studies.  
One site, Royal Perth Hospital Intensive Care Unit (RPH ICU), participated in all three 
studies. This allowed for comparison of mobilisation rates between studies which 
occurred across a four year period.  
This thesis covers four domains and the aims for each are described below.  
1) Mobilisation rates 
 To evaluate the effect of an early mobilisation program on mobilisation 
rates in a single centre with a heterogeneous patient population 
 To establish the prevalence and incidence of mobilisation of patients 
who also received an endotracheal tube (ETT), renal replacement 
therapy (RRT) and / or vasopressor infusions. This will be looked at in a 
single unit to assess capability of change as well as the prevalence and 
incidence of this practice nationally 
 To establish baseline levels of mobilisation for patients of different 
admission diagnoses in Australian ICUs 
 To benchmark mobilisation practices in Australia internationally with 
Scotland 
2) Early mobilisation and discharge destination 
 To determine if there is an association between patients who mobilise 
and a more favourable outcome at the time of hospital discharge 
3) Safety and feasibility of mobilisation 
 To evaluate the influence of implementing an early mobilisation 
program on adverse events in a single centre 
 To establish an adverse event rate for mobilisation of patients receiving 
an ETT, RRT and / or vasopressor infusions in a single centre, around 
Australia and internationally in Scotland.  
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 To establish an adverse event rate for mobilisation as a therapy for 
patients of different admission diagnoses in Australian ICUs and 
benchmark this internationally with Scottish ICUs.  
4) Barriers to mobilisation 
 Identify barriers to mobilisation practices for patients in Australia and 
compare these internationally with barriers identified in Scottish ICUs. 
1.3 Significance and originality 
This is the first study to investigate mobilisation of mechanically ventilated adults in 
a heterogeneous patient population at a local, national and international level. 
More than 2100 patients have been examined across the three studies of this 
thesis. Numbers of this proportion have not been examined in any other program of 
research on this topic. This thesis describes national and international baseline 
practices for early mobilisation which have not previously been documented. This 
information will provide valuable information for clinical practice, future systems 
change research, and from the basis of larger, more robust trials investigating the 
effect of early mobilisation on patient centred outcomes.  
 
5 
Chapter 2 Literature review 
2.1 Introduction  
Over 118 000 people are admitted to ICU in Australia every year (ANZICS and CORE 
2010). Care in the ICU is the most expensive common health care service available 
(Williams, Dobb et al. 2005). With technology, treatments have improved mortality 
with little thought to the quality of life and long term morbidity. Patients who are 
mechanically ventilated often have the legacy of weakness years after discharge 
from hospital (Herridge, Cheung et al. 2003; Cheung, Tansey et al. 2006; Herridge 
2009). Mobilisation has been discussed as a potential therapy to counteract this 
weakness and improve outcomes (Bailey, Thomsen et al. 2007; Hopkins, Spuhler et 
al. 2007; Morris 2007; Morris and Herridge 2007; Dean 2008; Needham 2008; 
Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Truong, Fan et al. 
2009; Garzon Serrano, Ryan et al. 2011; Adler and Malone 2012). The literature 
around this topic is limited. 
This chapter will discuss the intensive care unit as an entity as well as the 
physiological consequences often experienced by patients whilst receiving care. 
Literature focussing on early mobilisation as a therapy will be synthesised to 
examine definitions used for this term. While limited by scientific rigor and low 
patient numbers, studies using early mobilisation as an intervention in ICU are 
discussed. Furthermore the barriers to early mobilisation as a therapy will be 
summarised.  
2.2 Intensive care units 
2.2.1 Historical context of intensive care 
Intensive care is a relatively new division of medicine, evolving only in the last 
century (Judson and Fisher 2006). The first official general ICU in Australia was 
founded at St Vincent’s Hospital, Melbourne in 1961 (Judson and Fisher 2006). 
Practical work and research into positive pressure mechanical ventilation saw the 
success of this unit and from this point there was a steep rise in the number of ICUs 
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around Australia (http://www.ncah.com.au/careers/brief-history-of-intensive-care/243/ 
http://www.sccm.org/AboutSCCM/History_of_Critical_Care/Pages/default.aspx) (both 
accessed September 2012). 
2.2.2 Australian Intensive care units – classifications 
The Australian institute of Health and Welfare have defined what qualifies as an 
intensive care unit in Australia as:  
“a designated ward of a hospital which is specially staffed and equipped to 
provide observation, care and treatment to patients with actual or potential 
life-threatening illnesses, injuries or complications, from which recovery is 
possible. The ICU provides special expertise and facilities for the support of 
vital functions and utilises the skills of medical, nursing and other staff 
trained and experienced in the management of these problems.” ([accessed  
Aug 12 2012] http://meteor.aihw.gov.au/content/index.phtml/itemId/327234) 
Intensive care units are ranked according to the care processes provided and the 
clinical standards delivered. The Australian Council on Healthcare Standards (ACHS) 
has developed a three level classification system. The highest classification is level 
III and the ACHS has defined this as:  
“must be capable of providing complex, multisystem life support for an 
indefinite period; be a tertiary referral centre for patients in need of 
intensive care services and have extensive backup laboratory and clinical 
service facilities to support the tertiary referral role. It must be capable of 
providing mechanical ventilation, extracorporeal renal support services and 
invasive cardiovascular monitoring for an indefinite period; or care of a 
similar nature.” ([accessed Aug 12 2012] 
http://meteor.aihw.gov.au/content/index.phtml/itemId/327234) 
In order to make best use of resources, technology and skills, certain specialties are 
often located in a limited number of units within each state. Specialties include, but 
are not limited to: cardiothoracic surgery, trauma, neurosurgery, spinal and organ 
transplantation. Many units will manage a number of different specialties. 
Population numbers as well as distribution determines how many specialist units 
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are required within each state ([accessed August 2012] 
http://meteor.aihw.gov.au/content/index.phtml/itemId/327234). 
Adult long term ventilation units are not common in Australia and are not covered 
in this thesis. 
2.2.3 Australian Intensive Care Units - staffing 
In Australian hospitals, intensive care units are run by separate and specialised 
medical staff (http://www.cicm.org.au/intensivist.php)(Judson and Fisher 2006). Medical 
doctors with a background in internal medicine, anaesthesia or more recently, 
emergency medicine are able to specialise in intensive care medicine as a secondary 
specialty and are referred to as intensivists (http://www.cicm.org.au/intensivist.php). 
Doctors from other specialties are not allowed to admit patients directly to an ICU. 
Intensivists and/or their senior staff assess each case on an individual basis to 
determine the appropriateness of the admission ([accessed Aug 12 2012] 
http://www.cicm.org.au/intensivist.php). 
The nursing to patient ratio is most commonly 1:1 in Australia due to the severity of 
illness of the patients (Martin and Mathisen 2005; Judson and Fisher 2006; Rose, 
Presneill et al. 2009). There is a significant allied health input into Australian ICUs. 
The majority of these professions have a permanent presence in ICU or a referral 
system in place to provide the service on an as needs basis (Skinner, Berney et al. 
2008; ANZICS and CORE 2010).  
2.2.4 Australian intensive care units - epidemiology  
There are 29 level III adult ICUs in Australia and 129 other ICUs which are a 
combination of level I and level II ICUs (ANZICS and CORE 2010). The 2010 Annual 
Report ANZICS Centre for Outcome and Resource Evaluation (2010) state the 
average annual occupancy rate of ICU beds in Australia is 69.9% with approximately 
120 000 adults admitted to the 1627 physical ICU beds in Australian ICUs in 2010. 
With the population of people greater than 16 years being over 17.8 million people 
in 2010, the incidence of admission to ICU in Australia is 1:150 (ANZICS and CORE 
2010). Thirty eight percent of patients admitted are ventilated at some stage during 
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their ICU admission (ANZICS and CORE 2010). The characteristics of patients 
admitted to ICUs in Australia are listed in Table 1 below.  
Table 1 Epidemiology of patients admitted to intensive care units in Australia 
Descriptor 2010 statistics for Australian ICUs 
Age – median years 64.7 (49.8-75.8) 
Sex – Male 58% 
Top 5 admission diagnoses CABG surgery – 6.8% 
GI surgery for neoplasm – 4.5% 
Orthopaedic surgery - 4.1% 
Valvular heart surgery -3.6% 
Drug overdose - 3.3% 
APACHE II* score – median 14 (10-19) 
Mortality 6.4% in ICU 
10.1% in hospital 
Length of stay in ICU – median 1.8 (0.9-3.7) 
*APACHE II – Acute Physiological and Chronic Health Evaluation score. See Appendix 1 
(ANZICS and CORE 2010) 
 
Of all Australian Level III ICU beds, two thirds are staffed and funded for ventilated 
patients (Judson and Fisher 2006; ANZICS and CORE 2010). Patients occupying ‘non 
ventilator’ beds are often patients admitted after surgery such as cardiothoracic 
surgery that require close monitoring but are not admitted for failing organs 
(Judson and Fisher 2006; ANZICS and CORE 2010). The dynamics of this group of 
patients differs as their expected recovery is much quicker and routine than 
patients admitted in an emergency situation. It would be considered standard 
practice for patients who have undergone major surgery such as an open abdominal 
aortic aneurysm repair or coronary artery bypass grafting to mobilise and be 
discharged from the ICU the day after surgery (Brasher, McClelland et al. 2003; 
Kirkeby-Garstad and Sellevold 2006) Kirkeby-Garstad and Sellevold, 2006). These 
patients typically have a lower APACHE score and lower mortality rate in 
comparison to patients admitted for non-surgical or emergency surgical procedures 
(Moran and Solomon 2012). 
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2.2.5 Australian Intensive Care Units – cost 
The cost of providing care in an Australian ICU varies depending on what services 
are required. An average medical hospital admission costs AUD$4133 in total 
whereas some common diagnosis related groups utilising intensive care, cost on 
average AUD$63000. In 2005 the approximate cost per day of being in ICU was 
greater than AUD$3000 (Soloman and McLeod 1998; Brown and Lilford 2006). More 
current data on costs is not available. 
The USA spends approximately one third of its total health budget on intensive care 
service delivery (Higgins, Pettila et al. 2010) and while it is not known what 
percentage Australia spends on intensive care, the total health budget for Australia 
is $121.4 billion or 9.4% of gross domestic product (2009 – 10). ([accessed 12 Sept 
2012] www.aihw.gov.au)  
2.2.6 International Intensive Care 
There is little data available on international baseline practices. The classification of 
ICUs into Level I, II or III is consistent throughout the UK, the Americas and 
Australasia (Haupt, Bekes et al. 2003). However, variation in service delivery occurs 
between countries and units. Factors that often differ between countries are 
staffing ratios, sedation practices and presence of multidisciplinary team members 
in the ICU (Clarke 1999). Variations in one or all of these factors cause variation in 
care delivery patterns.  
Nurse to patient ratios have an important influence on patient management. It has 
been shown that units with a nurse to patient ration of 1:2 have higher usage of 
sedation than those with a 1:1 ratio (Martin and Mathisen 2005). Australia, as 
previously mentioned, most commonly has a nurse to patient ratios of 1:1, as does 
the United Kingdom. However, in the USA where the majority of studies examining 
early mobilisation originate, nurse to patient ratio is more commonly 1:2 ([accessed 
2012 Aug 12] http://www.aacn.org/WD/BeaconApps/Content/fall_08-09_recipients/CICU-
COLO.content?menu=BeaconApps). Differences in care practices make comparison of 
outcomes from studies across countries and individual units difficult.  
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Medical staffing in British and American ICUs is moving towards a similar model 
adopted by Australia where consultant doctors have specific training in intensive 
care medicine as well as training in a medical specialty such as anaesthetics, 
respiratory medicine or emergency medicine (Gajic and Afessa 2009) ([accessed 2012 
Nov 19] 
www.ics.ac.uk/professional/standards_safety_quality/standards_and_guidelines/standards
_for_consultant_staffing_2007). Intensivists in the USA are in far shorter supply and 
therefore ICUs are often staffed by surgeons or pulmonologists (Haupt, Bekes et al. 
2003; Gajic and Afessa 2009). Historically, ICUs in the UK were managed by 
anaesthetists and in contrast to Australian intensivists; British intensivists often 
continue to practice in both areas of medicine ([accessed 2012 Nov 19] 
http://www.ics.ac.uk/professional/standards_and_guidelines/standards_for_consultant_st
affing_2007). 
Variation in service delivery is also true for physiotherapy services internationally. 
Physiotherapy presence in Australian ICUs is reported as 100% in surveyed units 
(Skinner, Berney et al. 2008). Permanent ICU based physiotherapy staff are present 
in approximately 88% of Australian units (Skinner, Berney et al. 2008). Survey data 
from the UK state 38% of physiotherapy staff are full time in ICU but all ICUs 
received routine physiotherapy (Lewis 2003). Physical therapists had a high 
presence in US ICUs but frequently require a physician’s referral to initiate therapy 
(Hodgin, Nordon Craft et al. 2009).  Individual studies examining mobilisation in a 
US ICU comment that prior to the implementation of the study, physical therapy 
was uncommon unless mechanical ventilation was prolonged (Morris, Goad et al. 
2008; Schweickert, Pohlman et al. 2009; Needham, Korupolu et al. 2010). In 
Australia, mobilisation practices in ICU are most commonly lead by physiotherapists 
(Skinner, Berney et al. 2008). In the UK, Lewis (2003) found that 100% of surveyed 
physiotherapists in the UK offer mobilisation and rehabilitation exercises.  
No information could be found regarding other professions that may be involved in 
rehabilitation in ICUs in USA and UK. Suggestions of other professions that may be 
involved are respiratory therapists, exercise physiologists and nurse specialists. 
Respiratory therapists are an independent profession in the USA that have a major 
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role in managing respiratory care of patients ([accessed 12 February 2013] 
http://www/healthpronet.org/ahp_month/02_05.html) In Australia, this role is 
commonly adopted by physiotherapists. Exercise physiologists are currently not 
present in Australian ICUs (Skinner, Berney et al. 2008). The different professions 
and their differing roles within ICUs show how care delivery patterns vary 
internationally and make comparison of studies difficult. 
2.3 Consequences of being in ICU  
2.3.1 Immobility 
Admission to ICU is associated with immobility. Immobility can be due to sedation, 
paralysis, treatment techniques, or the perceived need for the patient to rest 
(Hudson and Lee 2003; Robson 2003; Foster 2005; Winkelman 2007; Chambers, 
Moylan et al. 2009; Trivedi, Shelly et al. 2009; Vincent and Norrenberg 2009; 
Griffiths and Hall 2010; Banerjee, Girard et al. 2011). Bed rest and its effect on body 
systems has been investigated for more than 40 years via a number of experimental 
protocols that include study cohorts as well as cast immobilisation, space flight and 
enforced bed rest on healthy volunteers (Bamman, Hunter et al. 1997; Bloomfield 
1997; Bamman, Clarke et al. 1998; Brower 2009; Truong, Fan et al. 2009). There are 
numerous well known negative effects on body systems associated with less than 
optimal mobilisation of biological tissues. These effects are summarised below in 
Table 2.  
Muscle loss associated with immobility is due to the decrease in number and 
magnitude of muscle contractions. The rate of muscle loss related to strict bed rest 
has been reported as 1 - 1.5% per day while cast immobilisation showed losses of 
1.3 – 6% per day (Bloomfield 1997; Topp, Ditmyer et al. 2002; Brower 2009; Truong, 
Fan et al. 2009). This indicates the more restricted the muscle is, the more muscle 
loss occurs. This muscle loss has shown to be attenuated by physical activity 
(Bamman, Hunter et al. 1997; Bamman, Clarke et al. 1998; Topp, Ditmyer et al. 
2002; vanderSchaaf, Beelen et al. 2004; Winkelman 2007; de Jonghe, Lacherade et 
al. 2009).  
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Mechanical ventilation of critically ill patients involves resting the muscles of 
respiration. This rest results in weakness that is proportionate to skeletal muscle 
weakness (DeJonghe, Lacherade et al. 2007). Levine et al.(2008) conducted a rare 
human study showing convincing evidence of atrophy in human diaphragm 
myofibres after only 18-69 hours of complete diaphragmatic inactivity on 
mechanical ventilation. This work confirms results obtained from animal studies 
(Powers, Kavazis et al. 2009). The clinical significance of such losses of 
diaphragmatic and respiratory muscle strength is still unknown but hypothesised to 
increase mechanical ventilation time and hence increase duration of immobility and 
length of stay in ICU (Levine, Nguyen et al. 2008). 
 
Table 2 Negative physiological effects associated with immobility 
Body system Impact of bed rest 
Musculoskeletal  Loss of contractile strength – more evident in weight 
bearing extensor muscles 
Greater loss of Type II than Type I muscle fibres 
Bone loss (Wolff’s law) 
Cardiovascular Micro vascular dysfunction 
Decreased total blood volume 
Orthostatic intolerance  
Increased heart rate 
Decreased stroke volume, cardiac output and peak oxygen 
uptake 
Increased risk of thromboembolic disease 
Electrolyte and 
hormonal 
Decreased protein synthesis 
Insulin resistance 
Depression 
Increased excretion of nitrogen and calcium 
Skin Pressure ulcers 
Neural Decreased neural drive to motor units 
(Bamman, Hunter et al. 1997; Bloomfield 1997; Bamman, Clarke et al. 1998; Brower 
2009; Truong, Fan et al. 2009)  
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2.3.2 Intensive care unit acquired weakness – definition, 
significance and incidence 
Critical illness and immobility are often experienced simultaneously by patients in 
intensive care (Griffiths and Hall 2010). A proportion of these patients experience 
levels of weakness greater than that expected from bed rest alone (Stevens, Dowdy 
et al. 2007; de Jonghe, Lacherade et al. 2009; Truong, Fan et al. 2009; Vincent and 
Norrenberg 2009; Griffiths and Hall 2010). This condition was first described in 1984 
by Bolton(1984) but to date the aetiology and pathogenesis remains unclear.  
Weakness associated with critical illness has been described as a myopathy, a 
neuropathy and / or a combination of both (Stevens, Dowdy et al. 2007; de Jonghe, 
Lacherade et al. 2009; Truong, Fan et al. 2009; Vincent and Norrenberg 2009; 
Griffiths and Hall 2010). Critical illness myopathy is diagnosed by electromyography, 
critical illness polyneuropathy is diagnosed by nerve conduction studies and critical 
illness polyneuromyopathy is formally diagnosed by both but clinically is often 
diagnosed by physical examination (DeJonghe, Lacherade et al. 2007; Stevens, 
Dowdy et al. 2007; Bittner, Martyn et al. 2009; Hermans and Gosselink 2011). 
The term intensive care unit acquired weakness (ICUAW) has been proposed and 
accepted by a panel of ICU experts at the Brussels Round Table Conference in 2009 
(Stevens, Marshall et al. 2009). The term refers to “clinically detected weakness in 
critically ill patients in whom there is no plausible aetiology other than critical 
illness” and encompasses the three elements of critical illness myopathy, critical 
illness polyneuropathy and critical illness polyneuromyopathy. (Stevens, Marshall et 
al. 2009) It is important to note the adoption of this broad term focuses not on the 
physiology behind the condition but on the outcomes that result – which is 
predominantly weakness. The position described in the literature is a functional, 
patient focused term and outlines a complex and important condition requiring 
further investigation.  
De Jonghe et al.(2007) comment that ICUAW is both “under recognised and under 
estimated”. The impact of ICUAW has shown to have lasting effects on function and 
quality of life up to five years after discharge from ICU in subgroups of the 
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population (Herridge, Cheung et al. 2003; Cheung, Tansey et al. 2006; Herridge, 
Tansey et al. 2011). The effect of ICUAW on a heterogeneous ICU patient population 
is not known.  
Studies reporting the incidence of ICUAW vary depending on the patient population 
and the classification used for identification of ICUAW. A systematic review of 
24 studies examining the effect of ICUAW on outcomes report nearly 50% of 
patients in ICU experiencing sepsis, multi organ failure or protracted mechanical 
ventilation will experience ICUAW (Stevens, Dowdy et al. 2007). For studies 
examining all patients who receive mechanical ventilation, incidence varies from 
25 to 50% (De Jonghe, Cook et al. 1998; DeJonghe, Sharshar et al. 2002). However, 
no time frame was given for the period of ventilation received. For patients 
admitted to an ICU for longer than seven days, incidence of ICUAW is estimated to 
be from 33% to 57% (Johnson 2007). The highest incidence is reported in patients 
who experience sepsis and systemic inflammatory response syndrome (SIRS) who 
show rates between 50 and 100% (Johnson 2007; Griffiths and Hall 2010). 
The impact of ICUAW also continues to impact on muscle strength after discharge 
from ICU (Herridge, Cheung et al. 2003; Cheung, Tansey et al. 2006; Herridge 2009; 
Herridge, Tansey et al. 2011). Loss of muscle strength in adulthood has been linked 
to increased risk of disability and morbidity (Bittner, Martyn et al. 2009). Detection 
and treatment techniques for patients with ICUAW have not yet been formalised 
but it is thought that early mobilisation may assist in attenuating the muscle loss 
(Winkelman 2007; Herridge 2008; Chambers, Moylan et al. 2009; de Jonghe, 
Lacherade et al. 2009; Herridge 2009; Truong, Fan et al. 2009; Vincent and 
Norrenberg 2009). 
2.3.3 Physiology of weakness in ICU 
The exact pathophysiology of weakness experienced by patients admitted to ICU is 
not known but there is a strong physiological rationale that identifies several 
contributing factors. These factors include: prolonged inactivity, inflammation, 
metabolic derangements, malnutrition and decreased micro vascular circulation to 
nerve and muscle tissue (de Letter, Schmitz et al. 2001; DeJonghe, Lacherade et al. 
15 
2007; Truong, Fan et al. 2009). The contribution of each factor in isolation is 
unknown and factors may be cumulative or synergistic and act on different 
timeframes (Brower 2009). 
Prolonged bed rest results in primary muscle atrophy (Morris 2007). If muscle loss in 
the immobile person is partly due to less activation of muscle tissue and decreased 
exposure to mechanical load, then patients who are immobilised and sedated may 
experience less muscle contractions and mechanical load. Therefore it could be 
postulated that muscle atrophy is greater in patients who are immobile and sedated 
(Chambers, Moylan et al. 2009). No evidence is available to support this premise. 
The addition of a pathological insult like inflammation results in secondary muscle 
atrophy (Morris 2007). Secondary atrophy leads to a loss of contractile proteins 
with a corresponding increase in non-contractile tissue content such as collagen 
(Morris 2007). The combination of inflammation and immobility leads to muscle 
damage more severe than that experienced by immobility alone (Morris 2007). 
Electrolyte and metabolic disturbances are common in patients admitted to the ICU. 
Decreased phosphate, decreased or increased magnesium, decreased potassium 
and decreased calcium can precipitate or aggravate weakness (DeJonghe, Cook et 
al. 1998). Therefore, patients in intensive care battle weakness as a result of 
immobility as well as from electrolyte imbalances caused by critical illness. 
The body’s reaction to injury and illness results in increased blood glucose levels, 
inhibition of insulin and ultimately insulin resistance (Reid and Campbell 2004). 
Production of this glucose by gluconeogenesis results in breakdown of protein and 
lean tissue which increases with severity of illness (Reid and Campbell 2004). This 
loss of lean muscle tissue is a contributor to the higher rate of muscle loss 
experienced by patients with critical illness compared to subjects experiencing bed 
rest only. Muscle loss in this patient population is reported as 2% per day with a loss 
of 50% within three weeks (Robson 2003; Reid and Campbell 2004). 
Malnutrition due to poor regulation of glucose as well as delayed feeding is a 
common issue in critically ill patients. It is known to be a catabolic process and 
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contributes to muscle loss and delayed healing and recovery (Robson 2003; Reid 
and Campbell 2004). Exercise on the other hand is anabolic and may help to 
ameliorate the negative effects of bed rest, malnutrition and critical illness.  
2.3.4 Risk factors for ICUAW 
Many elements of care have been proposed as potential risk factors for ICUAW. 
However, here has only been two studies conducted (de Letter, Schmitz et al. 2001; 
DeJonghe, Sharshar et al. 2002) where the primary focus was risk factors for critical 
illness polyneuromyopathy or intensive care unit acquired paresis. Both studies 
were observational in nature and lacked a comparative group (de Letter, Schmitz et 
al. 2001; DeJonghe, Sharshar et al. 2002). The weak study designs used and 
conflicting nature of the results in these two studies makes it difficult to draw 
definitive conclusions. Plausible physiological explanations can be given for many 
elements but results show association between risk factors not a causal link. 
The most investigated factor considered in ICUAW is multiple organ failure. Patients 
with two or more failing organs for two or more days have shown a much higher 
rate of ICUAW (DeJonghe, Lacherade et al. 2007; Stevens, Dowdy et al. 2007; 
Stevens, Marshall et al. 2009). Interestingly, severity of illness as measured by 
APACHE score has not shown to be consistently associated with weakness in the ICU 
(de Letter, Schmitz et al. 2001; Johnson 2007; Stevens, Dowdy et al. 2007). It has 
therefore been hypothesised that multi organ failure is associated with weakness 
not due to the link with illness severity but because of the high rate of inflammation 
and systemic inflammatory response syndrome commonly associated with organ 
failure (Johnson 2007; Stevens, Dowdy et al. 2007).  
Sepsis is also commonly associated with inflammation and ICUAW. In a 
meta-analysis, Johnson (2007) reported the odds ratio of being diagnosed with 
ICUAW if sepsis was present was 2.4 to 49. Inflammation has again been 
hypothesised as the link between these two factors. In the same study patients 
receiving RRT were 3.4 times more likely to experience ICUAW (Johnson 2007). 
Because patients with sepsis often receive RRT it is not clear if the association is due 
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to the treatment itself or the condition that is requiring the treatment, for example, 
sepsis. More research is needed to clarify this point.  
The influence of hyperglycaemia has been examined in two large studies. One has 
shown to be associated with ICUAW and inversely associated with tight glycaemic 
control (van der Berg 2007). A more recent, large, pragmatic RCT demonstrated 
decreased 90-day survival with tight glycaemic control which brings previous results 
into question (Griesdale, de Souza et al. 2009; NICE-SUGARStudyInvestigators 
2009). Reduction of weakness at the expense of mortality is clearly 
counterproductive and the role of hyperglycaemia in the development of ICUAW is 
far from established.  
The mode of action of neuromuscular blockers has lead to strong suspicion that 
increased doses of neuromuscular blockers may affect nerve end plates long term 
and could therefore contribute to ICUAW (de Letter, Schmitz et al. 2001; DeJonghe, 
Lacherade et al. 2007; Johnson 2007; Stevens, Dowdy et al. 2007). A recent 
systematic review has shown no consistent relationship (Stevens, Dowdy et al. 
2007).  
Other medications that have had examination as a risk factor are: corticosteroids; 
catecholamine infusions; aminoglycosides and midazolam. There are currently 
inconclusive findings within the literature examining the relationship between these 
medications and ICUAW (Johnson 2007; de Jonghe, Lacherade et al. 2009; Hermans 
G 2009). 
Physiological principles would suggest that patients with a lower muscle mass prior 
to admission to ICU may potentially suffer greater functional consequences and 
perhaps increased ICUAW. However, patients who are known to have a low muscle 
mass relative to others such as females compared to males and people of increased 
age have not shown definitively to be at higher risk of ICUAW or functional loss 
(Johnson 2007; Stevens, Dowdy et al. 2007). 
The literature has indicated that mechanical ventilation time is associated with 
ICUAW (Stevens, Dowdy et al. 2007; de Jonghe, Lacherade et al. 2009; Hermans G 
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2009). However, it is difficult to test if this is due to mechanical ventilation itself or if 
it is related to the higher rate of immobilisation and sedation that occurs 
concurrently during mechanical ventilation. Differentiation between the effect of 
mechanical ventilation and immobilisation on ICUAW has not been studied.  
Many ideas have been postulated for the risk factors for ICUAW without conclusive 
evidence. However, even if correctly identified, some risk factors are not able to be 
altered, for example gender, age and amount of failing organs. Isolation of factors 
such as sedation medication, bed rest and length of mechanical ventilation on 
ICUAW may remain indistinguishable. Awareness of the potential contributors to 
ICUAW may assist in the early identification of those patients who are at greater 
risk and allow therapists to optimise specific interventions for these individuals. 
2.4 Definition of early mobilisation in the ICU  
This section is currently under review for publication as a paper in the following 
format.  
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2.5 Early mobilisation  
2.5.1 Measurement of early mobilisation outcomes 
To date there is no valid, reliable measure developed that assesses function and is 
sensitive to change in the ICU period (Skinner, Berney et al. 2008). Due to this, 
surrogate measures from the chronic respiratory failure and gerontology specialties 
of medicine have been used. Examples include the six minute walk test (Burtin, 
Clerckx et al. 2009) and the Bartel index (Schweickert, Pohlman et al. 2009).  
In the seven studies examining implementation of early mobilisation numerous 
outcome measures have been used or adapted. These are listed below in Table 3. 
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Table 3 Outcome measures used in studies of early mobilisation 
 Bailey et 
al.(Bailey, 
Thomsen et al. 
2007) 
Morris et 
al.(Morris, 
Goad et al. 
2008) 
Bourdin et 
al.(Bourdin, 
Barbier et al. 
2010) 
Needham et 
al.(Needham and 
Korupolu 2010) 
Thomsen et 
al(Thomsen, 
Snow et al. 2008) 
Schweickert et 
al.(Schweickert, 
Pohlman et al. 2009) 
Burtin et 
al.(Burtin, 
Clerckx et al. 
2009) 
Activities 
conducted 
       
Activities on MV        
Time from admn 
to rehab (median 
days) 
6.5 5 8.5   1.7 14 
% of pts 
mobilised 
   (for each ex)  (amb) % of days mobilised  
Minutes 
mobilised 
       
Distance walked         
Activity level 
prior to ICU D/C 
       
Duration of 
mechanical 
ventilation 
       
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 Bailey et 
al.(Bailey, 
Thomsen et al. 
2007) 
Morris et 
al.(Morris, 
Goad et al. 
2008) 
Bourdin et 
al.(Bourdin, 
Barbier et al. 
2010) 
Needham et 
al.(Needham and 
Korupolu 2010) 
Thomsen et 
al(Thomsen, 
Snow et al. 2008) 
Schweickert et 
al.(Schweickert, 
Pohlman et al. 2009) 
Burtin et 
al.(Burtin, 
Clerckx et al. 
2009) 
LOS – ICU & 
hospital 
       
Hospital D/C 
destination 
       
Hand grip 
strength 
       
Quadriceps 
strength 
       
Independent 
function 
      (Bartel index & N of 
ADLs) 
Berg balance 
MRC        
6 MWT        
SF-36        
Admn = admission; D/C = discharge; LOS = length of stay; MRC = Medical Research Council score; MV = mechanical ventilation; SF-36 = short form 36; % = percent; 6 MWT = 
six minute walk test. 
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From these studies, the most commonly used outcome measures to evaluate early 
mobilisation have been: number of activities conducted; time from admission to ICU 
until activity; percentage of patients mobilised and hospital discharge destination 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; 
Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 
2010; Needham and Korupolu 2010). These are markers of exercise dosage and 
surrogate functional outcomes. None of these measures have been shown to be a 
valid measure of intensity or dosage of mobilisation or function in the intensive care 
patient population. This may reflect the difficulty of exercise prescription in the ICU 
setting. 
New measures of function for the ICU patient population are emerging but as yet 
lack rigorous testing. For example, the PFIT (Physical Function in ICU Test) was 
developed in Australia and uses simple measures of strength, endurance and 
function in a 12-point scale (Skinner, Berney et al. 2008). While this measure is 
simple to perform and is reliable, it has shown to have a floor effect for debilitated 
patients (Adler and Malone 2012). The Chelsea Critical Care Physical Assessment 
Tool (CPAx) has recently been published and has shown content and face validity 
and has shown to be reliable in a small of physiotherapists (Corner, Wood et al. 
2013). Neither tool has reported large usage in clinical trials.  
The comparison of outcomes for patients in different ICUs is complicated. This is 
due to the lack of validated measures, but also because patients admitted to ICU 
vary considerably depending on factors such as age, sex, height, weight, pre-morbid 
conditions, admission diagnosis, and severity of illness on admission. The APACHE II 
score is widely used to give a numerical value to the severity of illness for patients 
admitted to intensive care and allows for comparison of patients with different 
conditions (Knaus, Draper et al. 1985). It uses a 71 point scale, with a greater score 
indicating a worse severity of illness. This score closely correlates with the risk of 
hospital death (Knaus, Draper et al. 1985). An updated version, the APACHE III has 
been developed (Knaus, Wagner et al. 1991) but the APACHE II continues to be the 
more widely utilised system. Six of the seven studies on early mobilisation in ICU 
utilised the APACHE II scoring system for patient comparison of severity of illness 
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(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; 
Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Needham and 
Korupolu 2010).  
2.5.2 Previous studies utilising early mobilisation as an 
intervention 
From the available literature the implementation of mobility teams or protocols in 
ICU resulted in increased mobilisation (Bailey, Thomsen et al. 2007; Morris, Goad et 
al. 2008; Thomsen, Snow et al. 2008; Burtin, Clerckx et al. 2009; Schweickert, 
Pohlman et al. 2009; Bourdin, Barbier et al. 2010; Needham and Korupolu 2010). 
Although patient numbers were low and limited diagnostic groups were examined, 
these results are encouraging and provide preparatory information for larger more 
robust trials looking at mobilisation as a safe and feasible treatment option that 
optimises outcomes for all ICU patients.  
Activities undertaken by patients during ICU mobilisation studies have been 
described in four articles. Two studies reported the number of activities in total 
which were 1449 activities for 103 patients (Bailey, Thomsen et al. 2007) and 270 
activities for 20 patients (Bourdin, Barbier et al. 2010). These figures are difficult to 
interpret as results are dependent on patients length of stay, admission diagnosis 
and co-morbid conditions. More commonly, the percentage of activities that 
involved ambulation or weight bearing were reported. The percentage of activities 
involving ambulation varied from 11% to 53% of activities (Bailey, Thomsen et al. 
2007; Thomsen, Snow et al. 2008; Bourdin, Barbier et al. 2010) and one study 
reported 33% of activities were tilt tabling (Bourdin, Barbier et al. 2010).  
The documentation of episodes of mobilisation was inconsistent and reported in a 
number of different ways. Two studies reported the number of sessions per patient 
which were 5.5 and 7 episodes per patient post implementation (Morris and 
Herridge 2007; Needham and Korupolu 2010). An alternative two studies reported 
the number of study days where therapy was conducted was 88% and 87% of study 
days (Bailey, Thomsen et al. 2007; Schweickert, Pohlman et al. 2009). What 
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constituted therapy was not discussed in either study. The remaining three studies 
did not comment on episodes of mobilisation. 
Minutes of mobilisation was touched on by Bourdin et al.(2010) who reported the 
median time patients spent chair sitting was 150 minutes (IQR = 90 to 240 minutes). 
The six other studies did not refer to minutes of mobilisation as a focus area in their 
results (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 
2008; Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Needham and 
Korupolu 2010).  
Reports of patients mobilising with an ETT on mechanical ventilation, RRT and 
vasopressors is quite variable across the seven studies. Mobilisation with an ETT has 
seen the most support with three studies advocating this practice and reporting 
favourable outcomes (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; 
Thomsen, Snow et al. 2008) and only one study excluded patients with an ETT 
(Bourdin, Barbier et al. 2010). The first study conducted on early mobilisation as an 
intervention in ICU, set out to remove non-physiologic barriers such as ETTs to allow 
mobilisation (Bailey, Thomsen et al. 2007). After this change, 40.9% of all activities 
recorded were conducted with an ETT of which 42% were ambulation (Bailey, 
Thomsen et al. 2007). All studies examining mobilisation with an ETT reported this 
practice as being safe in the respiratory failure patient population.  
Mobilisation with RRT has not had significant discussion within the general 
literature. Schweickert et al(2009) allowed patients with continuous venovenous 
haemodiafiltration to mobilise, but patients on intermittent dialysis were excluded. 
No results regarding the number of episodes conducted with this therapy were 
reported. The study that excluded patients mobilising with ETTs also excluded 
patients with RRT (Bourdin, Barbier et al. 2010). The remaining studies did not 
comment on RRT. Therefore, there is little literature regarding the practice of 
mobilisation with RRT.  
The literature is divided when it comes to mobilisation of patients on vasopressor 
infusions. Thomsen et al.(2008) did not allow mobilisation with vasopressor 
infusions, Burtin et al.(2009) allowed the practice but not with significant support 
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(this was not defined further) and Morris et al.(2008) did allow patients to mobilise 
with vasopressors. It was not reported how many activities were conducted with 
vasopressor infusions running in the two studies that allowed this practice.  
Functional outcome measures were recorded in the only two RCTs (Burtin, Clerckx 
et al. 2009; Schweickert, Pohlman et al. 2009). The results were improved 
independence measured using the Bartel index (Schweickert, Pohlman et al. 2009) 
and increase in six minute walk distance at hospital discharge (Burtin, Clerckx et al. 
2009) (see Table 4). There was a trend towards more patients in the intervention 
group being discharged home in one study, but this was not statistically significant 
(Schweickert, Pohlman et al. 2009). The limitations of the results in both of these 
studies is that less than 10% of patients admitted to the units were recruited, 
patients were predominantly suffering respiratory failure and the patients in Burtin 
et al.’s (2009) study were only included if they received greater than five days of 
mechanical ventilation. Therefore, although these studies had rigorous design and 
positive results, the external validity of these findings is limited.  
Currently, no data exist on the effect of early mobilisation on all patients admitted 
to acute Level III ICUs.  
2.5.3 Safety  
Safety in the ICU is considered paramount due to the severity of illness of the 
patients. Therefore, all treatments in intensive care must be evaluated in terms of 
the potential benefit provided versus the potential for harm to patients. Early 
mobilisation as a treatment must also have this evaluation completed. As yet, an 
adverse event rate for early mobilisation in a heterogeneous ICU population has not 
been established.  
Subgroups of the population have had some investigation. Five studies investigating 
the implementation of early mobilisation for patients admitted to ICU with 
respiratory failure have reported adverse event rates. The classification criteria for 
an adverse event as well as the rate reported is listed in Table 4. The rates vary from 
0.96% to 3% of sessions encountering an event, none of which resulted in reported 
increased mechanical ventilation time, increased length of stay or death (Bailey, 
38 
Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; Burtin, 
Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; 
Needham and Korupolu 2010). For subgroups of the ICU population, early 
mobilisation, using the various definitions of early mobilisation, has shown to be a 
safe intervention. 
Adverse event rates for physiotherapy practices, of which mobilisation was included 
has been described in one Australian study (Zeppos 2007). The overall adverse 
event rate was 0.2%, or 27 of the 12 287 episodes of physiotherapy carried out over 
three months across five sites in Australia (Zeppos 2007). The physiotherapy 
treatments included respiratory, neurological and musculoskeletal treatments. An 
increase in respiratory rate on one occasion was the only adverse event related to 
mobilisation (Zeppos 2007). Minimal data was available about the patient 
populations assessed and the intensity, dose and timing of the interventions. This 
limited data is difficult to extrapolate due to the constraints of the study. 
The adverse event rate associated with mobilisation for all subgroups of the ICU 
population remains to be established for Australian ICUs 
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Table 4 Studies investigating early mobilisation: adverse events and outcomes 
Authors 
Year 
N Patient diagnostics Intervention Outcomes Adverse event 
classifications 
AE rate 
Bailey et al. 
2007 (Bailey, 
Thomsen et al. 
2007) 
103  Respiratory failure 
Sepsis – 39.8%; Pneumonia – 
19.4%; Cardiovascular disease – 
9.7%; Aspiration – 6.8%; Trauma – 
5.8%; GI bleed or liver failure – 
5.8%; Surgery – 5.8%; COPD – 
3.9%; Cancer – 1.9%; Asthma – 
1.0% 
Early activity protocol 
in RICU 
3 activities SOEOB, 
SOOB in chair & 
ambulation 
Time from ICU admission 
to SOEOB = 6.6 +/- 5.5 
days (no comparison 
group available) 
On D/C, 69.4% of pts 
ambulated >100 feet 
Fall to knees 
Tube removal 
SBP >200 mmHg  
SBP <90 mm Hg 
SpO2 <80% 
Extubation 
0.96% 
Bourdin et al. 
2010 (Bourdin, 
Barbier et al. 
2010) 
225  Respiratory failure (more than 50% 
had chronic respiratory disease) 
and whose ICU stay was greater 
than 1 week. 
Rehabilitation protocol 
Chair sitting, tilting-up 
(with arms supported 
or unsupported) and 
walking 
Median time from ICU 
admission to the start of 
rehabilitation = 5 (1.5-9) 
Contraindication to rehab 
intervention on 15% of 
days 
Drop in muscle tone 
Hypoxaemia (SpO2 
<88% for > 1 min) 
Unplanned extubation 
Orthostatic arterial 
hypotension 
3%  
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Authors 
Year 
N Patient diagnostics Intervention Outcomes Adverse event 
classifications 
AE rate 
Morris et al 
2008 (Morris, 
Goad et al. 
2008) 
330 Acute lung injury – 58.7%; Acute on 
chronic lung disease – 12.3%; Coma 
– 15.4%; Post-op – 4.3%; 
Congestive heart failure – 7.4%; 
Cardiac arrest – 1.9%;  
Mobility team (critical 
care nurse, nurse assist 
physical therapist) 
Time from ICU admission 
to OOB = 8.5 days* 
SpO2 frequently <88% 
MAP <65 mm Hg 
Myocardial infarction 
Increase in PEEP or 
change to assist 
control mode once 
weaning commenced 
N/A 
Needham et al 
2010 
(Needham and 
Korupolu 2010) 
57 
 
Medical ICU patients 
(no further details provided) 
MDT focused on 
reducing heavy 
sedation & increasing 
staffing to include PT 
and OT with new 
consultation guidelines 
Number of PT and OT 
treatments increased 
286%* 
MICU LOS ↓ 30%* 
Hospital LOS ↓18%* 
Cardiopulmonary 
arrest 
Loss of consciousness 
Fall 
Removal of any 
medical device 
Oxygen desaturation 
<85% for >3 minutes 
1.36% 
Thomsen et al 
2008 
(Thomsen, 
Snow et al. 
2008) 
104 Respiratory failure only  
Sepsis – 38.5%; Pneumonia – 
16.3%; Cardiovascular disease – 
14.4%; Trauma – 9.6%; GI bleed or 
liver failure – 8.7%; Surgery – 4.8%; 
Aspiration - 1.9%; Cancer - 1.9%; 
Transfer to a RICU 
where early activity is 
a priority 
11% of pts ambulated 24 
hours prior to t/f to RICU 
vs. 28% after t/f 
Predictors of ↑ 
ambulation = RICU transfer 
(OR 2.47)*; absence of 
N/A N/A 
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Authors 
Year 
N Patient diagnostics Intervention Outcomes Adverse event 
classifications 
AE rate 
COPD – 1.0%; Asthma - 1.0%; 
Pulmonary embolism - 1.0%; Renal 
disease - 1.0% 
sedatives (OR 1.88)*; ↓ 
APACHE II (OR 1.06)*; 
female (OR 1.88)* 
Schweickert et 
al 
2009 
(Schweickert, 
Pohlman et al. 
2009) 
104 Respiratory failure 
Acute lung injury - 55%; COPD - 8%; 
Asthma - 10%; Sepsis - 14%; 
Haemorrhage – 2%; Malignancy – 
4%; Other – 6% 
Early exercise & 
mobilisation by PT & 
OT during periods of 
daily interruption of 
sedation 
Time from admission to 
ICU to OOB = 1.7 days* 
Return to independent 
functional status at 
hospital D/C* 
Shorter duration of 
delirium* 
Fall to knees 
ETT removal  
SBP > 200 mm Hg,  
SBP <90 mm Hg  
SpO2 < 80%. 
0.2%  
(4% of 
sessions 
stopped due 
to instability) 
Burtin et al 
2009 (Burtin, 
Clerckx et al. 
2009) 
90 Surgical – 90% 
Cardiac surgery - 39%; transplant 
surgery - 24%; thoracic surgery -  
16%; other – 10% 
Bedside cycle 
ergometry for 20 mins 
at an individually 
adjusted intensity level 
Time from admission to 
ICU till cycle ergometry 
commencement = 14 days 
Isometric quadriceps 
force* 6-min walking 
distance* and subjective 
feeling of functional well 
being at hospital D/C* 
Malign arrhythmias  
Symptoms of 
myocardial ischaemia  
Respiratory distress 
leading to symptoms 
of intolerable 
dyspnoea 
0 
D/C = discharge; MICU = medical ICU; OOB = out of bed; OT = occupational therapist; PT = physiotherapist; RICU = respiratory ICU; SOEOB = sitting over edge of bed; SOOB = 
sitting out of bed; *= statistically significant result  
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2.5.4 Implementation and Feasibility 
Assessment of the feasibility of a treatment technique in ICU should take into 
account the patients, the setting and the workforce. Studies examining early 
mobilisation in ICU (see Table 4) have reported that a specific interventional 
technique is feasible because the technique was self-evidently possible in a clinical 
trial (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 
2008; Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Bourdin, Barbier 
et al. 2010; Needham and Korupolu 2010). In each of these studies many factors 
were controlled or modified in order to remove experimental bias or concentrate 
on a clinical sub-cohort of patients. To date, no study has demonstrated that 
outside the experimental context these behaviours or work practices have been 
adopted or transferred into other settings using a systems change approach. 
Evidence of clinical efficacy can only be translated into clinical utility if the proposed 
systems change is able to be implemented within a specific setting. The feasibility 
and sustainability of changes in early mobilisation work practices in ICU is yet to be 
reported. 
From the review of the literature, a major factor that impacts on the ability for an 
early mobilisation treatment strategy to be adopted in ICUs is the limited ability to 
be confident that the current evidence is generalisable. Overall, only a small 
proportion of the ICU patient population in any particular setting, in any particular 
timeframe has been the focus of clinical efficacy studies. Most feasibility studies 
have been limited to patients admitted to ICU with respiratory failure (Bailey, 
Thomsen et al. 2007; Morris, Goad et al. 2008; Burtin, Clerckx et al. 2009) thereby 
such findings have limited external validity for the broader ICU population. One of 
these studies (Bailey, Thomsen et al. 2007) did have a larger proportion of all 
patients in the specific setting available for recruitment, however on review this 
was undertaken in an ICU setting with a specific focus on respiratory care. It is 
unlikely that this ICU was the equivalent of a level III ICU since patients were only 
admitted after being stabilised in another acute ICU.  
43 
Results of studies examining early mobilisation are difficult to extrapolate to the 
Australian population for three reasons: the limited patient groups examined; the 
variation in settings and variation in workforce.  
In the literature, clinical efficacy studies report the use of experimental protocols 
that altered the normal workforce arrangements. For example, three studies 
employed additional staffing to form specifically trained mobility teams where 
previously there had been no permanent rehabilitation staff (Morris, Goad et al. 
2008; Schweickert, Pohlman et al. 2009; Needham and Korupolu 2010); three 
reported no increase in staffing (Bailey, Thomsen et al. 2007; Burtin, Clerckx et al. 
2009; Bourdin, Barbier et al. 2010) and one did not comment (Thomsen, Snow et al. 
2008). One study reported no additional staffing resources but did have additional 
equipment supplied to achieve the goal of cycle ergometry for ICU patients (Burtin, 
Clerckx et al. 2009).  
Of the seven studies examining early mobilisation as an intervention, only Morris et 
al.(2008) commented on total costs of the program. Taking into account the 
increased cost of wages for the mobility team, it was demonstrated the average 
cost per patient decreased after the implementation of a mobility team (Morris, 
Goad et al. 2008). This is most likely due to the decrease in patient length of stay 
however, no breakdown of costs was provided.  
The investigation into feasibility of early mobilisation of patients in the ICU is limited 
and therefore warrants further investigation with a specific focus on systems 
change in a heterogeneous patient population in Australian, level III ICUs.  
2.6 Barriers to mobilisation 
Barriers to early mobilisation of mechanically ventilated adults are largely 
unreported (Needham and Korupolu 2010; Adler and Malone 2012). Recently, 
Needham et al.(2012) has postulated that in order to progress the adoption of early 
mobilisation and determine its effect on patient centred outcomes, the barriers to 
its implementation need to be established. Barriers to new treatments in the ICU 
are influenced by country, unit culture and the admission diagnosis of the patient.  
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Reported barriers to mobilisation vary depending on how they were examined. 
Bedside data collection focuses on barriers for the individual patient, whereas 
interviews of staff opinion are more likely to reflect unit culture as a whole. The 
four studies examining barriers to mobilisation as an outcome differ in their study 
designs (Needham and Korupolu 2010; Winkelman and Peereboom 2010; Garzon 
Serrano, Ryan et al. 2011; Leditschke, Green et al. 2012). Two studies recorded 
barriers at the bedside during contemplation of patient mobilisation (Garzon 
Serrano, Ryan et al. 2011; Leditschke, Green et al. 2012) while the other studies 
conducted interviews of staff opinion (Needham and Korupolu 2010; Winkelman 
and Peereboom 2010). The disadvantage of interviews is that the identification of 
one primary barrier may prevent the exploration of other valid, but more individual 
barriers. For example, if sedation is discussed as a major barrier the fact that the 
patient is on RRT may not be considered. Cultural barriers need to be put into 
context with individual data in order to develop a more detailed picture of barriers 
to mobilisation.  
Two papers that surveyed or presented clinician opinion found that safety was the 
primary concern when considering mobilisation of any patient in ICU, followed by 
the use of sedation (Morris 2007; Winkelman and Peereboom 2010). These findings 
contradict Leditschke et al.’s (2012) findings of vascular access in the femoral 
region; respiratory instability and timing of procedures which were the most 
frequently reported barriers during the four week audit. Cardiac, respiratory and 
neurological stability of the patient was of concern in all studies but varied in level 
of importance (Morris 2007; Needham, Korupolu et al. 2010; Winkelman and 
Peereboom 2010; Leditschke, Green et al. 2012). Tied into safety and stability was 
the concern for line and attachment patency, particularly ETTs and femorally 
inserted lines (Morris 2007; Winkelman and Peereboom 2010; Leditschke, Green et 
al. 2012). Reported barriers to mobilisation vary depending on whether data is 
collected on clinician opinion or collected at the patient bedside. The commonality 
between the two approaches is the concern for patient safety. 
The variation in worldwide practice also plays an important part when interpreting 
articles. Areas where there is little physiotherapy input have reported lack of time 
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and staffing as barriers (Morris 2007; Needham, Korupolu et al. 2010). These 
barriers were not mentioned in the Australian study (Leditschke, Green et al. 2012) 
where physiotherapy presence is higher. Sedation was also listed as a higher 
concern in studies carried out in North American countries (Morris 2007; Needham, 
Korupolu et al. 2010). This correlates with the higher use of sedation in this region 
(Martin and Mathisen 2005). Barriers to mobilisation as reported in the literature 
therefore must be seen as context dependent.  
The difference between patients of different diagnostic specific categories has not 
been investigated. Although the Leditschke et al.(2012) did report a mixed medical 
surgical population, no comment was made on whether there were differences 
within the diagnostic specific categories. Further research into barriers for patients 
admitted into different diagnostic specific categories needs to be conducted. 
The culture of an ICU is very difficult to measure but plays an important part in 
mobilisation rates of mechanically ventilated patients. Attitudes of individual 
clinicians towards mobilisation and how these individuals interact with the MDT 
heavily influence the amount of activity patients receive. Winkleman and 
Peereboom (2010) commented that medical orders for mobilisation were positively 
associated with mobilisation. This study was conducted in the USA where 
physiotherapy is initiated by physician referral (Winkelman and Peereboom 2010). 
With greater understanding of the impact of weakness in patients admitted to ICU 
and with higher levels of evidence to support mobilisation therapy, physicians and 
MDTs may be influenced to adopt this therapy into their practice. The attitude of 
physicians working in ICU is therefore a potentially modifiable barrier to this 
treatment.  
Deciding to mobilise a patient involves complex interpretation of clinical situations 
balancing the perceived risks and benefits (Hopkins, Spuhler et al. 2007; Stiller 
2007; Timmerman 2007; Dean 2008; Gosselink, Bott et al. 2008; Perme and 
Chandrashekar 2008; Hanekom, Gosselink et al. 2011; Perme, Lettvin et al. 2011; 
Herridge, Batt et al. 2013). Early mobilisation is a relatively new therapy and it has 
not yet been established what the effect size of this therapy is. The nature of 
46 
adverse events that occur with early mobilisation has also not been confirmed. 
Without understanding what gains can come from this therapy it is difficult to know 
what an acceptable level of risk should be. Establishing an adverse event rate for 
early mobilisation will assist in understanding the barriers and their relative merit to 
the therapy (Morris 2007; Adler and Malone 2012; Needham, Davidson et al. 2012).  
Many barriers to early mobilisation may be modifiable within the system while 
others will remain unmodifiable (e.g. unstable spinal fractures) and delineation 
between these within the ICU context could be an early step in change of practice. 
Leditschke et al.(2012) resolved that unavoidable barriers to mobilisation were 
respiratory, hemodynamic and neurological stability as well as medical orders to 
rest in bed. Avoidable barriers were vascular access catheters in a femoral position, 
timing of procedures, sedation management and early ward transfer. Definitions of 
these categories and strategies of how to overcome avoidable barriers were not 
provided. The literature shows that future studies need to be explicit in their 
definitions of barriers in order to progress this area of research. 
2.7 Summary 
Intensive care therapy is relatively new and is continuing to develop. Focus is now 
on improving function as well as mortality. 
Intensive care often provides numerous therapies and is delivered in different ways 
in different units and countries, often dependent on the culture of the unit.  
Immobility leads to muscle weakness. Immobility as well as critical illness combined 
with sedation results in more weakness. This is termed ICUAW and risk factors for 
this require further research and definition. 
Early mobilisation is a loose term and for future studies should define both the 
baseline level as well as the change in mobilisation to determine what constitutes 
early. Mobilisation has been defined as moving against gravity and inducing axial 
loading of the spine and / or long bones. The activities that constitute mobilisation 
are sitting (either over the edge of the bed or in a chair), standing, using a tilt table 
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or ambulation. Baseline practice in Australia has not previously been documented 
or compared. 
Few studies have been conducted in this area and no studies have examined the 
whole ICU patient population. Studies that have been conducted have had low 
adverse event rates. The effect of early mobilisation on outcomes for all patients in 
ICU remains unknown. 
Few studies with low numbers have looked at barriers to early mobilisation. Results 
vary depending on study design. Barriers for all patients are unknown. Bedside data 
is important in establishing the complexity of barriers that exist at the local, 
national and international ICU level. 
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Chapter 3 Common methods 
3.1 Introduction 
The thesis consists of three studies. All studies were conducted independently but 
focus on mobilisation of mechanically ventilated adults admitted to intensive care. 
This section will describe the aims and hypotheses for the thesis as a whole as well 
as the methods that are common to all three studies. The definition of early 
mobilisation used for all three studies will be as described in the literature review.  
3.2 Aims 
The thesis examined early mobilisation of mechanically ventilated adults 
throughout their ICU stay and had four main areas of focus. These areas of focus 
and the associated aims for this thesis are described below. 
1) Mobilisation rates 
 To evaluate the effect of an early mobilisation program on mobilisation 
rates in a single centre with a heterogeneous patient population.  
 To establish the prevalence and incidence of mobilisation of patients 
who also received an ETT while mechanically ventilated, RRT and / or 
vasopressor infusions. This will be looked at in a single unit to assess 
capability of change as well as the prevalence and incidence of this 
practice nationally.  
 To establish baseline levels of mobilisation for patients of different 
admission diagnoses in Australian ICUs  
 To benchmark mobilisation practices in Australia internationally with 
Scotland.  
2) Early mobilisation and discharge destination 
 To determine if there is an association between a more favourable 
outcome at the time of hospital discharge and patients who mobilise in 
ICU  
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3) Safety and feasibility of early mobilisation 
 To evaluate the influence of implementing an early mobilisation 
program on adverse events in a single centre. 
 To establish an adverse event rate for early mobilisation of patients 
receiving an ETT and mechanical ventilation, RRT and / or vasopressor 
infusions in a single centre, around Australia and internationally in 
Scotland.  
 To establish an adverse event rate for early mobilisation as a therapy for 
patients of different admission diagnoses in Australian ICUs and 
benchmark this internationally with Scottish ICUs.  
4) Barriers to early mobilisation 
 Identify barriers to early mobilisation practices for patients in Australia 
and compared these internationally with barriers identified in Scottish 
ICUs.  
3.3 Design 
The studies that constitute this thesis are described in chronological order. At the 
conclusion of each study there were questions left unanswered that led to the 
natural progression of the next study. The individual study designs are explained in 
the methods section for that study.  
3.4 Hypotheses 
Hypotheses were devised for each individual study and can be found in the 
methods section specific for that study.  
3.5 Research tools and variables collected 
3.5.1 Mobilisation Data Collection Form 
The Mobilisation Data Collection Form (MDCF) (see Figure 1) was developed for 
Study One. The MDCF collects data relating to mobilisation and changes associated 
with mobilisation. Study Two utilised aspects of the MDCF but was devised by a 
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unique group of researchers and therefore does not cover all aspects of the MDCF. 
Study Three made slight adjustments to section three of the MDCF but remained 
similar across all other sections.  
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Figure 1 Mobilisation data collection form 
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The construction of the MDCF clearly defined each variable in a data dictionary (see 
Appendix 2). This data table was then used as a reference for physiotherapists 
completing data collection. The form was trialled for seven days to establish ease of 
use and relevance. Alterations were then made accordingly.  
The MDCF was divided into three sections.  
1) Baseline information and mobilisation data 
2) Adverse events occurring during mobilisation 
3) For patients not mobilised what barriers existed 
Ventilation data were divided into three separate rows; ETT/NTT, tracheostomy and 
mechanical ventilation. This was done intentionally to clarify whether patients with 
an ETT/NTT or a tracheostomy were on mechanical ventilation whilst an artificial 
airway was in situ at the time of mobilisation.  
The activities constituting mobilisation are defined in the data dictionary 
(Appendix 2). The activities under the heading of early mobilisation were in 
accordance with the definition of early mobilisation. Mobilisation activities in the 
MDCF were: sitting (either over the edge of the bed or in a chair or rehabilitation 
chair) or weight bearing exercises involving axial loading of the spine and / or long 
bones (tilt table, standing, or walking). Passive range of movement exercises were 
considered to be part of standard care and not classified as mobilisation as they do 
not involve movement against gravity and have not shown to sufficiently contribute 
to whole body functional rehabilitation (Cook and Campbell 1979; Jadad 1998). 
One column of the MDCF was used per episode of mobilisation. If more than one 
episode of mobilisation was carried out per day then an additional column was 
completed with the same date at the top of the new column. 
The MDCF was specially formatted so completed forms were able to be scanned for 
data entry. This data was then linked with information routinely collected as part of 
the quality assurance data base of each ICU. 
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3.5.2 Quality assurance database variables 
Variables from the quality assurance database were as follows: 
 Age 
Age of all patients was recorded to ensure adequate matching of groups in 
each study 
 Sex 
Sex of all patients was recorded to ensure adequate matching of groups in 
each study 
 Admission diagnosis 
Admission diagnoses were recorded using the APACHE III diagnostic codes as 
used by ANZICS Centre for Outcome and Resource Evaluation database 
(see Appendix 3). There are 21 main groupings of diagnoses, 11 of which 
apply to non surgical admissions and 10 for surgical admissions.  
 APACHE II score 
The APACHE II (acute physiological and chronic health evaluation, version 
two) is a prognostication system used to establish the risk of hospital 
mortality for critically ill adults (Knaus, Draper et al. 1985). Patients are 
scored on disease category, acute physiological abnormalities, age, pre-
existing functional limits, major co-morbidities and treatment location prior 
to ICU (Knaus, Draper et al. 1985). The final score of between 0 and 71 then 
gives a risk estimate for hospital death. APACHE II has shown to have an 
accuracy of within 3% of the actual observed (Knaus, Draper et al. 
1985)(www.anzics.com.au). The APACHE II scoring system is widely used in 
this area of research and recognized and therefore it is a useful comparative 
tool to include in this study (Bailey, Thomsen et al. 2007; Morris, Goad et al. 
2008; Thomsen, Snow et al. 2008; Burtin, Clerckx et al. 2009; Schweickert, 
Pohlman et al. 2009; Needham and Korupolu 2010). It gives an appreciation 
of the severity of illness of patients. 
APACHE II scores can be recorded at different time points during a patients 
stay in ICU. To portray the severity of illness of patients, the worst APACHE II 
score was recorded for all patients during their ICU stay was recorded for all 
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patients in all studies in accordance with protocol (Bailey, Thomsen et al. 
2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; Burtin, Clerckx 
et al. 2009; Schweickert, Pohlman et al. 2009; Needham and Korupolu 2010). 
 Days where mechanical ventilation was present 
Mechanical ventilation was an entry criterion for Study One and Three and 
in order to ensure inclusion criteria were met and calculate capture rates; 
patients receiving mechanical ventilation were identified and cross 
referenced with all patients included in the study from quality assurance 
databases.  
 Length of stay in ICU 
Length of stay in ICU was collected for all patients in Study One and Three to 
ensure groups were appropriately matched. Length of stay in ICU was 
observed as the time from admission to the time of discharge and was 
measured in hours and converted to days for reporting. 
 Length of stay in hospital 
Length of stay in hospital was collected for all patients in Study One and 
Three. Length of stay in hospital was observed as the time of admission to 
any area of the hospital until discharge from any area of the same hospital 
and was recorded in either days or hours but reported in days only.  
 Discharge destination from hospital 
The discharge destinations recorded for ANZICS Centre for Outcomes and 
Resource Evaluation database were used for all studies. The five locations 
identified for hospital discharge are: dead, home, another acute ICU, acute 
hospital, rehabilitation / nursing home (ANZICS and CORE 2010).  
3.5.3 Questionnaire 
In conjunction with Study One and Three, a questionnaire was sent to the senior 
physiotherapist in each unit to establish what resources were available in each unit 
and what the consensus position was on mobilisation of patients with an ETT, RRT 
and / or vasopressor infusions (See Appendix 4).  
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3.6 Evaluation measures 
From the variables collected, measures were derived to assess the four focus areas 
of the thesis. Within these measures, the cohorts in each study were described as 
whole entities and then in sub groups. The sub groups were devised from APACHE 
III admission diagnostic codes and APACHE II scores in accordance with literature in 
this area (Judson and Fisher 2006). A final sub set of the population was also 
devised for Study One only. This population was ‘patients who had the opportunity 
to mobilise’.  
Categories within each of the sub groups did not overlap and were all mutually 
exclusive.  
Diagnosis (sub group 1) 
The categories in this sub group were: cardiac; respiratory; gastrointestinal; 
neurology; sepsis; orthotrauma and metabolic. The categories were based on the 
APACHE III diagnostic codes for each organ system and included both operative and 
non-operative codes in each category (see Appendix 3). This is similar to previous 
studies (Moran and Solomon 2012). The orthotrauma category is a combination of 
trauma, musculoskeletal and skin diagnostic codes and gastrointestinal category 
included genitourinary and gynaecological surgery codes.  
In the literature there is considerable discussion surrounding patients admitted with 
respiratory conditions (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; 
Thomsen, Snow et al. 2008). This diagnostic breakdown allows for the comparison 
of patients admitted with respiratory conditions with patients admitted with 
alternative organ dysfunction.  
Classification (sub group 2) 
The categories in this sub group were: medical; surgical and trauma. These 
categories were also devised from the APACHE III admission diagnostic codes. All 
non-operative diagnoses, except trauma were classified as medical; all operative 
diagnostic codes, except trauma were classified as surgical and both operative and 
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non-operative trauma and burns categories were classified under the trauma 
category.  
 Of the seven studies evaluating early mobilisation, six examined only medical 
patients (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et 
al. 2008; Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; Needham 
and Korupolu 2010). Anecdotal evidence only is available on the impact of early 
mobilisation on patients who undergo surgery. Trauma patients are often excluded 
from trials evaluating mobilisation due to the high prevalence of fractures that 
impact upon weight bearing (Bailey, Thomsen et al. 2007; Burtin, Clerckx et al. 
2009; Schweickert, Pohlman et al. 2009) and have not previously been examined as 
a cohort.  
Severity of illness (sub group 3) 
A third sub group was created to examine the effect of severity of illness on 
mobilisation. Previous studies in this field have not examined patients according to 
the severity of illness of the patient. The categories of this sub group were five point 
increments of the APACHE II score starting from 0 - 4 and including the highest 
recorded APACHE II score of the studies (45 – 49).  
Those who had the opportunity to mobilise 
In certain conditions, mobilisation is contraindicated due to the risk of harm 
outweighing the benefits. These conditions include premature labour; unstable 
spinal or pelvic fractures; patients with written medical orders to rest in bed and 
patients where death is imminent.  
In an effort to examine improvement in mobilisation rates the removal of these 
patient groups helps eliminate those who were never and should never mobilise 
and help identify those who weren’t mobilised but could have been. Identification 
of this population was only possible in Study One.  
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3.6.1 Evaluation measures for mobilisation  
Currently, there is no accepted definition of rate of mobilisation for patients in ICU. 
Therefore, mobilisation rate was measured in a number of ways to display intensity, 
duration and frequency of mobilisation amongst the cohorts.  
The number of activities was calculated as the number of discreet tasks (sitting, 
standing, tilt tabling or ambulating) performed for the patient’s length of stay. The 
activity performed is also a determinant of exercise intensity and has been 
dichotomised into weight bearing (standing, tilt tabling and ambulation) and non-
weight bearing activities (sitting over the edge of the bed or in a chair).  
An episode of mobilisation is defined as one session of mobilisation with substantial 
rest periods on either side of that session. An episode was indicated by one column 
on the MDCF. Patients may have completed more than one episode per day which 
would be indicated by more than one column of the MDCF being completed on the 
same date. The number of episodes of mobilisation is a measure of frequency. The 
numbers of activities conducted during each episode were also recorded.  
The number of minutes of mobilisation was recorded on the MDCF by the treating 
physiotherapist and is a measure of duration of exercise. Minutes of mobilisation 
was measured for each episode of mobilisation, not each activity and commenced 
when the patient began one of the mobilisation activities and ended on return to 
bed.  
The proportion of patients mobilising with an ETT and mechanical ventilation, RRT 
and / or vasopressor infusions was recorded from data points on the MDCF. These 
measures gave an indication of the safety of mobilising patients who still required 
invasive support and what intensity of exercise could be safely achieved with these 
therapies.  
3.6.2 Evaluation of early mobilisation and discharge destination 
At this time there is no valid and reliable functional outcome measure appropriate 
for use in this patient population that is sensitive enough to detect change within 
ICU length of stay (Skinner, Berney et al. 2008). In the absence of this, a surrogate 
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measure of function is hospital discharge destination. This has been used in four 
previous studies (Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; Burtin, 
Clerckx et al. 2009; Schweickert, Pohlman et al. 2009). The location of discharge 
from hospital gives a gross indication of the patient’s abilities needed in order to 
achieve that destination. Discharge destination after ICU is not being used as a 
measure because function is often considered a criterion for discharge destination 
from ICU, therefore functional level on discharge from ICU would be unlikely to vary 
significantly pre and post intervention.  
3.6.3 Evaluation measures for safety and feasibility 
The adverse events listed on the MDCF were chosen after extensive review of the 
literature (see Table 4), consultation with the multi-disciplinary team and clinical 
experience. A serious adverse event was defined in line with Bailey et al. and 
Schweickert et al.’s studies as myocardial ischaemia, fall to the knees and / or 
removal of an ETT. Adverse events were defined as: removal of a line (arterial line, 
vascular catheter, intravenous (IV) line, tracheostomy tube, nasogastric tube, drain 
or other); fall; increase in FiO2, increase or commencement of vasopressor 
infusions; return to bed unstable CNS; return to bed due to unstable CVS; return to 
bed due to unstable respiratory system and patient refusal to continue. This more 
extended list of possible adverse events was chosen by an iterative process 
involving medical, nursing and physiotherapy staff to ensure all aspects of safety 
were examined.  
Study One involved a change in practice and in accordance with the ethics board’s 
recommendations a safety committee was established prior to commencement of 
the study involving two intensive care physicians and one clinical nurse specialist. 
Any serious adverse event was reported to this committee for further evaluation. As 
Study Two and Three were observational in nature, such study specific committees 
were not required.  
3.6.4 Evaluation measures for barriers to mobilisation 
Barriers to mobilisation were recorded in the third section of the MDCF and 
definitions for each barrier are provided in the data dictionary (Appendix 2). The 
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criteria were then divided into two groups: avoidable or partially modifiable barriers 
and unavoidable barriers. These groups were centred on those described in 
previous literature (Leditschke, Green et al. 2012) with adaptation to our specific 
cohort needs.  
The barriers deemed to be avoidable or partially modifiable were: sedation; ETT in 
situ; lack of resources; craniectomy without helmet; patient refused and procedure 
required. Barriers that were thought to be unavoidable were primarily physiological 
in nature and included: CNS unstable; CVS unstable; respiration unstable; 
orthopaedic orders to rest in bed and diarrhoea.  
3.7 Statistics 
A unique patient reference number was recorded at the top of the MDCF to allow 
linking of the mobilisation data with the physiological data recorded in quality 
assurance databases. The MDCF tool was printed in a scannable form for ease of 
data entry. On completion of the study, the forms were sent for scanning and 
results collated into SPSS format. The SPSS version 21.0 for Windows (SPSS; 
Chicago, IL) was used to analyse the data. 
Statistical analysis incorporated full demographics of each of the cohorts to 
maximise the external validity of the findings. The descriptive data was reported 
using mean and standard deviation or median and inter-quartile ranges where 
applicable in cases where the data did not fit parametric models. Cohort 
comparisons on demographic data were made using unpaired comparisons and all 
tests of significance were 2-sided. Statistical significance was set at 0.05 level of 
confidence. No alpha level adjustments were made for multiple comparisons as all 
hypotheses were established apriori and the magnitude of differences are 
interpreted in the clinical context.  
The number of episodes of mobilisation and activities of mobilisation were not 
normally distributed therefore the median number of episodes and activities per 
patient was reported.  
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Patients who mobilised and carried out weight bearing activities were recorded as a 
percentage of the whole group. Patients who mobilised with ETTs, RRT, vasopressor 
infusions or mechanical ventilation were also reported in this way.  
The day a patient first mobilised was the calendar day where any activity of 
mobilisation was carried out and the day of admission to ICU was considered to be 
calendar day 1. This data was not normally distributed and therefore the median 
and inter-quartile range was reported. 
Discharge destination as an evaluation tool described the percentage of patients in 
each of the five discharge locations. This was reported for the whole group as well 
as those who mobilised and did not mobilise.  
Adverse events were reported by description of the adverse event itself; the 
number of events per episode of mobilisation as well as the number of patients that 
experienced an adverse event as a proportion of the total population in question. 
Barriers were stated as the percentage of patients affected by this barrier at any 
time in their ICU stay as well as the number of episodes the barrier was present per 
patient in that cohort.  
For group comparisons, in general, where parametric assumptions were met, tests 
were used for independent and dependent two group comparisons. For non-
parametric paired comparisons Mann Whitney U tests were used.  
Specific statistical methods are described in each study. 
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Chapter 4 Study One 
4.1 Introduction 
Prior to the commencement of this study, mobilisation activities and associated 
adverse events were not recorded at RPH ICU. Patients with ETTs, RRT and / or 
vasopressor infusions were not mobilised. Furthermore, there were no formal 
communication strategies focussing on mobilisation as a form of rehabilitation 
among the members of the multidisciplinary team. This study involved the 
development of a program of early mobilisation designed to overcome these issues 
and identify barriers to mobilisation. 
Methods 
4.2 Aim 
The aim of this study was to implement a systems change that supported safe 
increases in mobilisation rates of all intensive care patients who were mechanically 
ventilated for three or more calendar days. Systems change was defined as a multi-
disciplinary approach that aims to improve the system as a whole from one of low 
mobilisation activity to higher activity. Particular focus was placed on increasing 
mobilisation in patients with ETTs, RRT and vasopressor infusions and identify 
modifiable barriers to mobilisation.  
4.3 Design 
The study used a before and after design comparing prospective and retrospective 
cohort data sets. This research examined a change in practice, therefore a before / 
after study design was the most appropriate in this health service context.  
4.4 Hypothesis 
From the review of the related literature the following global research hypotheses 
were generated: 
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4.4.1 Primary hypothesis 
 That the introduction of an ICU wide, early mobilisation protocol will be safe 
and feasible.  
4.4.2 Secondary hypotheses  
 That the introduction of an early mobilisation ICU wide protocol will not be 
associated with an increase in adverse events 
 That the introduction of an early mobilisation ICU wide program will 
increase mobilisation rates for all patients mechanically ventilated for three 
or more calendar days 
 That the introduction of an early mobilisation ICU wide program will 
increase mobilisation rates for patients with ETTs, RRT and/or vasopressor 
infusions 
 That the introduction of an early mobilisation ICU program will increase the 
percentage of patients discharged home and a decrease in percentage of 
patients who die at the time of hospital discharge.  
 Barriers to early mobilisation will be able to be identified and divided into 
two categories: barriers that are potentially manageable and barriers that 
are unable to be overcome.  
4.5 Study setting 
4.5.1 Location 
Royal Perth Hospital is a Level III, tertiary teaching hospital and an accredited 
trauma centre with approximately 900 hospital beds of which there are 23 ICU 
beds. Royal Perth Hospital ICU accepts admissions from a range of specialty areas 
including spinal injuries, trauma, heart and lung transplantation, general surgery 
and multi-organ failure. It does not provide paediatric or long term ventilation 
services. 
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4.5.2 Workforce 
The RPH ICU is managed by specialist trained intensivists as well as senior registrars, 
registrars and resident doctors. Physiotherapist cover is provided 24 hours per day, 
7 days per week. There is a complex staffing regimen for physiotherapists in this 
unit. For the majority of daytime working hours (0800 – 1630 hours) there are two 
physiotherapists present for 22 funded beds. This includes some overlap during 
change of shift. This overlap period is shorter on weekends (30 minutes) than during 
the week (two to two and a half hours). Evening shifts during the week have two 
staff members and on weekends have one staff member present in the unit. One 
physiotherapist is present in the hospital overnight on all days of the week. 
However, physiotherapists working evening or night shift are also responsible for all 
out of hours treatments and non-invasive ventilation service calls on the wards as 
well as all patients in the ICU. Nurse staffing ratios were predominantly one nurse 
to one patient. 
4.5.3 Patient population 
This study was examining a systems change for early mobilisation and aimed to be 
as inclusive as possible. However, a large proportion of patients are admitted to ICU 
for observation only or acute management after cardiac surgery. These patients 
often follow a routine pathway and have less chance of exhibiting consequences of 
bed rest. Patients admitted to the ICU and mechanically ventilated for three or 
more calendar days make up one third of admissions at RPH ICU and are likely to 
suffer greater muscle and function loss. The early mobilisation program was applied 
to all patients admitted to the ICU, for their entire stay in ICU but study data was 
recorded only for those patients admitted for three or more calendar days. 
Length of stay for ICU and hospital, age, sex, severity of illness and admission 
diagnosis were recorded for all patients as an assurance measure that the cohorts 
were matched. All of these measures are routinely recorded for the RPH ICU quality 
assurance database. 
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4.6 Study criteria 
4.6.1 Inclusion Criteria 
Patients aged 18 years and older admitted to RPH ICU and who received mechanical 
ventilation on three or more calendar days were included in the study.  
4.6.2 Exclusion Criteria 
The study aimed to evaluate a change in practice within RPH ICU therefore there 
were no specific exclusion criteria.  
4.6.3 Withdrawal Criteria  
Patients who were readmitted to the ICU during their hospital journey were 
withdrawn from analysis of results due to difficulty in statistical management of this 
event. 
In the event of a major trauma episode such as a bombing or chemical disaster, 
interruption of data collection would occur as these events fall outside the normal 
characteristics of the referral pattern relative to the retrospective cohort.  
4.7 Sample size expectations 
As this study was an analysis of a systems change, formal power calculations were 
not conducted. A 12 month period was chosen to examine influences of seasonal 
variation. Approximation of study numbers was based on RPH ICU 2007 admission 
rates. There were 1542 admissions in the 12 month period, of which less than one 
third were mechanically ventilated for three or more calendar days (<500). Aiming 
for a conservative 85% capture rate, the expected sample for the prospective phase 
of the study was approximately 425 patients prior to analysis.  
4.8 Outcome measures  
All definitions for outcome measures and their respective derived variables are as 
previously described in Chapter 3.  
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4.8.1 Safety 
Safety of the intervention was determined by adverse event rates as described in 
Chapter 3.6.3. Adverse events will be reported for all patients and all sub groups 
listed in 3.6. 
4.8.2 Mobilisation  
Mobilisation details were derived from data recorded using the MDCF. Mobilisation 
derived variables are listed in item 3.6.1. Mobilisation rates are reported for all 
patients and all sub groups as listed in clause 3.6. 
4.8.3 Function 
As described in section 3.6.2, discharge destination at time of hospital discharge 
were used as a surrogate measure for functional outcome. This measure was 
recorded for all patients and all sub groups listed in section 3.6 
4.8.4 Barriers to mobilisation 
Perceived barriers to mobilisation were recorded on the MDCF and were reported 
on for the following: 
 Barriers for 
 All patients 
 Patients who never mobilised 
4.9 Research Process 
4.9.1 Phase 1 - Retrospective  
Retrospective data was obtained from the RPH ICU QA database to establish an 
historical control. Patients included in the retrospective analysis were those 
meeting inclusion criteria of the study admitted in the 12 months prior to the 
current practice audit.  
4.9.2 Phase 2 - Current practice audit 
Mobilisation practices and associated physiological responses and adverse events 
were not recorded prior to this study at RPH ICU. To establish baseline practice, a 
10 week ‘current practice’ audit was conducted using the MDCF for all patients 
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meeting study inclusion criteria. This data was combined with interventional and 
physiological data from the RPH QA database. 
4.9.3 Phase 3 - Implementation  
Following a 10 week period of auditing there was a two week education block. 
Medical, nursing and physiotherapy staff all received presentations during their 
allocated education timeslots. For nursing staff this included morning and evening 
shifts both weekdays and weekends. An opportunity for discussion of concerns was 
provided with senior physiotherapists, senior nursing staff and senior medical staff 
in attendance to show support for the study and to answer queries.  
A multidisciplinary approach was the basis of the programme of early mobilisation. 
It was agreed to by all disciplines that mobility was to be a priority in patient’s daily 
schedules where appropriate. Communication opportunities were increased to help 
with coordination of all professions in achieving this goal. Prior to medical handover 
the Senior Physiotherapist and the Clinical Nurse Specialist met at each patient’s 
bedside to co-ordinate mobility events for that day. This was then followed by the 
medical handover where the Senior Physiotherapist or CNS discussed any patients 
who met the predetermined criteria requiring discussion with the medical team.  
Predetermined criteria for discussion were: 1) patients with an endotracheal tube in 
situ; 2) patients with vasopressor infusion(s) running at greater than 5mL/hour; 3) 
patients with an extra ventricular drain in situ. 
As well as allowing patients with ETTs, RRT and vasoactive infusions to mobilise, 
other strategies to improve mobilisation at RPH involved early communication with 
medical teams to identify accurate mobilisation restrictions and early ordering of 
helmets for patients who had undergone a craniectomy to minimise the risk of this 
being a barrier to mobilisation.  
All patients meeting study inclusion criteria had a mobility planner (see Figure 2) to 
help communicate daily and weekly goals to all team members, assist with 
motivation of the patient and assist in establishing a day/night routine.  
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Non-urgent procedures were encouraged to be worked around mobility wherever 
possible. If staff shortage or skill shortage was experienced, there was commitment 
from senior staff of all members of the MDT to assist with mobilisation as a priority.  
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Figure 2 Daily planner 
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4.10 Statistical Analysis  
Baseline statistical analyses used for this study were outlined in Chapter 3. 
Measures pertaining to demographic data involved comparison of Phase 1, 2 and 3. 
Measures pertaining to mobilisation in this study involved comparison of Phase 2 
and Phase 3.  
In addition to demographic analysis, length of stay in ICU and hospital were 
analysed using log transformation of the data and ANCOVA statistics. Covariates 
were age, sex and APACHE II scores.  
The student’s t-test was used for pair wise comparison of parametric data. 
Proportional data was analysed using Fisher’s exact test. Data pertaining to 
activities, episodes and minutes of mobilisation were all non-parametric in 
distribution and were analysed using Mann Whitney U test.  
4.11 Ethical Considerations 
Mobilisation of patients admitted to RPH ICU who required an ETT, RRT and / or 
vasopressor infusions had not been practiced prior to this study. In order for the 
culture of the unit to change and allow these practices, discussions were conducted 
at a variety of levels of management. Physiotherapists at RPH with an interest in 
this area were involved in a round table discussion about familiarity with these 
practices and experience of conducting these practices in other hospitals. A 
literature search was conducted to gain evidence of adverse event rates associated 
with these practices. This combined information formed a proposed set of 
guidelines for practice at RPH ICU. This proposal was taken to the medical 
consultant meeting for evaluation. The medical consultants discussed all points in 
detail and the issues of governance and communication were deliberated. An 
iterative process was undertaken until consensus was obtained by all members. The 
new practices were thought to be in accordance with best practice and there was 
unanimous support that the ethics application request a waiver of consent.  
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On approval of all components of the guidelines, ethics approval was sought and 
approved with reciprocal approval from Curtin University Human Research Ethics 
Committee (HREC 2008/099).  
Results 
4.12 Baseline results  
Phase 1 data was obtained retrospectively from the RPH ICU QA database. 
Demographic data from 500 consecutive patients meeting inclusion criteria prior to 
the current practice audit were obtained. The dates of admission of these patients 
were from 17/6/2007 to 30/7/2008. Phase 2 of the study ran from 4/8/2008 to 
12/10/2008. There were 270 admissions to RPH ICU during this time and 113 met 
inclusion criteria. Of these patients, mobility data were collected on 102 patients 
(90.3% captured).  
Phase 3 ran from 27/10/2008 to 1/10/2009. During this time there were 
1403 admissions of which 481 met inclusion criteria. Final mobility data was 
collected on 412 patients equating to an 85.7% capture rate (see Figure 3). 
Demographic data were obtained for all patients who met inclusion criteria 
regardless of whether mobility data was captured.  
During the study there were no major state or national disasters resulting in an 
alteration of normal referral patterns to RPH ICU and as such there were no 
interruptions in the data collection periods.  
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Figure 3 Recruitment process for Phase 3 of RPH study 
Total admissions to RPH ICU 
during study admission period 
= 1403  
 
Patients with single 
admissions to ICU only 
= 1207 
Patients greater than 18 years 
of age  
= 1182 
Patients who stayed 3 or more 
calendar days  
= 736 
Patients mechanically 
ventilated for 3 or more days 
= 481 
Patients recruited into study 
= 412 
196 excluded due to 
readmission 
25 patients excluded 
due to being less than 
18 years of age 
446 patients excluded 
due to LOS less than 3 
calendar days 
255 patients excluded 
due to mechanical 
ventilation less than 3 
calendar days 
69 patients missed 
from recruitment due 
to: 
 Miscalculated LOS 
 Recruitment 
occurring on 
weekend and not 
detected 
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4.12.1 Baseline results - setting 
Summary statistics for RPH ICU across all phases of the study are presented in 
Table 5.  
Table 5 Descriptive statistics for Phase 1, 2 and 3 of RPH study 
Royal Perth Hospital Phase 1&2 Phase 3 
Level III ICU beds 23 23 
Specialties included in unit 
- Cardiothoracic surgery 
- Neurosurgery 
- Trauma 
- Spinal 
- Transplantation 
 
 
 
 
 
 
 
 
 
 
 
 
PT attend medical handover   
Culture 
- Mobilisation with ETT 
- Mobilisation with RRT 
- Mobilisation with vasopressors 
 
X 
X 
X 
 
 
 
 
Equipment in unit 
- High back chair 
- Rocker recliner 
- Rehabilitation chair 
- Tilt table 
- Standing lifter 
 
5 
3 
4 
1 
0 
 
5 
3 
4 
1 
0 
X = not part of workforce practice.  = considered in current practice. 
4.12.2 Baseline results – workforce 
Physiotherapy staffing remained consistent during all phases of the study. On 
average across the week, physiotherapist to ICU bed ratio was 1:4.6. There was a 
one hour per week increase (from 10 to 11 hours) in physiotherapy assistant 
staffing which commenced midway through Phase 3 of the study. This was not 
thought to have impacted heavily upon results. Medical and nursing staff ratios 
remained the same throughout.  
4.12.3 Baseline results – patients 
Baseline summary demographic statistics for patients in all three phases of the 
study are outlined in Table 6. As this study examined a systems change, data for all 
patients who met inclusion criteria was analysed, not just those for whom mobility 
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data was recorded. No differences were seen in length of stay after adjustment for 
age, sex and APACHE II scores. 
Of note, the patients in Phase 3 have a higher severity of illness (as assessed by 
APACHE II) than both Phase 1 and Phase 2 (see Table 6). The difference in severity 
of illness between phases was investigated in an attempt to discover any alterations 
in admission patterns or state wide changes to health delivery. No such explanation 
was identified. 
Table 6 Summary demographic statistics for all patients meeting inclusion 
criteria in Phase 1, 2 and 3 
 Phase 1 Phase 2 Phase 3 p-value 
N of pts 500 113 481  
Age (mean) 50.56 (SD 
19.46) 
48.78 (SD 
18.14) 
51.43 
(SD19.42) 
>.187# 
Sex (% Male) 65.8% 66.4% 64.9% >.754#† 
APACHE II 
(mean) 
21.66 (SD 7.76) 20.37 (SD 8.02) 23.83 (SD 
7.98) 
Phase 1&2 = 
.858 
Phase 1&3; 2&3 
<.001 
LOS – ICU 
(median) 
6.08 (3.92 to 
10.61) 
6.00 (4.06 to 
10.46) 
6.79 (3.96 to 
12.65) 
>.106# 
LOS – 
hospital 
(median) 
18.92 10.88 to 
33.96 
20.83 (9.90 to 
37.79) 
22.58 (10.89 
to 39.59) 
>..107# 
#
pair wise comparison, independent t-tests 
LOS ICU and LOS Hospital analysis was done with log transformation and ANCOVA. Covariates were: 
age, sex, APACHE II. 
 
Baseline statistics for patients who had the opportunity to mobilise are shown in 
Table 7. 
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Table 7 Summary demographic statistics for patients who had the opportunity 
to mobilise 
 Phase 2 Phase 3 p-value 
N of pts 79 293  
Age (mean) 48.75 (SD16.84) 52.69 (SD 18.78) .092 
Sex (% Male) 60.8 60.4 .995
§
 
APACHE II – mean 19.70 (SD 7.90) 23.79 (SD 7.71) <.001 
LOS – ICU (median) 6.25 (4.67 to 10.58) 7.50 (4.83 to 12.44) .332 
LOS – hospital (median) 20.38 (11.12 to 37.5) 23.08 (13.02 to 42.33) .446 
LOS ICU and LOS Hospital analysis was done with log transformation and ANCOVA. Covariates were: 
age, sex, APACHE II. 
§
 Chi square test 
4.12.3.1 Baseline results – patient sub groups 
As described in section 3.6 of the methods, patients were divided into three 
different sub groups for diagnosis. Figures 4, 5 and 6 shows the breakdowns of 
these sub groups for all patients who met study inclusion criteria. In general, the 
subgroups of the three phases were relatively stable with the dominance of medical 
(orthotrauma and respiratory) diagnoses. 
 
Figure 4 Diagnosis (sub group 1) - breakdown of all patients meeting inclusion 
criteria in Phase 1, 2 and 3 
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Figure 5 Classification (sub group 2) - breakdown of all patients meeting 
inclusion criteria in Phase 1, 2 and 3  
 
Figure 6 Severity of illness (sub group 3) – APACHE II category breakdown for all 
patients meeting inclusion criteria in Phase 1, 2 and 3  
 
The breakdowns of each subcategory for patients who had the opportunity to 
mobilise are displayed in Figures 7, 8 and 9. For patients who had the opportunity 
to mobilise, no statistical difference was found between the proportion of each 
diagnostic specific category in Phase 2 and Phase 3 (see Appendix 5). 
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Figure 7 Diagnosis (sub group 1) - breakdown of patients who had the 
opportunity to mobilise in Phase 2 and 3 
 
Figure 8 Classification (sub group 2) - breakdown of patients who had the 
opportunity to mobilise in Phase 2 and 3 
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Figure 9 Severity of illness (sub group 3) – APACHE II category breakdown for 
patients who had the opportunity to mobilise in Phase 2 and 3 
 
4.13 Mobilisation rates 
Mobilisation rates were not recorded prior to study commencement. Therefore 
results presented are for both prospective Phases (2 and 3) of the study. 
4.13.1 Overall 
Measures of mobilisation for all patients recruited in Phase 2 and 3 are listed in 
Table 8. After implementation of the early mobilisation protocol, the percentage of 
patients mobilised rose significantly (p=.047). The increase in proportion of patients 
mobilised was not at the expense of the number of activities or episodes of 
mobilisation per patient which did not differ significantly between phases (p=.790 
and p=.483 respectively).  
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Table 8 Mobilisation rates for all patients recruited into Phase 2 and 3 
 Phase 2  Phase 3  p value 
% of patients who mobilised 53.9  64.6  .047*  
^N of activities per pt 1 (0 to 5)  2 (0 to 5) .246 
^N of activities per pt mobilised 4(2 to 8.75) 4 (2 to 8) .790 
^N of episodes per pt  1 (0 to 3) 1 (0 to 3) .076 
^N of episodes per pt mobilised  2.5 (1 to 4.75) 2 (1 to 6) .483 
% patients who wt bear  34.31  36.89  .648 
^Mins spent mobilising per pt 315 (75 to 815) 352.5 (150 to 813.8) .432 
% of total activities on MV 48.9 49.3 1.00 
Fisher’s exact test was used in the comparison of percentages 
Mann Whitney U test was used in the comparison of activities, episodes and minutes 
*statistically significant ^median (IQR) recorded for this statistic 
Mobilisation rates for patients who had the opportunity to mobilise are displayed in 
Table 9. The overall percentage of patients mobilised rose significantly (p=.002) as 
did the number of episodes of mobilisation per patient (p=.017). No other variables 
were found to have a systematic statistically significance difference however there 
was a trend towards increased number of activities, percentage of patients’ weight 
bearing and minutes of mobilisation in Phase 3.  
Table 9 Mobilisation rates for those who had the opportunity to mobilise in 
Phase 2 and 3 of RPH study 
 Phase 2  Phase 3  p value 
N of pts 79 293  
% of patients who mobilised 63.3  79.9  .002* 
^N of activities per pt 2 (0 to 5) 3 (1 to 7) .072 
^N of activities per pt mobilised 5 (2 to 9) 4 (2 to 8) .734 
^N of episodes per pt  1 (1 to 3) 2 (1 to 5) .017* 
^N of episodes per pt mobilised 2 (1 to 5) 2 (1 to 6) .666 
% patients who wt bear  41.77  47.78  .375 
^Mins spent mobilising per pt 322.5 (80.25 – 
873.75) 
365 (173.75 – 
781.50) 
.191 
*statistically significant; ^median (IQR) recorded for this analysis 
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From this point onwards, analysis of mobilisation rates were calculated only on 
patients who had the opportunity to mobilise unless otherwise stated. 
4.13.1.1 Overall mobilisation rates in the presence of ETT, RRT and 
vasopressors 
All patients who were recorded as mobilising with an ETT were, at the same time, 
receiving mechanical ventilation. For patients who received ETTs and vasopressors, 
there was a noticeable increase in mobilisation rates (p<0.001; p=0.003 
respectively). Mobilisation of patients receiving RRT increased between phases but 
did not reach statistical significance (p=.185) in the presence of very low numbers 
(see Figure 10).  
The number of episodes of mobilisation showed a corresponding increase (Fisher’s 
exact test) for ETTs (p<0.001) and vasopressors (p<0.001). Episodes of mobilisation 
with RRT increased but again only approached statistical significance (p=0.055) (see 
Figure 11). 
Figure 10 Percentage of patients mobilised with ETT, RRT and vasopressors in 
situ during Phase 2 and 3 
Note: the minimal data seen for Phase 2 reflects that the work practices of mobilising with ETTs, RRT 
and vasopressor infusions was new. 
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Figure 11  Percentage of episodes carried out with ETT, RRT and/or vasopressors 
in situ during Phase 2 and 3 
 
Error bars represent standard error for each variable 
Note: the minimal data seen for Phase 2 reflects that the work practices of mobilising with ETTs, RRT 
and vasopressor infusions was new. 
4.13.1.2 Day first mobilised 
For patients admitted to RPH ICU for 3 or more calendar days and who had the 
opportunity to mobilise, the median time till first mobilisation was 5.1 days in 
Phase 2 and 4.9 days in Phase 3 (p=.413).  
4.13.2 Sub group analysis  
Using the three sub groupings described in 3.6 of the methods, mobilisation rates 
were compared across diagnoses.  
4.13.2.1 Sub group analysis – diagnosis (sub group 1) 
The comparison of diagnostic specific categories in the first sub group showed an 
increase in the percentage of patients mobilised in the orthotrauma category 
(p=.001). No other category showed statistically significant improvements despite 
an overall increase in percentage of patients mobilised in Phase 3 of the RPH study 
(see Appendix 6). 
Numbers of activities, episodes, minutes, weight bearing activities and activities on 
mechanical ventilation per patient were not significantly different between 
categories in this breakdown (see Appendix 7). 
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As previously stated, overall increases were seen in patients mobilising with ETTs 
and vasopressors. Diagnostic sub groups that also showed increases in number of 
episodes of mobilisation with an ETT were respiratory, gastrointestinal and sepsis 
and for episodes of mobilisation with vasopressor infusions, the respiratory sub 
group increased statistically (see Tables 10 and 11). No change was observed in sub 
groups for episodes of mobilisation with RRT (see Table 12).  
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Table 10 Diagnosis (sub group 1): number of episodes of mobilisation with an 
ETT present for each category  
 Phase 2 
Episodes of mob with ETT 
/episodes ETT present 
Phase 3 
Episodes of mob with ETT 
/episodes ETT present 
p 
value 
Cardiac 0/37 8/190 .360 
Respiratory 1/74 38/368 .011* 
Gastrointestinal 0/55 19/135 .002* 
Neurology 0/15 6/104 1.00 
Sepsis 0/42 15/140 .024* 
Orthotrauma 0/65 7/236 .353 
Metabolic 0/2 1/33 1.00 
Total 1/290 97/1211 <.001 
Analysis using Fisher’s exact test 
 
Table 11 Diagnosis (sub group 1): number of episodes of mobilisation with 
vasopressor infusion present within each category  
 
Phase 2 
Episodes of mob / episodes 
vasopressors present 
Phase 3 
Episodes of mob / episodes 
vasopressors present 
p 
value 
Cardiac 0/22 16/139 .131 
Respiratory 0/38 17/176 .047* 
Gastrointestinal 0/36 6/81 .175 
Neurology 0/4 0/19 1.00 
Sepsis 0/14 10/82 .349 
Orthotrauma 0/20 7/133 .595 
Metabolic 0/1 0/18 1.00 
Total 0/135 56/648 <.001 
Analysis using Fisher’s exact test 
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Table 12 Diagnosis (sub group 1): number of episodes of mobilisation where 
RRT was present within each category  
 Phase 2 
Episodes of mob / episodes 
where RRT present 
Phase 3 
Episodes of mob / episodes 
where RRT present 
p 
value 
Cardiac 0/5 1/18 1.00 
Respiratory 0/1 16/58 1.00 
Gastrointestinal 0/11 6/29 .162 
Neurology 0/0 1/2 1.00 
Sepsis 0/9 0/25 1.000 
Orthotrauma 0/0 2/46 1.000 
Metabolic 0/0 0/5 1.000 
Total 0/26 26/183 .051 
Analysis using Fishers exact test 
4.13.2.2  Sub group analysis – classification (sub group 2) 
The percentage of patients who mobilised rose significantly in the surgical (p=.048) 
and trauma (p=.001) categories of this sub group. No difference was seen in the 
medical category (p=.342). The average number of minutes of mobilisation per 
patient increased in the trauma sub group (p=.015). All other results for activities, 
episodes, activities of weight bearing and mobilisation with mechanical ventilation 
were not significantly different between Phase 2 and Phase 3 for these diagnostic 
specific categories (see Appendix 8).  
The percentage of patients who mobilised with ETTs and vasopressors increased in 
the medical and surgical categories but not in the trauma category. The low 
numbers of patients receiving RRT explains how the larger change in percentage 
seen in Figure 12 does not achieve statistical significance. Only data for Phase 3 is 
shown graphically in Figure 12. Phase 2 data is not presented as only one patient 
mobilised with an ETT in the medical diagnostic group. No other episodes of 
mobilisation with ETTs, RRT or vasopressor infusions were recorded during Phase 2. 
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Figure 12 Classification (sub group 2): percentage of patients mobilised with an 
ETT, RRT or vasopressors within each category of Phase 3 
 
     Statistically significant increase occurred in this diagnostic specific category when compared with 
Phase 2 
Medical and surgical patients saw increases in episodes of mobilisation with ETTs 
(see Table 13) and with vasopressor infusions (see Table 14). No change was 
detected for the number of episodes of mobilisation with RRT in any category (See 
Tables 13, 14 and 15).  
Table 13 Classification (sub group 2): number of episodes of mobilisation with 
an ETT present for each category  
 Phase 2 
Episodes of mob with 
ETT /episodes ETT 
present 
Phase 3 
Episodes of mob with 
ETT /episodes ETT 
present 
p value 
Medical 1/159 70/722 <.001* 
Surgical 0/72 22/282 .011* 
Trauma 0/59 5/207 .590 
Total 1/290 97/1211 <.001* 
Analysis using Fisher’s exact test 
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Table 14 Classification (sub group 2): number of episodes of mobilisation with 
vasopressor infusion present within each category 
 Phase 2 
Episodes of mob / 
episodes vasopressors 
present 
Phase 3 
Episodes of mob / 
episodes vasopressors 
present 
p value 
Medical 0/64 34/356 .005* 
Surgical 0/54 17/175 .015* 
Trauma 0/17 5/117 1.00 
Total 0/135 56/648 <.001* 
Analysis using Fisher’s exact test 
Table 15 Classification (sub group 2): number of episodes of mobilisation where 
RRT was present within each category 
 Phase 2 
Episodes of mob / 
episodes where RRT 
present 
Phase 3 
Episodes of mob / 
episodes where RRT 
present 
p value 
Medical 0/16 17/94 .126 
Surgical 0/10 7/51 .587 
Trauma 0/0 2/38 1.00 
Total 0/26 26/183 .051 
Analysis using Fisher’s exact test 
4.13.2.3 Sub group analysis – severity of illness (sub group 3) 
Results for activities, episodes, and minutes of mobilisation, weight bearing 
activities and activities of mobilisation on mechanical ventilation within each 
APACHE II grouping were all non-significant. Graphing of the percentage of each 
group mobilised as well as the number of activities, episodes and minutes of 
mobilisation are shown in Figures 13 to 16. These figures show a trend towards 
increased mobilisation in each of the APACHE groupings. The p-values for each 
APACHE II grouping in each variable can be found in Appendix 9. Statistical 
comparison of APACHE II groups is difficult due to low numbers in each grouping.  
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Figure 13 Percentage of each APACHE II grouping that was mobilised in Phase 2 
and Phase 3 
 
Figure 14 Number of activities carried out per patient mobilised in each 
APACHE II group during Phase 2 and Phase 3 
 
Note: Error bars represent the standard error for each variable 
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Figure 15 Number of episodes of mobilisation per patient mobilised in each 
APACHE II group during Phase 2 and Phase 3 
 
Note: Error bars represent the standard error for each variable 
Figure 16 Number of minutes of mobilisation per patient mobilised in each 
APACHE II group during Phase 2 and Phase 3 
 
Note: Error bars represent the standard error for each variable 
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There was a significant increase in patients mobilising with an ETT in APACHE 
groups 15-19 (p=.014) and 20-24 (p=.049) during Phase 3 of the study. No other 
significant results were found when examining patients treated with RRT or 
vasopressors (see Appendix 10). While statistical significance was not achieved, 
clinically there was an increase in occurrence of these practices. Figure 17 shows 
the percentage of episodes of mobilisation carried out in the presence of an ETT, 
RRT or vasopressors. Phase 2 data is not shown in this graph as only one episode of 
mobilisation with an ETT occurred during this phase of the study. This patient was in 
the APACHE II group 20-24. No mobilisation with RRT or vasopressor infusions 
occurred during Phase 2. 
Figure 17 The percentage of episodes of mobilisation within each APACHE II 
category carried out with ETT, RRT and vasopressors in situ in Phase 3 
 
4.14 Change in practice 
Figure 18 relates to workforce activity. It shows the percentage of the whole 
mobilised population that is in each APACHE II grouping for Phase 2 and Phase 3. 
There is a clear shift to the right indicating patients who were more severely ill were 
more likely to be mobilised after introduction of the protocol.  
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Figure 18 The percentage of the whole population mobilised during Phase 2 and 
Phase 3 
 
After implementation of the early mobilisation protocol, mobilisation rates 
increased (p=.002) for those who had the opportunity to mobilise. Using odds ratio, 
it was calculated that patients were OR 3.0 (95% CI: 1.7 to 5.3) times more likely to 
mobilise in Phase 3. The increase in number of patients mobilised did not come at 
the expense of the number of activities or episodes of mobilisation per patient did 
not change systematically between phases (p=.734; p=.666).  
Mobilisation within diagnostic specific categories showed a significant increase in 
the orthotrauma category only. The lack of significance in all other categories in the 
presence of an overall increase in mobilisation is suggestive of an across the board 
improvement rather than individual category focus.  
Mobilisation practices were graphed in monthly increments to examine levels of 
variability across a 12 month period. Figure 19 shows the percentage of patients 
mobilised in Phase 2 and Phase 3 each month. The decrease in percentage of 
patients mobilised during March coincides with an increased number of patients 
admitted with neurological trauma injuries.  
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The target areas for change in practice were patients with ETTs, RRT and 
vasopressor infusions. This change in practice was successful with overall increases 
in mobilisation in the presence of these therapies (see Figure 10 and Figure 11) 
Figure 19 Percentage of patients mobilised per month who had the opportunity 
to mobilise with corresponding median APACHE II score during Phase 2 
and Phase 3 
 
4.15 Discharge destination 
Discharge destination was chosen as a surrogate measure to examine function. 
Figure 20 shows the hospital discharge location for all patients in Phase 2 and 
Phase 3. There was a slight increase in the number of patients who were discharged 
home in Phase 3 but this was not statistically significant.  
Figure 21 outlines hospital discharge locations for patients who did and did not 
mobilise in Phase 2 and Phase 3. Patients who were mobilised in both Phase 2 and 
Phase 3 were more likely to go home than patients who did not mobilise. 
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Figure 20 Discharge destinations of patients in Phase 2 and Phase 3 
 
Figure 21 Discharge destinations of patients in Phase 2 and Phase 3 who did and 
did not mobilise 
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4.16 Safety 
Adverse events related to mobilisation were not recorded prior to this study 
therefore only prospective data from Phase 2 and Phase 3 is presented in this 
section.  
4.16.1 Overall safety 
There were no serious adverse events during this study. Three adverse events were 
recorded in Phase 2 and 15 in Phase 3; one of which required an increase in 
inotrope dose from the bedside nurse. This patient did not need to return to bed 
and remained in the chair. It was the opinion of the treating teams that no adverse 
event resulted in an increase in the patient’s length of stay. The natures of all 
adverse events are listed in Table 16. 
Table 16 Description of adverse events for patients in Phase 2 and Phase 3 
Adverse event Phase 2  
n (% of total) 
Phase 3  
n (% of total) 
IV line removed 1 (33.3) 1 (6.7) 
Withdrawal of participation 2 (66.7) 5 (33.3) 
NGT removed  1 (6.7) 
CNS unstable  2 (13.3) 
CVS unstable  5 (33.3) 
Increase dose of inotropes  1 (6.67) 
Total 3 (100) 15 (100) 
Note: Values in brackets are the percentage of the total adverse events in that phase of the study.  
 
Adverse event rates are expressed as a percentage of the total number of episodes 
conducted. The number of patients who experienced these events was also 
recorded in alignment with previous studies definitions and recording 
formats.(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et 
al. 2008; Schweickert, Pohlman et al. 2009) For this study, the adverse event rate is 
1.3% (3 out of 226 episodes in 3 patients) for Phase 2 and 1.1% (15 out of 1318 
activities in 13 patients) for Phase 3 (p=1.000). 
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Of interest, 60% of adverse events in Phase 3 occurred greater than one week after 
admission to ICU.  
4.16.2 Safety within each sub group 
The patients who experienced adverse events had a variety of diagnoses and 
classifications (see Table 17 and 18). Numbers were low throughout all sub groups 
resulting in descriptive reporting of the data. Patients with sepsis and trauma 
diagnoses in Phase 2 had the highest adverse event rates.  
Adverse events for all APACHE II groupings are listed in Table 19. Patients in the 
APACHE grouping of 30-34 had the highest rate of adverse events during Phase 3. 
The natures of these events were: three episodes of CVS instability; three 
withdrawals of participation by the patient and one removal of an IV line. 
Table 17 Diagnosis (sub group 1): patients who experienced an adverse event in 
Phase 2 and Phase 3 
Diagnostic 
specific 
category 
Phase 2 Phase 3 
N of 
pts  
N of 
episodes 
Rate -  
AE/total 
episodes (%) 
N of 
pts  
N of 
episodes 
Rate - 
AE/total 
episodes 
(%) 
Cardiac    3 3 1.9 
Respiratory 1 1 1.2 4 5 1.0 
Gastrointestin
al 
   2 2 1.3 
Neurology    2 2 3.2 
Sepsis 1 1 5.9 2 3 2.3 
Orthotrauma 1 1 4.0    
Metabolic       
Total 3 3 1.3 13 15 1.1 
AE = adverse event 
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Table 18 Classification (sub group 2): patients who experienced an adverse 
event in Phase 2 and Phase 3 
Diagnostic 
specific 
category 
Phase 2 Phase 3 
N of 
pts  
N of 
episodes 
Rate -  
AE/total 
episodes (%) 
N of 
pts  
N of 
episodes 
Rate - 
AE/total 
episodes 
(%) 
Medical 2 2 1.4 11 12 1.5 
Surgical    2 3 0.9 
Trauma 1 1 5.0    
Total 3 3 1.3 13 15 1.1 
AE = adverse event 
Table 19 Severity of illness (sub group 3): adverse events within each APACHE 
grouping for Phase 2 and Phase 3 
APACHE 
group 
Phase 2 Phase 3 
N of 
pts  
N of 
episodes 
Rate 
AE/episode 
(%) 
N of 
pts  
N of 
episodes 
Rate 
AE/episode 
(%) 
15-19 2 2 2.9 2 2 1.0 
20-24 1 1 2.4 2  2 0.6 
25-29 0   3 3 0.8 
30-34 0   5 7 3.3 
35-39 0   0   
40-44 0   1 1 3.8 
Total 3 3 1.3 13 15 1.1 
 
4.16.3 Safety of patients receiving ETT, RRT and / or vasopressors 
The focus areas of change during this study were mobilisation of patients with ETTs, 
RRT and / or vasopressor infusions. Patients in Phase 2 did not mobilise with these 
three therapies on a routine basis and there were no adverse events related to 
these therapies during Phase 2. There were 3 recorded adverse events in Phase 3. 
Two were due to cardiovascular instability during RRT and one was withdrawal of 
patient participation whilst an ETT was in situ.  
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4.17 Barriers to mobilisation 
Table 20 outlines the individual barriers that were identified. The barriers that 
significantly decreased were: sedation; lack of resources; ETT in situ and 
craniectomy with no helmet. The barriers that had an increased incidence was 
procedures (p=.007) and respiratory instability (p=.024). The barriers that remained 
unchanged were physiological in nature.  
Table 20 Number of patients and number of episodes of mobilization where 
barriers to mobilisation were present for all patients during Phase 2 
and Phase 3 
Barrier Phase 2 Phase 3 p-value   
 (for Total N 
of barriers/ 
pts) 
No of pts 
(%) 
Total N of 
barriers/pt 
No of pts (%) Total N of 
barriers/pt 
Sedation 91 (89.2) 3.7 327 (79.4) 3.3 0.023* 
ETT in situ 92 (90.2) 3.6 11 (2.7) 0.1 <.001* 
Lack of 
resources 
20 (19.6) 
0.5 
48 (11.6) 
0.2 
0.049* 
Craniectomy  6 (5.9) 0.3 6 (1.5) 0.0 0.017* 
Procedures 29 (28.4) 0.4 177 (43.0) 0.7 0.007* 
Respiratory 
unstable 
18 (17.7) 
0.5 
118 (28.6) 
1.0 
0.024* 
CVS unstable 62 (60.8) 2.1 214 (51.9) 1.9 0.121 
Orthopaedic 
orders 
15 (14.7) 
0.7 
89 (21.6) 
1.8 
0.132 
CNS unstable 31 (30.4) 1.2 156 (37.9) 1.5 0.170 
Decline 7 (6.9) 0.2 16 (3.9) 0.1 0.446 
Diarrhoea 5 (4.9) 0.1 23 (5.6) 0.1 1.000 
Total 102 (100) 13.2 412(100) 10.7  
*statistically significant result using Mann Whitney U test 
The most common barriers recorded for all patients in Phase 2 were: ETT in situ, 
sedation and CVS instability. The top five barriers affecting patients after 
implementation of a mobility protocol were: sedation, CVS instability, procedures, 
CNS instability and respiratory instability (see Figure 22).  
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The number of barriers to mobilisation per patient overall decreased from 13.23 in 
Phase 2 to 10.67 in Phase 3 (p=.023). Individual barriers per patient are displayed in 
Figure 23. 
Figure 22 The percentage of patients in Phase 2 and Phase 3 who experienced 
each barrier at any stage during their ICU admission 
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Figure 23 The number of barriers per patient that were present during Phase 2 
and Phase 3 
 
Note: Error bars represent standard error for each variable 
For patients that never mobilised the number of barriers per patient did not differ 
between Phase 2 and 3 (p=0.307). The barriers ETT in situ and craniectomy without 
a helmet were reduced in Phase 3 (p<.001 and p=.013). All other barriers remained 
similar between (see Table 21). 
The top three barriers for patients who never mobilised during Phase 2 were the 
same as those for all patients: ETT in situ, sedation and CVS instability. For Phase 3, 
barriers for patients who never mobilised differed slightly and were: sedation, CVS 
instability and CNS instability (see Figure 22). 
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Table 21 Barriers for patients that never mobilised during Phase 2 and Phase 3 
Barrier Phase 2 Phase 3 p-value (for 
N of pts N of pts 
(%) 
Total N of 
barriers / pt 
N of pts 
(%) 
Total N of 
barriers / pt 
Sedation 43 (91.5) 3.19 117 (80.1) 3.01 0.079 
ETT in situ 44 (93.6) 3.26 5 (3.4) 0.06 <.001* 
Lack of 
resources 
6 (12.8) 0.34 8 (5.5) 0.09 0.110 
Craniectomy  4 (8.5) 0.45 1 (0.7) 0.01 0.013* 
Procedures 12 (25.5) 0.30 45 (30.8) 0.47 0.347 
Respiratory 
unstable 
4 (8.5) 0.38 29 (19.9) 0.72 0.079 
CVS unstable 28 (59.6) 1.83 73 (50.0) 1.57 0.314 
Orthopaedic 
orders 
10 (21.3) 0.98 54 (37.0) 3.73 0.051 
CNS unstable 16 (34.0) 1.43 73 (50.0) 2.03 0.065 
Decline 0 (0.0) 0.00 2 (1.4) 0.01 1.000 
Diarrhoea 2 (4.3) 0.04 4 (2.7) 0.04 0.635 
Total 47 (100) 12.19 146 (100) 11.73  
*statistically significant result using Mann Whitney U test 
Figure 24 The percentage of patients who never mobilised in Phase 2 and 
Phase 3 who experienced each barrier during their ICU admission 
 
4.18 Summary 
This study is the first study to examine early mobilisation of a heterogeneous ICU 
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the study. The percentage of patients successfully mobilised after implementation 
of an early mobilisation program increased significantly when looking at all patients 
as well as when examining patients who had the opportunity to mobilise. This did 
not come at the expense of the number of episodes and activities conducted for 
each patient. Mobilisation rates can be increased for all patients in a unit that was 
positive towards mobilisation prior to implementation.  
Workforce behaviour changed with the introduction of the program. There was a 
marked increase in the number of patients mobilised with ETT, RRT and vasopressor 
infusions across diagnostic groups and APACHE II groups. Patients with medical and 
surgical diagnoses showed greater improvement than those with trauma diagnoses. 
Workforce mobilisation activity also shifted from being concentrated on patients 
with low APACHE II scores to those with higher APACHE II scores.  
The proportion of patients discharged home on hospital discharge was higher for 
patients who mobilised in both prospective phases of the study. Although there was 
no significant increase in the percentage of patients who were discharged home at 
hospital discharge overall between phases, there was a 20% increase in the number 
of patients who were mobilised in Phase 3. Therefore this additional 20% of 
patients who mobilised achieved similar rates of discharge home.  
There were no serious adverse events recorded during the study. The adverse event 
rate for mobilisation of patients in the ICU remained low and consistent between 
phases of the study. This rate was similar to other studies conducted in this field 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; 
Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 
2010; Needham and Korupolu 2010). Adverse event rates did not change 
significantly between diagnostic groups. Early mobilisation of a heterogeneous 
patient population in a single centre is safe.  
Sedation was the most common barrier to mobilisation across all diagnostic and 
APACHE II sub groups. Areas that were targeted in the mobilisation protocol such 
as. ETTs, lack of resources, helmets for patients with a craniectomy, patient 
declining intervention and cardiovascular instability all decreased as barriers in 
101 
Phase 3. Despite sedation not being a target of the protocol, it also decreased 
significantly as a barrier after introduction of early mobilisation practices.  
The successful introduction of an early mobilisation program into a single ICU 
created further interest in mobilisation practices around the country. No study had 
previously recorded baseline mobilisation levels for patients in the ICU in Australia. 
To adequately define ‘early’ mobilisation and evaluate its effect as a therapy on 
patient centred outcomes, knowledge of baseline practice is required. This thought 
process assisted in the construction of Study Two.  
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Chapter 5 Study Two 
5.1 Introduction 
The Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS 
CTG) is a collaborative group of clinicians interested in quality research in the area 
of critical care. For the past five years (2007 to 2012) this group has conducted point 
prevalence studies in adult ICUs around Australia and New Zealand. This 
collaboration prevents duplication of efforts and funding to obtain epidemiological 
data on patients in intensive care. Data from the 10 previous ANZICS CTG point 
prevalence studies has resulted in two publications (Group 1987; Lilford 1994). 
The point prevalence study in 2010 was co-ordinated by the ANZICS CTG and had 
endorsement by their management team. Prior to the 2010 point prevalence study, 
mobilisation data had not been collected in Australia or New Zealand. The growing 
interest in early mobilisation and discussion of preliminary results of the PhD 
candidate’s first study at an annual CTG meeting (May 2009) resulted in the idea of 
nesting a sub study examining baseline mobilisation practices within the overall 
point prevalence program. Collaboration occurred between interested 
physiotherapists on data points required. Definitions of mobilisation activities were 
taken from Study One of the candidates thesis. Due to financial constraints, the 
amount of barriers and adverse events able to be reported was condensed.  
This study was carried out chronologically between Study One and Study Three of 
this thesis and forms a bridge between the two studies. The candidate played an 
integral part in the study but was not the lead investigator of the point prevalence 
study. Permission to present this data was obtained from all other investigators. 
The key staff involved in the construction of the physiotherapy aspect of point 
prevalence study were (in alphabetical order): Dr Sue Berney, Associate Professor 
Linda Denehy, Hon Professor Ian Seppelt, Professor Steve Webb and the PhD 
candidate Meg Harrold. Mobilisation data collected from this study has not 
previously been reported. 
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Methods  
5.2 Aim 
The aim of this study was to establish a snapshot of mobilisation practices of 
patients in ICUs around Australia and New Zealand.  
For the candidate’s program of research, the following new information was added 
to the point prevalence data collection: 
 Mobilisation rates for mechanically ventilated adults in Australian and New 
Zealand ICUs 
 Adverse event rate around Australia and New Zealand 
 Barriers to mobilisation for patients in Australian and New Zealand ICUS 
5.3 Design  
The point prevalence study is a prospective, observational epidemiological study 
carried out at a single time point for all units involved. The physiotherapy point 
prevalence study was nested within the larger point prevalence study conducted by 
ANZICS CTG in 2010.  
5.4 Study setting 
5.4.1 Location 
All 182 (35 level III and 147 level I and II) Australian and New Zealand ICUs who 
admit adult patients were invited to participate in this study.  
5.4.2 Data collectors 
The demographic data was obtained by research coordinators. Mobility data was 
collected by physiotherapy staff in each unit with the assistance of the research 
coordinators.  
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5.5 Study criteria 
5.5.1 Inclusion criteria 
All adult patients admitted to the participating units at any time during the study 
day were included. 
5.5.2 Exclusion criteria 
There were no specific exclusion criteria for this study 
5.6 Raw data collection 
The physiotherapy point prevalence data collection sheet consisted of 25 items: two 
related to service provision; two to respiratory care (did they receive treatment, if 
so, what technique); 10 relating to mobilisation practices and barriers to 
mobilisation; 11 relating to factors interfering to physiotherapy and two items 
related to unplanned or adverse events occurring during physiotherapy (see 
Appendix 11). The adverse events section applied to both respiratory treatment and 
mobility treatment. Separation of these two types of treatment was not possible.  
Definitions for the mobility sections of the form were based on the candidate’s first 
study and the candidate was responsible for these aspects of the data dictionary 
(see Appendix 12). All definitions were decided upon a priori. The final 
physiotherapy data collection sheet was constructed by consensus of the 
investigators involved in the physiotherapy point prevalence.  
The raw data provided information which formed the derived variables relating to 
mobilisation rates, safety and barriers to mobilisation. 
5.6.1 Mobilisation rates 
Raw data collected that relate to this program of research were: 
 The time patients spent out of bed and ambulating. These were both 
measured categorically for ease of data collection and organised into the 
following categories: <5 mins; 5to < 15 mins; 15 to < 30 mins; 30 to < 60 
mins; 1 to < 2 hours; 2 to <4 hours; 4+ hours 
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 Activities conducted. These included: exercises; tilt table; sitting over edge 
of bed; standing; sitting out of bed; ambulation.  
To align with Study One and Three of this programme of research, reported 
mobilisation activities did not include ‘exercises’ but did include all other categories 
measured. Weight bearing was classified as using a tilt table, standing or 
ambulating.  
5.6.2 Safety 
To examine safety, adverse events associated with physiotherapy were recorded. 
An adverse event was defined a priori as:  
 Fall: Patient descends to knees or buttocks In an uncontrolled manner 
during a mobilization activity  
 Deterioration in gas exchange: During the process of mobilization (i.e. not 
prior to commencement), the patients oxygenation deteriorates sufficiently 
to warrant a sustained PEEP ≥10 cm H2O OR if was PEEP ≥10 cm H2O at 
commencement, an increase of 20% from PEEP at initiation of mobilization 
was required  
 Reduction in blood pressure: During the process of mobilization the patient’s 
blood pressure falls sufficiently to require return to bed, whether or not this 
also necessitated a commencement or increase in vasoactive medication  
 Deterioration in mental state: During the process of mobilization, there is a 
drop in Glasgow Coma Scale by one point or more, a clear and sustained 
change in mentation compared with prior to mobilisation, or a sustained 
increase in the patient’s intracranial pressure above 20 mmHg, if monitored  
 Arrhythmias: During the process of mobilization, the patient experiences an 
abnormal heart rhythm that requires return to bed or medical attention  
 Unplanned extubation / decannulation: During the process of mobilization 
the patient’s endotracheal tube, nasotracheal tube or tracheostomy tube 
was dislodged or removed and was then unable to be used in its intended 
capacity  
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 Unplanned removal of lines: During the process of mobilization, a line (e.g. 
NGT, IV line, ICC) was dislodged or removed and was then unable to be used 
in its intended capacity.  
Adverse event rates were described as the number of adverse events divided by the 
number of activities carried out. The number of patients who experienced adverse 
events was also recorded.  
5.6.3 Barriers to mobilisation 
Barriers to mobilisation were agreed upon by consensus. The categories are limited 
in number and therefore broad in nature due to budget limitations of the study. The 
following seven categories of barriers to mobilisation were as follows:  
 Unconscious / unresponsive (neurological injury, metabolic coma, drug 
intoxication) 
 Agitation or deep sedation 
 Haemodynamically unstable 
 Severe respiratory failure 
 Unstable trauma (spine, spinal cord or pelvis) 
 Severe neuromuscular weakness (e.g. unable to support own head despite 
being conscious) 
 Other 
Due to the broad nature of the categories it was not possible to divide these into 
modifiable and non-modifiable barriers. Barriers to mobilisation are therefore 
expressed as the total number in each category.  
5.7 Research process 
Data regarding all mobility and rehabilitation activities undertaken by patients in 
the previous 24 hours were collected from the nursing or physiotherapy notes and / 
or from the daily observation chart. 
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5.8 Ethical considerations 
Ethics approval, when required, was approved by the ethics committee of each 
participating hospital with the need for participant consent waived. Data were 
de-identified before submission to the co-ordinating centre. 
Results 
5.9 Baseline results 
5.9.1 Baseline results – setting 
In total, 38 of 182 ICUs participated in the study (33 Australian, 5 New Zealand). 
Thirty units were Level III accredited units (86% of all Level III ANZ units); eight were 
Level I and II accredited units (5.4% of all ANZ Level I and II units).  
5.9.2 Baseline results – patients 
Data was collected on 513 patients but complete data collection was only obtained 
in 498 patients (97.1%). The number of patients, average age, sex and median 
APACHE II score for each site is listed in Table 22. 
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Table 22 Number of patients and percentage of patients who mobilised at each 
site in Study Two 
Site N of 
patients 
% 
mobilised 
Sex 
(%Male) 
Age – mean 
(SD) 
APACHE II 
median(IQR) 
203 11 72.7 70.0 55.1 (22.6) 15 (10 to 20) 
204 7 14.3 57.1 61.7 (15.2) 22 (16 to 29) 
205 18 33.3 44.4 57.5 (17.3) 16 (8.5 to 21) 
206 26 26.9 65.4 61.3 (16.1) 20 (13 to 23) 
207 12 66.7 58.3 61.4 (16.0) 14.5 (9.2 to 22) 
208 9 66.7 77.8 67.6 (14.3) 13 (12 to 15) 
209 14 35.7 57.1 60.1 (20.6) 13 (9.2 to 19.2) 
210 27 37.0 63.0 58.8 (19.1) 14 (8 to 18) 
211 44 38.6 58.1 56.5 (15.9) 17.5 (12.7 to 23.5) 
212 9 22.2 88.9 62.4 (20.7) 21 (12 to 23) 
213 13 38.5 69.2 59.0 (12.1) 19 (12 to 33) 
215 16 43.8 62.5 67.6 (14.0) 20 (12 to 33) 
301 10 20.0 90.0 51.9 (12.6) 23 (9 to 34) 
401 11 36.4 80.0 70.1    (8.8) 15 (9 to 20) 
402 13 46.2 53.8 51.4 (22.6) 21 (14.5 to 25) 
403 12 33.3 66.7 64.1 (10.1) 19.5 (16 to 25.2) 
407 14 50.0 50.0 59.7 (14.1) 16.5 (11.2 to 23.2) 
409 8 50.0 50.0 55.0 (16.7) 16.5 (7.7 to 21) 
501 8 50.0 50.0 63.8   (7.2) 14.5 (12.5 to 23.5) 
502 12 50.0 41.7 58.0 (18.3) 18 (7.7 to 29.7) 
503 8 12.5 100 42.9 (13.3) 17.5 (16 to 20.5) 
504 24 33.3 52.2 58.3 (17.7) 15 (12 to 21) 
506 8 62.5 62.5 58.9 (19.8) 15.5 (13.2 to 23.5) 
507 4 50.0 66.7 74.5   (6.0) 23 (16.7 to 27) 
602 7 28.6 71.4 54.9   (9.5) N/A 
603 7 42.9 57.1 68.9 (13.4) 28 (26 to 32) 
701 12 16.7 83.3 57.5 (12.7) 20 (15.2 to 32.7) 
801 31 41.9 67.7 58.9 (14.8) 16 (12 to 19) 
802 17 23.5 64.7 61.1 (16.4) 18.5 (15 to 24.7) 
803 6 83.3 66.7 72.0    (6.4) 18 (14.7 to 24) 
804 7 42.9 57.1 61.1 (13.0) 31 (21 to 33) 
808 10 80.0 80.0 64.6 (14.3) 19 (14.7 to 24.2) 
810 6 16.7 33.3 59.7 (23.6) 20 (18 to 25.2) 
811 18 27.8 55.6 59.3 (17.0) 19 (14.7 to 29.5) 
812 12 33.3 45.5 70.0 (14.9) 17.5 (15 to 20.7) 
813 9 44.4 88.9 54.4 (19.9) 16 (12 to 24) 
903 20 40.0 80.0 42.7 (18.5) N/A 
904 13 35.7 38.5 59.4 (14.9) 22 (13.5 to 25) 
Total 513 39.3 62.9% 59.2 (16.8) 18 (13 to 23) 
N/A = not available 
RPH ICU 
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5.10 Mobilisation 
5.10.1 Overall 
Of the 513 patients, 202 patients were mobilised in the preceding 24 hours (39.3%). 
The total number of activities conducted was 412, of which 216 were weight 
bearing. This equated to a median of two activities per patient mobilised, one of 
which was a weight bearing activity. 
The time spent mobilising in the 24 hour period was recorded for sitting activities 
and weight bearing activities. For all patients the mode for sitting activities was two 
to four hours and for weight bearing activities it was less than five minutes.  
No patients were recorded to have mobilised on mechanical ventilation however 
three patients mobilised with an ETT and supplemental oxygen in situ. One of these 
patients was extubated later that day. These three patients carried out six activities 
of mobilisation. All patients were from the one hospital and no adverse events 
occurred during these activities.  
Thirteen patients who received RRT on the day of auditing were also recorded as 
having mobilised. It is not known if mobilisation occurred simultaneously with RRT 
or if it occurred during a break in the circuit. With this limitation in mind, 
21 activities of mobilisation were conducted in these 13 patients. Two adverse 
events occurred: one reduced blood pressure and one deterioration of mental 
state.  
Vasopressor infusions were present at some stage during the audit day for 
147 patients. Of these, 30 patients mobilised and carried out 61 activities, 30 of 
which were weight bearing activities. This equates to a total of 14.8% of the total 
activities were carried out on patients who received vasopressors at some stage 
that day. Two patients experienced adverse events (decrease in blood pressure and 
decrease in mental state); the second patient also received RRT.  
5.10.2 Mobilisation - sites 
Mobilisation rates varied between sites. Figure 25 shows a box plot of percent of 
patients mobilised at all sites with error bars representing the maximum and 
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minimum percent of patients mobilised, as well as the individual result for all sites 
included in the study. The percentage of patients who completed weight bearing 
activities is displayed in a similar graph in Figure 26. Of those that mobilised the 
percentage that then participated in weight bearing activities is displayed in 
Figure 27.  
Figure 25 Percentage of patients mobilised at each site in Study Two 
Note: box plot represents the median and middle 50% of sites and the error bars are the minimum 
and maximum. Each cross represents one site. 
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Figure 26 Percentage of patients who weight bear at each site in Study Two 
Note: box plot represents the median and middle 50% of sites and the error bars are the minimum 
and maximum. Each cross represents one site. 
 RPH ICU 
 
Figure 27 Percentage of patients that were mobilised who also weight bear in 
Study Two 
 
Note: box plot represents the median and middle 50% of sites and the error bars are the minimum 
and maximum. Each cross represents one site. 
 RPH ICU 
 
0
10
20
30
40
50
60
70
80
90
100
P
er
ce
n
t 
Sites 
0
10
20
30
40
50
60
70
80
90
100
P
e
rc
e
n
t 
Sites 
112 
5.10.3 Sub group analysis – diagnosis (subgroup 1) 
Patients admitted with a respiratory diagnosis had the highest percentage of 
patients who mobilised, closely followed by patients with sepsis diagnoses. Patients 
with respiratory diagnoses who carried out weight bearing activities again recorded 
the highest rate; however patients with sepsis diagnoses had one of the lowest 
rates of weight bearing. Patients with neurological and trauma conditions show low 
rates of both mobilisation and weight bearing (See Figure 28). 
Figure 28 Diagnosis (sub group 1): the percentage of patients who mobilised and 
who weight bear in each diagnostic specific category 
 
5.10.4 Sub group analysis – classification (sub group 2) 
Patients admitted for surgical reasons had the highest percentage of patients who 
mobilised and carried out weight bearing activities. Weight bearing activities were 
proportionately less in patients admitted with medical conditions compared with 
surgical conditions (see Figure 29).  
0
10
20
30
40
50
60
70
80
90
100
P
er
ce
n
t 
Diagnosis 
% of pts mobilised
% of pts who wt bear
113 
Figure 29 Classification (sub group 2): the percentage of patients who mobilised 
and who weight bear in each diagnostic specific category 
 
5.10.5 Subgroup analysis – severity of illness (sub group 3) 
As severity of illness scores increased, the percentage of patients who mobilised 
decreased apart from the APACHE II grouping of 40 – 44 which did have a higher 
percentage of patients mobilised than the 35 – 39 grouping (see Figure 30). 
Percentage of patients who carried out weight bearing activities followed a similar 
trend with a slight increase in rate in the 30 – 34 APACHE II grouping in comparison 
to the previous group. No patients in the 35-39 or 40 – 44 APACHE II grouping 
participated in weight bearing activities (see Figure 30). 
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Figure 30 Severity of illness (sub group 3): percentage of each APACHE II group 
who mobilised and weight bear 
 
5.11 Safety 
For patients who did mobilise, 13 adverse events occurred during respiratory, 
mobility therapy or both, in 11 patients. This equates to an adverse event rate of 
6.4% (13 adverse events / 202 episodes).  
Figure 31 is a graphical representation of the adverse events in this study. The 
adverse events listed as ‘other’ include three episodes of dizziness, one of increased 
blood pressure and one of shortness of breath.  
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Figure 31 Number of adverse events overall for Study Two 
 
5.12 Barriers 
The largest barrier to mobilisation was reported as haemodynamic instability. This 
was closely followed by agitation or deep sedation. Unstable trauma and severe 
neurological weakness were the least recorded barriers (see Figure 32). 
Nearly 20% of barriers were classified as ‘other’. There were 15 different types of 
barriers mentioned in this section. Patient drowsiness and fatigue was the most 
commonly stated barrier in the ‘other’ section, followed by patient refusal.  
0
1
2
3
4
5
6
7
C
o
u
n
t 
Adverse event 
No of adverse events
116 
Figure 32 Barriers to mobilisation for all patients in Study Two 
 
5.13 Summary 
This study captured mobilisation activity on one day in 38 ICUs across Australia and 
New Zealand which represented 86% of all level III ICUs in the area.  
Of the 497 patients with complete data, 39.3% mobilised. The percentage of 
patients mobilised at each individual site varied considerably from 12.5% to 83.3%. 
However, if the patients did mobilise, a median of 75% of patients also carried out 
weight bearing activities.  
No patients were mobilised with mechanical ventilation. Two patients did mobilise 
with an ETT in situ but were not connected to mechanical ventilation. Due to 
wording of the questionnaire, it was not possible to determine accurately the 
number of patients who mobilised with vasopressor infusions and RRT. It can be 
shown that 13 out of the 58 patients who received RRT at some stage during that 
day mobilised and 30 out of the 147 patients who had vasopressor infusions 
running at some stage during that day mobilised. 
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Patients admitted for respiratory or sepsis conditions had the highest proportion of 
patients carry out mobilisation. Analysis of APACHE II subgroups showed that 
prevalence of mobilisation was higher in patients with lower APACHE II scores than 
in patients with higher groupings.  
Haemodynamic instability was the largest barrier to mobilisation, followed closely 
by sedation. These results are difficult to interpret due to the broad nature of the 
categories available on the questionnaire.  
Adverse event rates across all patients were low and there were no serious adverse 
events.  
This study showed low levels of mobilisation on any one day for patients admitted 
to Australian and New Zealand ICUs. It is not clear if this is an accurate 
representation of daily mobilisation levels or if this is due to the weak study design. 
One day of data does not provide enough information about patterns of 
mobilisation throughout patients’ length of stay and how barriers to mobilisation 
change with time.  
Results from Study Two revealed a need to conduct a study capturing patients’ total 
length of stay to establish base line practice of mobilisation as well as what barriers 
exist to conducting mobilisation. This was in line with what would subsequently be 
decided upon at the Society of Critical Care Medicine conference as one of the key 
priorities for the area of early mobilisation in ICU research (Needham 2012). In 
2010, two years prior to these conference proceedings, a third study was designed 
to examine mobilisation activity and barriers to mobilisation in Australia and to 
benchmark this internationally. 
The ambiguities of the results from Study Two were the motivation for a more 
robust assessment of baseline mobilisation practice in Australia and lead to Study 
three.  
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Chapter 6 Study Three 
6.1 Introduction 
This chapter covers the third and final study of this program of research. The need 
for a more comprehensive examination of baseline practice came after review of 
the many limitations of the point prevalence study. The study was conducted across 
two countries, Australia and Scotland, and examined baseline mobility practice.  
Results of this study are predominantly descriptive and comparison between 
countries will be performed on baseline results to show differences in 
demographics between the two countries. In many instances statistical comparison 
is not possible due to differences in patient populations, workforce and settings.  
Methods 
6.2 Aim 
The aims of this study were: 
1) To quantify baseline levels of mobilisation in Australian and Scottish ICUs  
2) To establish an adverse event rate for mobilisation in Australian and Scottish 
ICUs 
3) To benchmark Australian practices internationally with Scottish practices 
6.3 Design 
The study was a series of eight-week prospective observational studies looking at 
mobility practices carried out around Australia and Scotland. The audits consisted of 
a four-week recruitment period and then a further four-week period of follow up 
auditing of those patients already recruited but not yet discharged from ICU.  
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6.4 Hypothesis 
From the related literature and previous studies conducted, the following 
hypotheses were generated: 
 The proportion of patients who mobilise during their ICU stay will be above 
40% in both Australia and Scotland 
 Adverse event rates in both Scotland and Australia will occur in less than 6% 
of activities conducted 
 Barriers to mobilisation within Australian and Scottish ICUs will be similar 
and can be divided into avoidable and non-avoidable barriers 
6.5 Study setting 
6.5.1 Locations and recruitment 
A research collaboration was formed between the PhD candidate and senior 
researchers in Scotland after discussion of common research interests at ICU 
conferences and on line networks. The lead researcher in the Scottish 
Physiotherapy group is Dr Lisa Salisbury. Through this collaboration, invitation was 
made to senior physiotherapists of all Scottish ICUs to participate in Study three.  
Australian sites were recruited through collaboration and presentations with the 
intensive care network at ANZICS and ANZICS CTG conferences as well as word of 
mouth.  
Sites were enrolled if they had established quality assurance databases that 
collected the necessary demographic patient information required for this study 
and the physiotherapist on site was able to access this information. Involvement in 
the study was voluntary and under the premise that data recorded would be 
available for use by the original site after publication by the chief investigator.  
6.5.2 Workforce 
The candidate made initial contact with the senior physiotherapist working in the 
ICU of each site and in all cases this person remained the primary contact for the 
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study. Junior physiotherapists assisted with daily data collection and data was 
validated on patient discharge by the senior physiotherapist at each site.  
6.6 Study population 
6.6.1 Inclusion criteria 
Patients aged over 18 years admitted to ICU and received mechanical ventilation in 
the ICU.  
6.6.2 Exclusion Criteria 
There were no exclusion criteria.  
6.6.3 Withdrawal Criteria 
Patients whose total length of stay was not captured at the study census date were 
withdrawn from analysis. Census date was put at eight weeks after commencement 
of the study to capture as many patients total length of stay as possible. 
6.7 Sample size expectations 
It was anticipated that 8 sites around Australia and 8 sites around Scotland would 
be recruited. The sample size was one of convenience as it required an eight week 
commitment to data collection with no remuneration offered. The aim was to 
include approximately 25% of all 29 Level III ICUs in Australia (the six tertiary 
Level III ICUs in New Zealand were not included) and have a comparable number of 
sites in Scotland.  
Census dates were decided upon using Australian data from previous years and 
results from Study One. The median length of stay for Australian patients admitted 
to ICU in 2010 was 1.8 days (0.9 to 3.7) (ANZICS and CORE 2010) and approximately 
two thirds of patients were mechanically ventilated (Judson and Fisher 2006). Data 
from Study One showed patients who were mechanically ventilated for three or 
more calendar days had an average length of stay of 25 days (SD 26 days). In order 
to capture as many patients total length of stay in ICU it was decided that there be a 
recruitment phase of four weeks (28 days) and an audit period of another 
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four weeks (28 days). The audit period was to ensure patients recruited towards the 
end of the recruitment four weeks had their total length of stay captured.  
6.8 Outcome measures 
6.8.1 Mobilisation rate 
Mobilisation details were recorded using the MDCF2 (see Appendix 13) and from 
this information, mobilisation rates were derived as described in section 3.6.1 and 
were recorded for: 
 All patients  
 Patients at each site 
 Patients within each sub group  
6.8.2 Safety 
Safety levels were determined by adverse event rates (as previously defined in 
section 3.6.3) for the following groupings of patients: 
 All patients  
 Patients at each sites 
 Patients receiving an ETT, RRT and/or vasopressor infusions 
 Patients within each sub group  
6.8.3 Barriers to mobilisation 
Barriers to mobilisation for this study were recorded on the MDCF2 (see 
Appendix 13). From this information, barriers to mobilisation were expressed as 
unavoidable or avoidable / partially modifiable. 
6.9 Research process 
After initial agreement to participate in the study, ethics applications specific to 
each sites requirements were obtained as well as formal approval of access to the 
quality assurance patient database.  
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Sites began data collection at a time convenient to their unit. Ethics approval for 
19 hospitals necessitated this staggered approach. However, once data collection 
had commenced, recruitment occurred on all consecutive patients meeting 
inclusion criteria for a four week period. Patients who were recruited in this four 
week period but whom had not yet been discharged continued to be audited until 
they were discharged from the ICU or until the census date was reached, whichever 
came first. The aim of this was to capture as many patients total lengths of stay as 
possible. 
A standardised, scannable data collection form was used across all sites and labelled 
the MDCF2 (see Appendix 13). This form was constructed from the MDCF used in 
Study One with an additional four categories added to Section 3 ‘for patients not 
mobilised’. These categories were: ‘Sedated’, ‘Comatosed’, ‘RRT in progress’ and 
‘Imminent death’. The data dictionary was updated accordingly (see Appendix 14). 
The one page questionnaire used in Study One was also given to the lead 
physiotherapists at each site in this study (Appendix 14). This was to establish the 
size of the unit and the resources available to staff at each unit.  
Data were collected by physiotherapists working at each site. While this does 
potentially introduce bias, feasibly it represented the best possible way of collecting 
all mobilisation data. 
6.9.1 Data linkage 
The MDCF2 was specially designed with a perforated edge for easy removal of the 
top section of the form. This top section recorded the patient name or identifier as 
well as the unique study number to be written on it for easy identification by the 
collecting therapist. This top section could then be removed prior to transfer of data 
outside the ICU. On completion of the audit, the top sections of all forms are kept 
on site in a locked cupboard in accordance with ethics applications. The main 
section of the forms included the unique study number to allow data linkage whilst 
maintaining confidentiality.  
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Data linkage of mobilisation data and demographic data from the quality assurance 
database was performed by the senior physiotherapist at each site as they were the 
only person with access to both the patient identifier and the unique study number.  
6.10 Statistical analysis 
Statistics for this study were predominantly descriptive in nature. Where there were 
two independent groups with data that was normally distributed, student t-tests 
were used in analysis to compare means. For non-parametric data, two 
independent groups were analysed using Mann Whitney U tests.  
6.11 Ethics 
This study was observational in nature and did not pose substantial ethical risk. 
Permission to access demographic, physiological and length of stay data was 
obtained from participating sites’ management committee. This information is 
obtained on a routine basis for individual patients as a matter of quality assurance. 
Ethics approval was obtained from all 10 Australian hospitals (see Appendix 15). 
Permission to access quality assurance data bases for each site was also gained 
prior to commencement of the study. The hospitals involved were: 
Australia 
The Alfred Hospital - Victoria 
The Austin Hospital - Victoria 
Fremantle Hospital – Western Australia 
Princess Alexandra Hospital - Queensland 
Prince Charles Hospital - Queensland 
Royal Hobart Hospital - Tasmania 
Royal Perth Hospital – Western Australia 
Sir Charles Gairdner Hospital – Western Australia 
St Vincent’s Private Hospital – New South Wales 
Wollongong Hospital – New South Wales 
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A waiver of ethics was granted for Scotland (Appendix 16). However, Caldicott 
guardianship was still required for each National Health System (NHS) region. 
Cauldicott approval was obtained for all nine hospitals which were located in six 
NHS regions (see Appendix 16). The hospitals and NHS regions are listed below. 
Scotland 
Aberdeen Royal Infirmary – NHS Grampian 
Forth Valley Royal Hospital – NHS Forth Valley 
Royal Infirmary of Edinburgh – NHS Lothian 
Ninewells Hospital – NHS Tayside 
Perth Royal Infirmary – NHS Tayside 
Queen Margaret Hospital – NHS Fife 
Raigmore Hospital – NHS Highland 
St John’s Hospital – NHS Lothian 
Western General Hospital – NHS Lothian 
Results 
6.12 Baseline results 
Baseline results for both Australian and Scottish cohorts will be compared 
statistically.  
6.12.1 Baseline results – setting: Australia 
Ten sites were involved in data collection in the Australian arm of the study. This 
consisted of one rural ICU and nine metropolitan ICUs, one of which was in a private 
hospital. All units only admitted level III ICU patients. The sites were spread over 
five states of Australia: three in Western Australia, two in Victoria; two in New 
South Wales; two in Queensland and one in Tasmania.  
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Descriptive statistics are outlined in Table 23. The average number of beds across all 
10 sites was 19.4 (SD 7.17). Specialties covered at each ICU varied with all sites 
having at least one specialty area.  
Attitudes towards mobilisation with ETTs, RRT and or vasopressor infusions varied 
across sites. Half of sites stated that as a general rule they did mobilise patients with 
an ETT and the same sites also allowed mobilisation of patients with vasopressor 
infusions. Mobilisation with RRT in situ was allowed in six of the 10 sites but these 
sites did not correlate with the acceptance of mobilisation with ETTs and 
vasopressor infusions.  
Table 23 Descriptive statistics for Australian sites 
Site 1 2 3 4 5 6 7 8 9 10 
Level III ICU beds 34 18 12 24 20 10 23 23 12 18 
Specialties included in unit           
- Cardiothoracic surgery          X 
- Neurosurgery   X  X      
- Trauma  X X  X     X 
- Spinal   X  X     X 
- Transplantation   X   X    X 
PT attend medical handover X   X     X X 
Culture           
- Mobilisation with ETT   X X X   X X  
- Mobilisation with RRT    X X X    X 
- Mobilisation with 
vasopressors 
  X X X   X X  
Equipment in unit           
- High back chair 10 0 4 4 10 3 5 0 6 4 
- Rocker recliner 0 8 3 0 6 0 3 0 2 2 
- Rehabilitation chair 8 0 0 4 2 2 4 5 0 3 
- Tilt table 1 1 0 1 1 1 1 2 1 1 
- Standing lifter 1 1 0 0 0 0 0 1 1 0 
6.12.1 Baseline results – setting: Scotland 
Nine sites participated in data collection for the Scottish arm of the study, all of 
which had a combination of level II and level III operational ICU beds. Only patients 
mechanically ventilated and admitted to Level III ICU beds were admitted into the 
study.  
126 
Descriptive statistics are listed in Table 24. On average the number of beds in each 
unit was 9.0 (SD 4.18) which was significantly less (p=.001) that those ICUs audited 
in Australia (19.4 (SD 7.17)).  
No Scottish site covered cardiothoracic surgery or transplantation specialties. 
Mobilisation with an ETT and vasopressor infusions was permitted at eight out of 
the nine sites compared with mobilisation of patients with RRT which was allowed 
at six sites.  
Table 24 Descriptive statistics for Scottish sites 
Site 1 2 3 4 5 6 7 8 9 
Level III ICU beds 13 7 12 9 3 9 8 4 16 
Specialties included in unit          
- Cardiothoracic surgery X X X X X X X X X 
- Neurosurgery  X X  X X X X  
- Trauma     X     
- Spinal  X X X X X X X  
- Transplantation X X X X X X X X X 
PT attend medical handover  X X X      
Culture          
- Mobilisation with ETT         X 
- Mobilisation with RRT    X X  X   
- Mobilisation with 
vasopressors 
  X       
Equipment in unit          
- High back chair 0 3 4 0 1 3 1 2 2 
- Rocker recliner 5 16 4 0 0 0 2 2 5 
- Rehabilitation chair 0 0 0 1 1 3 1 0 2 
- Tilt table 1 1 1 1 1 1 1 1 1 
- Standing lifter 0 1 0 1 0 1 1 0 0 
 
6.12.2 Baseline results – workforce 
Data for the study was collected by physiotherapists in each unit. Staffing levels 
varied at each site. The mean ratio of physiotherapists to ICU beds for Australia was 
1:5.6 (SD 1.82) and for Scotland it was 1:6.7 (SD 2.36) which were not statistically 
different (p=.298).  
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6.12.3 Baseline results – patients in Australia and Scotland 
The number of patients in the Australian cohort was more than 3.7 times that of the 
Scottish cohort. The mean APACHE II scores for the Scottish population was higher 
but not statistically different (p=.069). The length of stay in both ICU and hospital 
was longer for patients in Scotland (see Table 25). 
Table 25 Baseline demographic results for Australian and Scottish cohorts of 
Study three 
 Australia Scotland p-value 
N of pts 665 179  
Age (mean) 59.7 (SD 17.07) N/A  
Sex (% Male) 66.6 N/A  
APACHE II (mean) 16.81 (SD 7.30) 17.96 (SD 7.16) .069 
LOS – ICU (median) 2.00 (1.00 to 4.17) 3.85 (1.98 to 8.67) <.001* 
LOS – hospital (median) 10.58 (6.58 to 18.02) 16.00 (6.00 to 33.00) .002* 
Note: Due to ethics board requirements, age and sex was not allowed to be collected for patients in 
the Scottish arm of the study. 
*statistically significant result. Comparison of mean values was analysed with t-test. Comparison of 
median values was analysed with Mann-Whitney test 
6.12.4 Baseline results – Australian and Scottish patient sub groups  
Patients meeting inclusion criteria in the Australian and Scottish cohorts were 
pooled and divided into the three previously described sub groups. The breakdown 
of each sub group for both Australia and Scotland are displayed in Figures 33, 34 
and 35. These three graphs show clear differences in admission diagnoses and 
severity of illness patterns between the two countries.  
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Figure 33 Diagnosis (sub group 1): breakdowns for all patients meeting inclusion 
criteria in Australian and Scottish cohorts 
 
Figure 34 Classification (sub group 2): breakdowns for all patients meeting 
inclusion criteria in Australian and Scottish cohorts 
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Figure 35 Severity of illness (sub group 3): breakdowns for all patients meeting 
inclusion criteria in Australian and Scottish cohorts 
 
6.12.5 Baseline results – sites 
Breakdowns of diagnosis and classification sub groups for each Australian site are 
shown in Figure 36 and Figure 37 and in Figure 38 and Figure 39 for Scottish sites. 
Numbers in each severity of illness category were too small to graph meaningfully. 
Results for RPH ICU are singled out in Figure 36 and Figure 37 as this unit is the only 
unit common to all three studies in this thesis. 
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Figure 36 Diagnosis (sub group 1): baseline results for each Australian site in Study Three 
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Figure 37 Classification (sub group 2) baseline results for each Australian site in Study Three 
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Figure 38 Diagnosis (sub group 1): baseline results for each Scottish site in Study Three 
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Figure 39 Classification (sub group 2): baseline results for each Scottish site in Study Three 
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6.13 Mobilisation rates 
6.13.1 Overall 
The variation between Australia and Scotland in baseline demographics makes the 
comparison of mobilisation statistics clinically unsound. The mobilisation results for 
the Australian and Scottish cohorts are shown in Table 26 and 27. Although the 
proportion of patients who mobilised in Scotland was lower (42.5%), the number of 
activities and episodes conducted per patient mobilised was higher (6.3 and 3.8). 
The percentage of patients who weight bear was markedly higher in the Australian 
cohort (57.1% compared with 29.1%).  
Table 26 Overall mobilisation results for the Australian cohort of Study three 
 Australia  
% of patients who mobilised 68.8 
^N of activities per pt 2.9 
^N of activities per pt mobilised 4.2 
^N of episodes per pt  1.4 
^N of episodes per pt mobilised  2.1 
% patients who wt bear  57.1 
^Mins spent mobilising per pt 193 
% of activities carried out on MV 9.3 
Day first mobilised 2 (1 to 3) 
^ median 
Table 27 Overall mobilisation results for the Scottish cohort of Study three 
 Scotland  
% of patients who mobilised 42.5 
^N of activities per pt 2.7 
^N of activities per pt mobilised 6.3 
^N of episodes per pt  1.6 
^N of episodes per pt mobilised  3.8 
% patients who wt bear  29.1 
^Mins spent mobilising per pt 692 
% of activities carried out on MV 34.4 
Day first mobilised 4.5 (2 to 10.8) 
^ median  
Overall mobilisation rates in the presence of ETT, RRT and vasopressors 
Out of the three therapies, mobilisation with vasopressor infusions was the most 
common to occur. For the Australian population of the study, mobilisation with 
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vasopressor infusions occurred in 17.1% of episodes (152 episodes) where 
vasopressor infusions were running. Mobilisation with RRT was present during 8.5% 
(12 episodes) of possible episodes and 2.0% (40 episodes) of episodes were carried 
out where an ETT was present. All episodes of mobilisation where the patient had 
an ETT in situ were also receiving mechanical ventilation. 
In the Scottish population mobilisation with these therapies was lower. Mobilisation 
in the presence of an ETT occurred in 1.1% (7 episodes) of episodes possible. 
Mobilisation with RRT or vasopressor infusions occurred in 1.1% (1 episode) and 
2.8% (8 episodes) of episodes respectively.  
Day first mobilised 
The median time to patients first getting out of bed was day 2 (1 to 3) for Australian 
patients and day 4.5 (2 to 10.8) (p=.003) for Scottish patients. Statistical comparison 
of these results is of limited validity due to the differences in diagnostic makeup of 
the populations.  
6.13.2 Mobilisation results for individual sites. 
Mobilisation results for individual Australian sites are shown in Table 28. Site seven 
is highlighted as this represents RPH ICU, the one site common to all three studies. 
The proportion of patients mobilised at each site varies between 28.6% and 92.2%.  
Scottish mobilisation results are displayed in Table 29. The proportion of patients 
mobilised at individual sites varied from 21.1% to 68.8%.  
The percentage of patients who mobilise and the percentage of patients who 
weight bear are displayed in Figure 40 and Figure 41 for Australian and Scottish 
cohorts. The difference between those who mobilise and those who weight bear 
are the proportion of patients who sat only.  
6.13.3 Mobilisation results in sub groups  
Results of mobilisation in each of the three sub groups for both Australia and 
Scotland populations are shown in Tables 30 through to 35. 
136 
For the diagnosis sub group, patients in the respiratory category had the highest 
percentage of patients mobilised in both cohorts. The category that experienced 
the greatest number of activities, episodes and minutes of mobilisation was sepsis 
for Australian and Scottish patients. Mobilisation with ETTs, RRT and vasopressors 
did not have the same consistency. For Australia, patients in the respiratory 
category were most likely to mobilise with an ETT or RRT and cardiac patients were 
most likely to mobilise with vasopressor infusions. In the Scottish cohort, the 
patients who mobilised most with an ETT were those in the metabolic category. 
Only patients in the gastrointestinal category mobilised with RRT and patients with 
sepsis had the highest rate of mobilisation with vasopressor infusions.  
Patients in the surgical category of the classification sub group had the highest 
proportion of patients mobilised in both the Scottish and Australian cohorts. 
Medical patients recorded the most amounts of activities, episodes and minutes of 
mobilisation per patient in Australia in contrast to Scotland where patients in the 
trauma category recorded the highest values in these areas. Mobilisation of 
patients with RRT was most common in medical patients in Australia and Scotland. 
Mobilisation with an ETT was seen most commonly in medical patients for 
Australian cohort and in surgical patients in the Scottish cohort. Surgical patients in 
the Australian population and medical patients in the Scottish population saw the 
highest rate of mobilisation with vasopressor infusions. 
Patterns of mobilisation in the severity of illness sub group for Australian patients 
showed the day first mobilised got progressively higher with increasing APACHE II 
groupings. This was not observed in the Scottish cohort.  
137 
Table 28 Mobilisation rates for individual Australian sites in Study three 
 1 2 3 4 5 6 7 8 9 10 
N of pts 62 57 31 164 115 49 79 69 16 23 
% pts mobilised 62.9 54.4 67.7 78.7 92.2 28.6 59.5 69.6 87.5 39.1 
% pts who weight bear 33.9 49.1 41.9 72.0 87.0 12.2 46.8 52.2 81.3 34.8 
N of activities per pt mobilised 3.9 5.0 2.5 1.7 6.8 4.4 5.4 3.2 4.3 8.6 
N of episodes per pt mobilised 2.4 2.5 2.1 0.9 2.8 3.2 2.6 2.1 1.8 4.2 
N mins per pt mobilised 347 404 208 75 718 263 430 312 300 712 
% of episodes with ETT 1.4 0.0 2.0 0.0 2.9 0.0 2.9 0.5 20.0 5.2 
% of episodes with RRT 0 0 0 0 14.3 0 18.2 13.0 0 0 
% of episodes with vasopressors 2.1 7.1 7.4 5.4 45.4 3.9 12.2 0.0 8.3 0.0 
Day first mobilised 3 (2 to 5) 2 (2 to 4) 2 (2 to 3) 1 (1 to 2) 2 (2 to 2) 3.5(1.8 to 8.5) 2 (2 to 5) 2(2 to 3.8) 2(1 to 2.2) 5(3 to 8.2) 
 RPH ICU 
Note: Highlighted numbers represent the highest value for that criterion 
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Figure 40 The proportion of patients who mobilised and the proportion who weight bear in Australian sites for Study three 
 
Note: The difference between the blue and red bars of the graph highlights those patients who sat only. 
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10
P
er
ce
n
t 
Site 
% of pts mobilised
% of pts who wt bear
139 
Table 29 Mobilisation rates for individual Scottish sites in Study three 
 1 2 3 4 5 6 7 8 9 
N of pts 26 16 48 19 2 19 14 14 21 
% pts mobilised 30.8 68.8 41.7 21.1 50.0 42.1 64.3 50.0 38.1 
% pts who weight bear 15.4 68.8 29.2 5.3 50.0 31.6 64.3 14.3 19.0 
N of activities per pt mobilised 5.3 9.9 8.4 3.8 4.0 3.6 7.6 3.3 3.1 
N of episodes per pt mobilised 4.6 4.7 4.5 4.8 2.0 2.3 3.9 2.9 2.4 
N mins per pt mobilised 579 619 1022 1144 295 244 627 493 596 
% of episodes with ETT 0.0 4.9 0.6 3.0 0.0 1.1 0.0 0.0 1.7 
% of episodes with RRT 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 
% of episodes with vasopressors 0.0 8.7 4.7 5.7 0.0 0.0 0.0 0.0 0.0 
Day first mobilised 6(2 to 13.2) 2(1 to 8) 8.5(2.2 to 12) 11.5(4 to 31.8) 1 2(1 to 10.8) 3(2 to 8) 3(2 to 10) 5(2 to 7.5) 
Note: Highlighted numbers represent the highest value for that criterion 
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Figure 41 The proportion of patients who mobilised and the proportion who weight bear in Scottish sites for Study Three  
 
Note: The difference between the red and blue bars of the graph highlights those patients who sat only. 
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Table 30 Diagnosis (sub group 1): mobilisation rates for patients of different diagnostic specific categories in the Australian cohort of 
  Study Three 
Diagnostic specific category Cardiac Respiratory Gastrointestinal Neurology Sepsis Orthotrauma Metabolic Other  
N of pts 339 56 91 54 22 56 20 27 
% pts mobilised 74.9 85.7 75.8 46.3 59.1 41.1 50.0 59.3 
% pts who weight bear 67.0 69.6 59.3 31.5 50.0 26.8 40.0 33.3 
N of activities per pt mobilised 4.1 6.0 3.2 2.7 9.5 3.0 2.4 4.6 
N of episodes per pt mobilised 1.9 2.9 2.0 1.9 4.6 2.1 1.3 3.4 
N mins per pt mobilised 358 626 214 189 893 186 156 488 
% of episodes with ETT 2.1 6.2 1.6 1.3 0.0 0.0 0.0 0.0 
% of episodes with RRT 0 18.4 0 0 8.6 0 0 0 
% of episodes with vasopressors 29.9 12.4 7.5 1.8 3.1 0.0 0.0 2.2 
Day first mobilised 2 (1 to 2) 2.5 (1 to 5) 1 (1 to 3) 2 (1 to 4) 4 (3 to 6) 4 (2 to 7) 2 (1 to 2.2) 2 (1.2 to 5) 
 Note: Highlighted numbers represent the highest value for that criterion 
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Table 31 Diagnosis (sub group 1): mobilisation rates for patients of different diagnostic specific categories in the Scottish cohort of Study 
Three 
Diagnostic specific category Cardiac Respiratory Gastrointestinal Neurology Sepsis Orthotrauma Metabolic Other  
N of pts 26 37 41 21 18 15 17 4 
% pts mobilised 38.5 54.1 51.2 19.0 38.9 33.3 41.2 50.0 
% pts who weight bear 23.1 32.4 46.3 14.3 27.8 6.7 35.3 0 
N of activities per pt mobilised 9.8 4.7 5.4 8.3 12.7 5.0 3.9 1.0 
N of episodes per pt mobilised 5.6 3.4 2.9 6.0 6.4 5.0 1.7 1.0 
N mins per pt mobilised 1156 681 460 841 1236 568 325 333 
% of episodes with ETT 1.4 0 2.5 1.9 0 0 3.4 0 
% of episodes with RRT 0 0 5.3 0 0.0 0 0.0 0 
% of episodes with vasopressors 3.0 5.8 0 0 6.5 0 6.3 0 
Day first mobilised 8.5 (3 to 19) 5 (2.2 to 10.2) 3 (2 to 9) 2 (2 to 9.5) 8 (1 to 14) 8 (4 to 14.5) 2 (1 to 4)  
 Note: Highlighted numbers represent the highest value for that criterion 
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Table 32 Classification (sub group 2): mobilisation rates for patients of different classification categories in the Australian cohort of Study 
Three 
Diagnostic specific category Medical Surgical Trauma Missing 
N of pts 171 429 38 27 
% pts mobilised 59.6 76.0 36.8 59.3 
% pts who weight bear 45.6 66.7 18.4 33.3 
N of activities per pt mobilised 6.0 3.6 3.8 4.6 
N of episodes per pt mobilised 3.1 1.8 2.6 3.4 
N mins per pt mobilised 626 279 233 488 
% of episodes with ETT 3.1 1.6 0.0 0.0 
% of episodes with RRT 12.1 0.0 0.0 0.0 
% of episodes with vasopressors 11.6 25.3 0.0 2.2 
Day first mobilised 3 (2 to 5) 2 (1 to 2) 5 (3.5 to 8) 2 (1.2 to 5) 
        Note: Highlighted numbers represent the highest value for that criterion 
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Table 33 Classification (sub group 2): mobilisation rates for patients of different classification categories in the Scottish cohort of 
Study Three 
Diagnostic specific category Medical Surgical Trauma Missing 
N of pts 102 62 11 4 
% pts mobilised 43.1 45.2 18.2 50.0 
% pts who weight bear 26.5 38.7 9.1 0.0 
N of activities per pt mobilised 5.9 7.3 9.5 1.0 
N of episodes per pt mobilised 3.7 3.9 9.0 1.0 
N mins per pt mobilised 702 688 919 333 
% of episodes with ETT 0.5 2.5 0.0 0.0 
% of episodes with RRT 1.4 0.0 0.0 0.0 
% of episodes with vasopressors 3.6 2.0 0.0 0.0 
Day first mobilised 5 (2 to 12) 4.5 (2 to 9.8) 4 (1 to 4) 1.5 (1 to 1.5) 
   Note: Highlighted numbers represent the highest value for that criterion 
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Table 34 Severity of illness (sub group 3): mobilisation rates for patients of different APACHE II categories in the Australian cohort of 
Study Three 
APACHE grouping 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 Missing 
N of pts 7 75 197 175 95 48 18 14 5 2 29 
% pts mobilised 71.4 73.3 77.7 70.9 71.6 43.8 55.6 28.6 0.0 0.0 62.1 
% pts who weight 
bear 
71.4 58.7 68.5 60.0 58.9 31.3 16.7 28.6 0.0 0.0 44.8 
N of activities per 
pt mobilised 
1.6 2.2 3.3 4.4 6.2 8.0 2.0 9.8 0.0 0.0 4.6 
N of episodes per 
pt mobilised 
1 1.4 1.7 2.2 3.0 4.4 1.8 3.8 0.0 0.0 3.1 
N mins per pt 
mobilised 
12 189 273 369 550 839 208 744 0 0 429 
% of episodes 
with ETT 
0.0 0.0 2.1 2.6 1.1 1.6 1.4 4.7 0.0 0.0 2.7 
% of episodes 
with RRT 
0.0 0.0 0.0 3.7 17.2 19.4 0.0 0.0 0.0 0.0 0.0 
% of episodes 
with 
vasopressors 
0.0 18.0 21.3 23.7 21.7 6.6 0.0 0.0 0.0 0.0 3.5 
Day first 
mobilised 
1(1 to 2) 1(1 to 2) 2(1 to 2) 2(1 to 3) 2.5(2 to 4.8) 4(2 to 5) 5.5(3.8 to 8) 9(5 to 13)   2(1 to 5) 
Note: Highlighted numbers represent the highest value for that criterion 
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Table 35 Severity of illness (sub group 3): mobilisation rates for patients of different APACHE II categories in the Scottish cohort of Study 
Three 
APACHE grouping 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 Missing 
N of pts 1 17 37 45 33 24 5 1 1 0 15 
% pts mobilised 0.0 35.3 45.9 46.7 36.4 54.2 40.0 0.0 0.0  33.3 
% pts who weight 
bear 0.0 29.4 27.0 33.3 30.3 33.3 40.0 0.0 0.0  13.3 
N of activities per 
pt mobilised 0.0 5.2 6.5 4.6 6.5 7.3 22.0 0.0 0.0  5.2 
N of episodes per 
pt mobilised 0.0 2.5 4.0 3.6 3.7 3.5 12.0 0.0 0.0  4.2 
N mins per pt 
mobilised 0.0 408 762 552 625 885 1643 0.0 0.0  675 
% of episodes 
with ETT 0.0 8.0 0.0 2.3 0.7 1.9 0.0 0.0 0.0  0.0 
% of episodes 
with RRT 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0  0.0 
% of episodes 
with 
vasopressors 0.0 25.0 1.9 2.9 1.7 9.4 0.0 0.0 0.0  0.0 
Day first 
mobilised  1.5(1 to 3.5) 8(2 to 14) 5(2.5 to 8.5) 7(4 to 14) 2(1 to 3) 15(14 to 15)    3(2 to 21) 
Note: Highlighted numbers represent the highest value for that criterion 
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6.14 Discharge destination 
6.14.1 Overall  
For all patients in the Australian cohort, 66.0% of patients were discharged home 
from hospital. The mortality rate for this group was 10.7% which is slightly lower 
than the national average (ANZICS CORE). Patients discharged to rehabilitation / 
nursing home facilities, another acute hospital, another ICU or data were missing 
accounted for 23.3% (7.7%, 11.4%, 0.3% and 3.9% respectively). 
The discharge destinations for patients in Scotland did not follow the same pattern 
of Australia. Patients were discharged home in 54.7% of cases and mortality was 
22.9% at hospital discharge. However, patients going to other destinations 
accounted for 22.4% of patients which is consistent with the Australian cohort 
(rehabilitation / nursing home – 14.0%; acute hospital – 1.1% and missing data – 
7.3%).  
6.14.2 Discharge destination for individual sites 
The discharge destinations for each site in the Australian and Scottish cohorts are 
displayed in Figure 42 and Figure 43. The proportion of patients being discharged 
home at each site ranged from 40.3% to 82.6% for Australian sites and from 0% to 
73.7% in Scottish sites.  
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Figure 42 Discharge destination for all Australian sites 
 
Figure 43 Discharge destination for all Scottish sites 
Note: Site 5 had a cohort of two patients.  
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6.14.3 Discharge destination for patients who mobilised and did not 
mobilise 
Discharge destination was analysed for patients who did and did not mobilise and 
results are shown in Figure 44 and Figure 45 for Australian and Scottish cohorts. 
Australian patients had a higher likelihood of being discharged to an acute hospital 
than Scottish patients (p<.001). In both cohorts discharge to another ICU was rare. 
The difference between the mobilised and non-mobilised cohorts was more 
noticeable in the Australian population than in the Scottish.  
Figure 44 Discharge destination for Australian patients who mobilised and did 
not mobilise  
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Figure 45 Discharge destination for Scottish patients who mobilised and did not 
mobilise  
 
6.14.4 Sub groups 
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trauma categories was divergent with the rate for Australian trauma patients being 
21.5% and Scottish trauma patients being zero. 
APACHE II scores are used to predict outcome therefore it is to be expected that 
mortality rates increased as the APACHE II score increased. This was true in the 
Australian cohort. Small numbers in the APACHE II groupings for the Scottish cohort 
make results less meaningful; however they do follow the same general trend.  
Figure 46 Diagnosis (sub group 1): discharge destination for each category of the 
Australian cohort in Study Three 
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Figure 47 Diagnosis (sub group 1): discharge destination for each category of the 
Scottish cohort in Study Three 
 
Figure 48 Classification (sub group 2): discharge destination for each category of 
the Australian cohort in Study Three 
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Figure 49 Classification (sub group 2): discharge destination for each category of 
the Scottish cohort in Study Three 
 
Figure 50 Severity of illness (sub group 3): discharge destination for each 
category of the Australian cohort in Study Three 
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Figure 51 Severity of illness (sub group 3): discharge destination for each 
category of the Scottish cohort in Study Three 
 
6.15 Safety 
6.15.1 Overall safety 
For this study, there were 50 adverse events recorded, 32 in the Australian 
population and 18 in the Scottish population. The adverse event rate for Australia 
equates to 3.2% (32 events / 996 episodes) and for Scotland is 6.2% (18 events / 
292 episodes). These rates were found to be significantly different (p=.040). 
6.15.2 Safety at each site 
Adverse event rates ranged from 1.9% to 6.3% of episodes in Australian sites. A 
much larger range was seen in Scottish sites with rates ranging between 0% and 
27.0% of episodes (Table 36 and 37). 
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Table 36 Adverse event rates for each Australian site in Study three 
Site N of patients N of episodes an AE occurred Adverse event rate% 
1 2 2 2.1 
2 3 3 3.9 
3 2 2 4.4 
4 7 7 6.3 
5 6 7 2.4 
6 1 1 2.2 
7 5 5 4.1 
8 2 2 1.9 
9 1 1 4.0 
10 2 2 5.3 
Total 31 32 3.2 
Table 37 Adverse event rates for each Scottish site in Study three 
Site N of patients N of episodes an AE occurred Adverse event rate% 
1 2 10 27.0 
2 1 2 3.8 
3 3 3 3.3 
4 0 0 0.0 
5 0 0 0.0 
6 1 1 5.6 
7 1 1 2.9 
8 1 1 5.0 
9 0 0 0.0 
Total 9 18 6.2 
 
6.15.3 Safety within each sub group 
Adverse event rates were calculated for each diagnostic specific category within sub 
group 1. The results for the Australian population are displayed in Table 38 and for 
the Scottish population in Table 39. Patients in the gastrointestinal category had the 
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highest adverse event rate (3.6%) and patients in the metabolic category had no 
adverse events.  
The adverse event rate for the Scottish orthotrauma category appears 
disproportionately high at 20.0%. Both the number of events (five) and total 
numbers of episodes of mobilisation (25) were low in this category and therefore 
this rate is not likely to be an accurate representation.  
Table 38 Diagnosis (sub group 1): adverse events in each category for the 
Australian cohort of Study Three 
Diagnostic specific 
category 
N of patients N of episodes an 
AE occurred 
Adverse event 
rate% 
Cardiac 11 12 1.2 
Respiratory 5 5 1.7 
Gastrointestinal 8 8 3.6 
Neurology 2 2 3.0 
Sepsis 3 3 2.4 
Orthotrauma 1 1 1.4 
Metabolic 0 0 0 
Missing 1 1 1.4 
Table 39 Diagnosis (sub group 1): adverse events in each category for the 
Scottish cohort of Study Three 
Diagnostic specific 
category 
N of patients N of episodes an 
AE occurred 
Adverse event rate 
Cardiac 1 1 1.0 
Respiratory 2 2 2.1 
Gastrointestinal 2 2 1.8 
Neurology 1 2 6.1 
Sepsis 1 6 6.7 
Orthotrauma 2 5 20.0 
Metabolic 0 0 0 
Missing 0 0 0 
 
Adverse events for Australian patients in sub group 2 were relatively consistent 
between categories. The trauma category of the Scottish cohort recorded a high 
adverse event rate once again due to low overall numbers (see Table 40 and 41).  
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Table 40 Classification (sub group 2): adverse events in each category for the 
Australian cohort of Study Three 
Diagnostic specific 
category 
N of 
patients 
N of episodes an AE 
occurred 
Adverse event 
rate 
Medical 8 8 1.3 
Surgical 21 22 1.9 
Trauma 1 1 1.9 
Missing 1 1 1.4 
Table 41 Classification (sub group 2): adverse events in each category for the 
Scottish cohort of Study Three 
Diagnostic specific 
category 
N of 
patients 
N of episodes an AE 
occurred 
Adverse event 
rate 
Medical 3 8 3.1 
Surgical 5 6 3.0 
Trauma 1 4 21.0 
Missing 0 0 0 
 
Adverse events for severity of illness groupings were low and consistent across 
categories in the Australian population. For Scottish patients, a higher adverse 
event rate was seen in the 20-24 category. The adverse event rate for the higher 
APACHE II category was considerably lower at 2.1% showing no relationship 
between APACHE II score and adverse event rate (see Table 42 and 43).  
Table 42 Severity of illness (sub group 3): adverse events within each category 
for the Australian cohort of Study Three 
APACHE II group N of patients N of episodes an AE occurred Adverse event rate 
5-9 2 2 1.6 
10-14 10 10 2.0 
15-19 6 7 1.3 
20-24 7 7 1.7 
25-29 3 3 1.8 
30-34 1 1 5.0 
35-39 1 1 2.6 
Missing 1 1 1.2 
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Table 43 Severity of illness (sub group 3): adverse events within each category 
for the Scottish cohort of Study Three 
APACHE II group N of patients N of episodes an AE occurred Adverse event rate 
10-14 3 4 3.60 
15-19 1 4 4.12 
20-24 3 8 10.26 
25-29 2 2 2.11 
 
6.15.4 Safety of patients receiving ETT, RRT and / or vasopressors 
Adverse events in the presence of an ETT, RRT or vasopressor infusions were rare 
and are therefore reported descriptively. There were no adverse events in the 
Australian and one in the Scottish population for patients mobilising with an ETT 
(patient refused to participate in mobilisation). For patients with RRT, the Australian 
cohort recorded one adverse event (patient refusal) and no events occurred in the 
Scotland cohort. Patients treated with vasopressor infusions mobilised more 
frequently and had slightly higher numbers of adverse events. Scotland reported 
two episodes where the patient’s vasopressor infusions needed to be increased. 
Australian patients reported eight episodes. These were: two episodes of increased 
vasopressor requirements, three episodes where the patient returned to bed due to 
cardiovascular system instability, one increase in fraction of inspired oxygen, one 
dislodgement (but not removal of) a vascular catheter, one episode where the 
patient returned to bed due to central nervous system instability and one episode 
where the patient returned to bed due to low oxygen saturations.  
6.16 Barriers to mobilisation 
Barriers to mobilisation for all patients in Study Three are shown in Table 44 for 
Australian patients and Table 45 for Scottish patients. The number of barriers 
reported per patient was higher in the Scottish population at 8.9 barriers per 
patient than in the Australian population (5.2 barriers/patient p=.012).  
The most common barrier in both cohorts was sedation. This barrier affected a 
much larger percentage of patients than other barriers. After sedation, 
cardiovascular instability was the next largest barrier affecting patients in Scotland 
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and the third largest barrier in Australian patients. The presence of an ETT was a 
noticeable barrier for Australian patients (second largest) but less so in Scottish 
populations (sixth largest).  
Table 44 Barriers to mobilisation for all Australian patients in Study three 
Barrier N of Pts (%) Barriers/pt 
Procedure 81 (12.2) 0.2 
Sedation 408 (61.4) 1.6 
CNS unstable 103 (15.5) 0.5 
CVS unstable 239 (35.9) 0.8 
Respiratory unstable 61 (9.2) 0.3 
Orthopaedic orders 48 (7.2) 0.3 
Decline 14 (2.1) 0.0 
Lack of resources 37 (5.6) 0.1 
ETT in situ 243 (36.5) 1.0 
Diarrhoea 7 (1.1) 0.0 
Coma 44 (6.6) 0.2 
Imminent death 44 (6.6) 0.1 
Dialysis 29 (4.4) 0.2 
Transfer to ward 6 (0.9) 0.0 
Fatigue 1 (0.2) 0.0 
Total 665 (100) 5.2 
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Table 45 Barriers to mobilisation for all Scottish patients in Study three 
Barrier N of Pts (%) Barriers/pt 
Procedure 59 (33.0) 1.7 
Sedation 135 (75.4) 3.5 
CNS unstable 53 (29.6) 2.4 
CVS unstable 80 (44.7) 3.2 
Respiratory unstable 52 (29.1) 3.2 
Orthopaedic orders 11 (6.1) 7.0 
Decline 10 (5.6) 1.2 
Lack of resources 24 (13.4) 2.5 
ETT in situ 33 (18.4) 2.5 
Diarrhoea 4 (2.2) 1.5 
Coma 25 (14.0) 2.7 
Imminent death 25 (14.0) 1.5 
Dialysis 16 (8.9) 4.5 
Transfer to ward 23 (12.8) 1.2 
Fatigue 10 (5.6) 2.1 
Total 179 (100) 8.9 
 
Barriers for patients who never mobilised during their ICU stay are outlined in 
Table 46 for Australian patients and in Table 47 for Scottish patients. The number of 
barriers per patient for Australian patients was 7.8 barriers per patient which is 
higher than that found for all patients in the Australian cohort and was 6.7 barriers 
per patient for Scottish patients which is lower than that found for all patients in 
the Scottish cohort.  
The top three barriers to mobilisation for Australian patients were similar to the 
whole population with slightly different order (Sedation, cardiovascular instability 
and ETT in situ). The top two barriers for Scottish patients who did not mobilise 
were the same as for the whole population and affected a similar proportion of 
patients. The third largest barrier for patients who did not mobilise was CNS 
instability affecting 28.2% of patients. 
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Table 46 Barriers to mobilisation for Australian patients not mobilised in 
Study three 
Barrier N of Pts (%) Barriers/pt 
Procedure 34 (16.4) 0.3 
Sedation 129 (62.3) 1.9 
CNS unstable 55 (26.6) 0.8 
CVS unstable 80 (38.6) 1.2 
Respiratory unstable 20 (9.7) 0.3 
Orthopaedic orders 33 (15.9) 0.8 
Decline 8 (3.9) 0.0 
Lack of resources 23 (11.1) 0.1 
ETT in all 68 (32.9) 1.3 
Diarrhoea 2 (1.0) 0.0 
Coma 29 (14.0) 0.5 
Imminent death 39 (18.8) 0.3 
Dialysis 16 (7.7) 0.3 
Transfer to ward 4 (1.9) 0.0 
Fatigue 0 (0.0) 0.0 
Total 207 (100) 7.8 
Table 47 Barriers to mobilisation for Scottish patients not mobilised in Study 
three 
Barrier N of Pts (%) Barriers/pt 
Procedure 25 (24.3) 1.6 
Sedation 75 (72.8) 2.7 
CNS unstable 29 (28.2) 2.0 
CVS unstable 44 (42.7) 2.5 
Respiratory unstable 26 (25.2) 2.5 
Orthopaedic orders 9 (8.7) 6.4 
Decline 2 (1.9) 1.0 
Lack of resources 9 (8.7) 1.1 
ETT in all 20 (19.4) 1.9 
Diarrhoea 0 0 
Coma 15 (14.6) 1.9 
Imminent death 22 (21.4) 1.4 
Dialysis 11 (10.7) 2.7 
Transfer to ward 18 (17.5) 1.1 
Fatigue 1 (1.0) 1.0 
Total 103 (100) 6.7 
 
To compare barriers per patient in those who did and did not mobilise, results were 
graphed for the Australian and Scottish cohorts in Figure 52 and Figure 53. Note the 
differences in axis.  
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Patients who did mobilise in Scotland had more barriers per patient (11.8) than 
those who did not mobilise (6.7). This is opposite to that experienced in the 
Australian cohort. For Australia, patients who did mobilise recorded 4.1 barriers per 
patient and those who didn’t mobilise had 7.8 barriers per patient.  
Figure 52 Barriers per patient for Australian patients who did and did not 
mobilise in Study three 
Note: error bars represent standard error 
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Figure 53 Barriers per patient for Scottish patients who did and did not mobilise 
in Study three 
Note: error bars represent standard error  
Avoidable or partly modifiable barriers constituted 60.2% of barriers in the 
Australian population and 53.2% in the Scottish population. Barriers seen to be 
unavoidable therefore made up 39.2% of barriers in the Australian population and 
47.8% in Scottish populations. 
6.17 Summary 
At the conclusion of this study, data was collected on 665 patients across 10 
Australian ICUs and nine Scottish ICUs. This is the first study to examine baseline 
practice of early mobilisation nationally and benchmark it internationally.  
Patients in the Australian cohort were more likely to mobilise than patients in the 
Scottish cohort. However, the number of activities and episodes of mobilisation per 
patient that mobilised was higher in the Scottish cohort. With finite resources 
available to both cohorts, there appears to be different approaches in how to 
distribute these. In the Australian cohort there appears to be more patients 
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mobilised, but at a lower rate and in the Scottish cohort less patients mobilise but 
those who do, work at a higher rate. 
The overwhelming observation from this study is that while there are common 
themes in mobilisation work practices, patients of different diagnoses, classification 
and severity of illness vary in the frequency and duration of mobilisation activities 
carried out in ICU.  
Results from this study are in alignment with those from Study One that shows an 
association between patients who mobilise and better discharge destination from 
hospital.  
Adverse event rates were low in both the Scottish and Australian cohorts. Adverse 
events that were recorded rarely required medical intervention. Patients who did 
experience an adverse event continued to mobilise on subsequent days which leads 
to the belief that the adverse events recorded were in fact transient instability 
rather than harmful events.  
Sedation remained the most commonly reported barrier in both the Scottish and 
Australian cohort. A higher percentage of patients experienced sedation as a barrier 
in the Scottish cohort. Physiological instability and the presence of an ETT were also 
frequently reported barriers. 
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Chapter 7 Discussion 
This chapter will focus on the results of all studies in this program of research. The 
thesis aims outlined in Chapter 3 will form the sub headings of this chapter and help 
guide the discussion.  
7.1 Introduction 
Mortality rates in ICU have been progressively improving and with this there has 
been an increased focus on improving functional ability of those who survive 
(Eddleston, White et al. 2000; Hodgin, Nordon Craft et al. 2009; Herridge, Tansey et 
al. 2011; Adler and Malone 2012; Needham, Davidson et al. 2012). Muscle 
weakness heavily impacts upon function and is a serious side effect of critical illness 
(Carson, Bach et al. 1999; Eddleston, White et al. 2000; Rubenfeld 2002; Herridge, 
Cheung et al. 2003; Dowdy, Eid et al. 2005; Cheung, Tansey et al. 2006; Herridge 
2009; Herridge, Tansey et al. 2011). Early mobilisation as an intervention in 
intensive care is an evolving therapy aimed to attenuate weakness often 
experienced by patients admitted to intensive care. The extent of the direct and 
indirect impacts of early mobilisation has not yet been established. The majority of 
studies examining early mobilisation as an intervention in ICU have been published 
in the past 10 years (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; 
Thomsen, Snow et al. 2008; Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 
2009; Bourdin, Barbier et al. 2010; Needham and Korupolu 2010). Indeed, four of 
the seven studies on efficacy were published after the start of data collection for 
this thesis (Burtin, Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Bourdin, 
Barbier et al. 2010; Needham and Korupolu 2010). 
To date there have been very few studies examining early mobilisation in acute 
critically ill patients. The studies that have been conducted focus primarily on 
patients with respiratory failure (Bailey, Thomsen et al. 2007; Morris, Goad et al. 
2008; Thomsen, Snow et al. 2008; Schweickert, Pohlman et al. 2009; Needham and 
Korupolu 2010). The program of research described in this thesis is the first to 
describe early mobilisation in a heterogeneous patient population. It examines a 
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systems change in a single ICU that allowed improved mobilisation levels for all 
mechanically ventilated patients. As well, there is reporting of baseline levels of 
mobilisation nationally in Australia. Finally, benchmarking of these rates 
internationally with Scottish ICUs was achieved. Previously there has been no 
reporting of baseline mobilisation levels for all mechanically ventilated patients in 
ICUs nationally or internationally.  
Results from this thesis will assist in two areas. Firstly, to inform future system 
changes in ICU involving whole of workforce practices and secondly to provide a 
basis from which to design a valid and generalizable randomised controlled trial 
examining the influence of mobilisation on patient centred outcomes.  
Early mobilisation has evolved during the time taken to conduct this program of 
research. Through formal ethics applications and conference presentations to 
informal meetings with clinicians, knowledge of what is involved in early 
mobilisation of mechanically ventilated patients has improved. Conducting two 
studies around Australia, one with the ANZICS CTG, which measured early 
mobilisation levels, may have inadvertently altered work practices in Australia. 
There is now a raised level of awareness among the workforce regarding 
mobilisation in the ICU and a questioning of the parameters required to safely 
conduct this therapy.  
7.2 Definition of early mobilisation  
The term ‘early mobilisation’ has been used in the literature quite broadly and is 
often used interchangeably with terms such as rehabilitation, ambulation and 
exercise in ICU. To progress this area of research, a clear definition was required. 
The two key aspects to the definition are what timing constitutes mobilisation as 
being ‘early’, and what activities come under the umbrella of mobilisation. After 
review of the literature, ‘early’ was defined as within ICU when the patient is 
physiologically stable. The definition of physiological stability is more complex and 
should involve collaboration with members of the MDT at the unit level to 
determine what parameters are deemed acceptable.  
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Activities that constitute mobilisation included those where movement was against 
gravity and involved axial loading of the spine and / or long bones. These activities, 
in hierarchical order of difficulty from lowest to highest were: sitting over the edge 
of the bed, sitting in a chair, utilisation of a tilt table to 40 degrees or greater, 
standing and ambulating. Patients can utilise anything from no assistance to 
maximal assistance to achieve these activities. 
The definition of early mobilisation outlined above was used for all studies in this 
thesis. Both aspects of ‘early’ and ‘mobilisation’ in the control and intervention 
arms of the study were documented in Study One. The importance of documenting 
standard care for future trials formed the basis of Study Two and study three.  
7.2.1 Change in mobilisation practice 
Loss of muscle mass in patients requiring care in ICU is noticeable within days of 
admission (Hudson and Lee 2003; Robson 2003; Winkelman 2004; Foster 2005; 
Winkelman 2007; Chambers, Moylan et al. 2009; Vincent and Norrenberg 2009; 
Griffiths and Hall 2010). Patients in ICU experience a decrease in the number and 
size of muscle contractions whilst critically unwell due to a combination of sedation 
and bed rest (Bloomfield 1997; Bamman, Clarke et al. 1998; de Letter, Schmitz et al. 
2001; Topp, Ditmyer et al. 2002; Levine, Nguyen et al. 2008; Powers, Kavazis et al. 
2009). There is a physiological rationale for why mobilisation may reverse or slow 
the rate of this muscle loss (Brower 2009). As yet there is no definitive proof of this 
or even if mobilisation of mechanically ventilated patients can be achieved outside 
the respiratory failure patient population. Study One is the first study to report 
mobilisation rates before and after implementation of a targeted early mobilisation 
program for patients in a heterogeneous patient population. Intensive care units 
are complex workplace settings and it is critical to demonstrate that 
implementation strategies can change practice. 
At the conclusion of Study One a significant increase in the percentage of patients 
mobilised was achieved. Proportions of patients who mobilised rose from 53.9% to 
64.6% of all patients and from 63.3% to 79.9% for patients that had the opportunity 
to mobilise. Processes that were implemented during the systems change involved 
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clarification of communication channels and acceptance of mobilisation of patients 
with ETTs, RRT and vasopressor infusions. Improved communication has been a 
common element in previous studies that have implemented a change in practice 
(Bailey, Thomsen et al. 2007; Thomsen, Snow et al. 2008; Bailey, Miller et al. 2009; 
Needham and Korupolu 2010). Mobilisation of patients with ETTs, RRT and 
vasopressor infusions has not specifically been targeted in prior research. However, 
Needham et al.(2010) described their technique to achieve improved mobilisation 
rates was to first identify areas in need of improvement and address them formally. 
This was a key component to the success of their study. Importantly, Study One was 
conducted prior to this study being reported and also validates these findings. 
Mobilisation with ETTs, RRT and vasopressor infusions had been identified as an 
area for improvement at RPH and hence it was a target of the early mobilisation 
program.  
In previous ICU studies, culture has been shown in previous studies to influence 
mobilisation practices (Thomsen, Snow et al. 2008; Needham and Korupolu 2010). 
High levels of enthusiasm towards this study in the three key professions within the 
MDT at RPH ICU is thought to have positively influenced work practices but the size 
of this influence is difficult to measure. Consensus of the different focus points of 
each profession within the MDT gave a more patient focused approach to 
mobilisation. The increase in the percentage of patients mobilised is likely to be due 
to a combination of changes to process and culture but also an unknown proportion 
must be apportioned to a Hawthorne effect of conducting a study with no blinding. 
Future studies examining sustained changes in work practices will verify this.  
Although attitudes towards mobilisation among staff were positive prior to the 
study, practice at RPH ICU changed with the implementation of an early 
mobilisation program in two ways. First, there was an increase in the volume of 
mobilisation conducted seen by the significant rise in the proportion of patients 
mobilised (20%) as well as a non-significant rise in the number of minutes of 
mobilisation for this increased proportion of patients. The second change seen was 
a trend towards mobilisation of patients with a higher severity of illness. Graphing 
of the proportion of patients mobilised in each APACHE II category for Phase 2 
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resulted in a bell shaped curve where patients at either end of the APACHE II 
spectrum were mobilised less than the middle categories (Figure 13). Graphing of 
the same proportions for Phase 3 showed increases in all categories as well as more 
consistent rates across all APACHE II categories. After implementation, the average 
APACHE II score of patients who mobilised increased. This may reflect the fact that 
there is a specific limited capacity of the workforce and therapists may 
preferentially mobilise patients with greater illness severity. Future studies 
examining mobilisation will need to consider controlling for severity of illness and 
diagnosis.  
Examination of the workload as a total entity showed a shift of activity towards the 
higher APACHE II categories (see Figure 18) which was sustained over a 12 month 
period. Thomsen et al.(2008) conducted the only other study of similar time period 
(12 months) that examined a systems change targeting increased mobilisation 
levels. Mobilisation rates in Thomsen et al.’s (2008) study were sustained at a 
higher level however, patients were of a single diagnostic category (respiratory) 
only. Study One of this thesis is the first study to document sustained change in 
mobilisation practices for all patients mechanically ventilated for more than three 
calendar days.  
Increases in mobilisation rates of selected ICU patient populations have previously 
been achieved by increases in staffing (Morris, Goad et al. 2008; Schweickert, 
Pohlman et al. 2009; Needham and Korupolu 2010). Study One was conducted with 
no increase in staffing or resources and managed to increase the proportion of 
patients mobilised and increase, although not significantly, the number of episodes 
(frequency), activities (intensity) and minutes (duration) of mobilisation per patient. 
With no increase in staffing, it appears that workforce efforts of the MDT were 
directed towards increasing the number of patients who achieved mobilisation and 
maintaining the frequency and intensity of the exercise prescribed to all patients. 
Alternative aspects of physiotherapy were not measured during this study. 
Therefore, it is difficult to know if the increase in mobilisation came at the cost of 
other treatments such as respiratory care. Proportions of patients mobilised post 
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implementation in Study One are comparable with results seen at the conclusion of 
Morris et al.’s (2008) study.  
Mobilisation with ETTs, RRT and vasopressor infusions 
No guidelines or evidence exists for safe mobilisation of patients with ETTs, RRT 
and / or vasopressors. Studies frequently refrain from mentioning these practices. 
Opinion articles have previously documented ‘readiness’ criteria for mobilisation 
within the ICU and included statements about mobilisation with each therapy 
(Stiller and Phillips 2003; Hopkins, Spuhler et al. 2007; Stiller 2007; Timmerman 
2007; Perme and Chandrashekar 2008; Hanekom, Gosselink et al. 2011; Herridge, 
Batt et al. 2013). However, there is no consensus view. Even if consensus of 
guidelines was present, the implementation of mobilisation with these therapies 
would not be uniform as each patient in ICU is its own case. 
Patients mobilising with ETTs increased significantly in Study one. After 
implementation of the early mobilisation program, 14.1% of patients mobilised with 
an ETT where only one patient (1.0%) mobilised with an ETT prior to 
implementation. Achieving safe increases in the proportion of patients mobilising 
with an ETT is in line with literature for the respiratory failure patient population 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008). 
Results from Study One show that ETTs are not a contraindication to mobilisation. 
This does not mean all patients with an ETT in situ can be safely mobilised, it merely 
shows that if a therapist chooses to mobilise a patient who has an ETT in situ, it is 
associated with a low rate of adverse events. Further investigation into how 
therapists chose who is appropriate to be mobilised needs to be conducted.  
Mobilisation with vasopressor infusions has had the most documentation in 
previous papers and views range from supporting the practice (Morris, Goad et al. 
2008; Schweickert, Pohlman et al. 2009), supporting the practice but with 
constraints on the dose of vasopressors (Timmerman 2007; Perme and 
Chandrashekar 2008; Burtin, Clerckx et al. 2009), to not supporting the practice at 
all (Bailey, Thomsen et al. 2007; Hopkins, Spuhler et al. 2007; Bourdin, Barbier et al. 
2010). Study One showed a significant increase in the proportion of patients who 
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mobilised with vasopressor infusions (13.4%). Previously this practice had not 
occurred at RPH ICU. This is the first study we are aware of to describe the 
achievement of this in a heterogeneous ICU patient population. This change in 
practice allowed patients to be mobilised sooner and more often. 
Schweickert et al.(2009) supported mobilisation with continuous RRT but not 
intermittent haemodialysis and neglected to document rates of mobilisation with 
RRT. Patients in Study One who mobilised with RRT increased after study 
implementation but this did not reach statistical significance due to low numbers of 
patients receiving this therapy. Comparative studies in this field cannot be found 
and further research is required to document mobilisation practices of patients with 
RRT.  
This thesis is the first to document mobilisation levels in the presence of ETTs, RRT 
and vasopressor infusions. The fact that not all patients with these therapies did 
mobilise suggests there are additional factors in why patients being treated with 
these therapies are not mobilised. This is raises the issue of barriers to mobilisation 
and indicates why it is vital that barriers are identified and quantified.  
Day first mobilised  
Exercise prescription is one of the most common forms of rehabilitation. The safe 
dose of mobilisation resulting in the optimal outcome for patients will rely on the 
known principles of prescription: type, frequency, intensity and duration 
(http://www.ncwc.edu/academics/divisions/math-sci/ex-sci/prescription.php). What is 
fundamental to exercise prescription in ICU is the more temporal element of 
prescribing exercise which is when can it be initiated and how soon can it be 
progressed. For example, sitting out of bed at day 4 of a patient’s ICU stay is likely 
to produce different outcomes to the same activity being carried out at day 14.  
Previous literature has reported when mobilisation was initiated for patients in the 
respiratory failure population but not in a heterogeneous patient population 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; 
Schweickert, Pohlman et al. 2009). Study One showed for patients who were 
mechanically ventilated for 3 or more calendar days the median times to 
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mobilisation were 5.1 days in Phase 2 and 4.9 days in Phase 3 of the study. With the 
systems change this meant an additional 20% of patients, who were of a higher 
severity of illness, safely mobilised at approximately the fifth day of their admission. 
This information will help to inform future clinical practice to determine safe timing 
of early mobilisation.  
7.2.2 Sub groups 
One of the difficulties of interpreting the thematic elements of the limited literature 
on mobilisation in ICU is that there are different sub-groups of focus represented in 
the literature. This thesis has not only recognised these issues but has analysed 
mobilisation in the context of three of the most common sub-group breakdowns: 
diagnosis; classification and illness severity.  
Diagnosis (sub group 1) 
Statistically significant increases in the percentage of patients mobilised were noted 
in sub group 1 for patients in the orthotrauma category. Patients admitted with 
orthopaedic or traumatic injuries are frequently excluded from studies examining 
early mobilisation (Bailey, Thomsen et al. 2007; Burtin, Clerckx et al. 2009; 
Schweickert, Pohlman et al. 2009). The increase in percentage of patients mobilised 
in the orthotrauma category was unexpected but opens up new possibilities for 
research in this area. It is unclear as to what specific change helped to achieve this 
result, but may be due to improved communication between medical staff and 
surgeons on deciding the appropriateness of rest in bed orders and the MDT 
working together to achieve rehabilitation that involves more than one discipline of 
the team.  
Patients in the respiratory category experienced the highest number of episodes, 
activities, weight bearing activities and minutes per patient mobilised. This category 
also saw the highest proportion of patients mobilised (84.3% of all patients, 89.2% 
of those who had the opportunity to mobilise). The high rates in the respiratory 
category are not solely due to an above average length of stay but more likely due 
to the change in guidelines that allowed patients with ETTs, RRT and vasopressors 
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to mobilise. This is supported by the large number of patients who mobilised with 
these three therapies.  
The proportion of patients in the respiratory category of this study who mobilised is 
comparable with those described in Morris et al.’s (2008) study (80%) and Needham 
et al.’s (2010) study (93%) who had similar or higher APACHE II scores. Clearly, the 
respiratory category of the ICU population, in which the majority of the early 
mobilisation research has been undertaken, has the highest rate of mobilisation. 
Therefore, change in practice within this category is not likely to appear as dramatic 
as in other categories.  
Patients admitted for gastrointestinal or sepsis concerns experienced the next 
highest number of episodes, activities, weight bearing activities and minutes of 
mobilisation per patient. This category of patients had a higher than average length 
of stay in ICU but high activity levels witnessed are likely to be due to physiotherapy 
staff perceiving these two groups of patients required early mobilisation as a high 
priority due to knowledge of the pathological processes involved with sepsis and 
muscle wasting. Patients with sepsis had the highest rate of patients mobilising on 
mechanical ventilation, closely followed by patients in the respiratory and 
gastrointestinal categories. Currently, no literature is available that examines these 
two sub groups of patients. The potential for improvement in mobilisation rates in 
these patients is large and warrants further attention in future studies.  
Patients admitted for neurological reasons showed a decrease in patients who 
mobilised. Severity of illness was markedly higher for patients in Phase 3 of the 
study (Phase 2 APACHE II score – 16; Phase 3 APACHE II score – 22). This increase in 
severity of illness may account for the decrease in patients able to safely mobilise.  
Mobilisation with ETTs, RRT and vasopressor infusions in this sub group mirrored 
those of the whole group. Significant increases in the proportion of patients who 
mobilised with ETTs were seen in patients in the respiratory, sepsis and 
gastrointestinal categories. Only patients in the respiratory category showed 
significant increase in proportion of patients mobilised with vasopressor infusions. 
The small number of patients receiving vasopressor infusions in Phase 2 of the study 
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may have influenced this result. Low numbers in Phase 2 is again likely to explain 
the non-significance of the increases in proportion of patients mobilised with RRT.  
The safe mobilisation of patients with ETTs and vasopressor infusions in the 
respiratory category is consistent with existing literature in this area (Bailey, 
Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; 
Schweickert, Pohlman et al. 2009). What has not previously been shown is the safe 
and feasible practice of mobilisation of patients with ETTs and vasopressor infusions 
in patients admitted with sepsis and gastrointestinal concerns. This success can 
assist in informing future clinical practice. 
Classification (sub group 2) 
The surgical and trauma categories of this sub group saw a significant increase in 
the proportion of patients mobilised. The ICU surgical patient population as a whole 
has not been examined previously. Of the seven studies in this area, six were 
conducted in respiratory or medical ICUs or did not have any surgical admissions 
during the study period (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; 
Thomsen, Snow et al. 2008; Schweickert, Pohlman et al. 2009; Bourdin, Barbier et 
al. 2010; Needham and Korupolu 2010). The remaining study (Burtin, Clerckx et al. 
2009) focused on in bed cycle ergometry and did not aim to mobilise patients out of 
bed. Therefore, there is little data with which to compare these results to. It is 
probable that the increase seen in the percentage of surgical patients mobilised in 
Phase 3 was achieved by allowing patients with vasoactive infusions in situ to 
mobilise given the large number of patients requiring these medications. 
As discussed for patients in the orthotrauma category of the diagnostic sub group, 
patients in the trauma category of the classification sub group showed a surprising 
increase in proportion of patients mobilised. Patients admitted with traumatic 
injuries have not previously been examined in robust trials but this should not rule 
them out for assessment of readiness to mobilise in a clinical setting. 
In this study, the proportion of medical patients who mobilised did not increase 
significantly. This fails to confer with previous results described in the literature 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; 
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Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; Needham and 
Korupolu 2010). The percentage of patients mobilised in the medical category was 
above the average of the whole group prior to implementation of change. It may be 
that patients in this category were already achieving positive results and significant 
change above this level was difficult to achieve.  
Patients in the medical category of this sub group experienced the highest number 
of episodes, activities, weight bearing activities, episodes on mechanical ventilation 
and minutes of mobilisation per patient. This was closely followed by the surgical 
category.  
Significant increases were seen in the percentage of patients mobilised and number 
of episodes of mobilisation with ETTs and vasopressor infusions in situ for the 
medical and surgical categories. The practice of mobilising patients with ETTs and 
vasopressor infusions has been shown possible in medical patients (Bailey, Thomsen 
et al. 2007; Morris, Goad et al. 2008; Thomsen, Snow et al. 2008; Schweickert, 
Pohlman et al. 2009) but this study is the first to show feasibility and significant 
improvement in rates among patients admitted for surgical reasons. Larger studies 
are required to determine practice of mobilisation with RRT in these categories.  
Severity of illness (sub group 3)  
The APACHE II score is a commonly used measure of severity of illness and 
correlates closely with mortality (Knaus, Draper et al. 1985). The pattern of 
mobilisation for APACHE II categories differed between Phase 2 and 3. The 
proportion of patients mobilised within each category for Phase 2 appeared bell 
shaped with the highest proportion of patients mobilised in category 25-29 and 
lower percentages of mobilisation for categories either side of this. A relatively 
consistent proportion of patients were mobilised for all categories in Phase 3. The 
average APACHE II score of patients who mobilised increased from 20.2 to 23.1 in 
Phase 3. This result demonstrates the change in practice towards mobilisation of 
more severely ill patients that occurred with implementation of the study.  
Substantial increases in the number of episodes, activities, weight bearing activities 
and minutes of mobilisation were seen in higher APACHE II groupings of Phase 3. 
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The prevalence of RRT and vasopressor infusions increased in the higher APACHE II 
categories. The change in policies surrounding these therapies at RPH allowed 
mobilisation rates to improve in the higher categories more so than in the lower 
categories. Previous studies have not examined the influence of severity of illness 
on mobilisation rates in mechanically ventilated patients. Future studies should 
observe and document if these changes are influenced by policy change, additional 
staffing or changes in culture.  
7.2.3 Change across the three studies 
Royal Perth Hospital ICU was the only unit to participate in all three studies. This 
provides a unique opportunity to compare rates of mobilisation recorded using 
different study designs. Chronologically, Study One was concluded approximately 
six months prior to Study Two and two years prior to Study three. The overall 
percentage of RPH patients who mobilised varied between all studies from 53.9% in 
phase 2 and 64.6% in phase 3 of Study One, 40.0% in Study 2 and 59.5% in Study 
three.  
Study One aimed to implement a systems change with regard to mobilisation 
practices. At the conclusion of the study mobilisation rates were increased. The 
carry over effect of Study One can be seen two years later in the results of Study 
three. The proportion of patients mobilised was mid-way between Phase 2 and 
Phase 3 rates. After the intense period of change was over at the conclusion of 
Study One, it is positive to see that although rates dropped, the proportion of 
patients mobilised did not return to baseline. The number of activities and episodes 
each patient received did not alter significantly between Study One and Study Three 
but the percentage of patients who participated in weight bearing activities did rise 
in Study three. The influence of case mix changes must be taken into account, but 
from these results it appears workforce efforts were directed towards increasing 
intensity of mobilisation activities for those patients who were mobilised rather 
than the proportion of patients mobilised. With a finite amount of resources there 
will always be a compromise between the numbers of patients mobilised and the 
intensity of activity conducted.  
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The point prevalence design indicates the proportion of patients mobilised on one 
day. Per day rates will always be lower than rates seen across a patient’s total 
length of stay. The proportion of patients mobilised at RPH in Study Two was 40.0%. 
This was comparable with the median rate of all sites in Study Two. Rates for RPH in 
Study Three were also comparable with the median of all sites. So capture of the 
percentage of patients who mobilised on one day or the percentage of patients who 
mobilised at any stage during their whole length of stay varied but the relative 
position of the workforce practices when compared to other ICUs remained 
consistent. The point prevalence study design may not be strong enough to draw 
many other conclusions from. 
The number of activities, episodes and minutes of mobilisation recorded at RPH ICU 
in Study 3 were above average in comparison to other sites. Case mix is an obvious 
variable that influences which patients are able to mobilise, but once it is decided a 
patient is safe to mobilise, case mix plays less of an influence on the frequency and 
intensity of mobilisation delivered. Length of stay of patients will influence the 
number of opportunities for mobilisation, however if this is comparable between 
sites, intensity and frequency of activities can be compared. When comparing sites 
with similar lengths of stay in ICU, RPH has one of the highest rates of activities, 
episodes and minutes of mobilisation, second only to site 10.  
Mobilisation of patients with RRT and vasopressor infusions remained consistent 
and high between Phase 3 of Study One, Study 2 and Study three. However, 
mobilisation of patients with ETTs decreased substantially from 14.1% in Study One 
to 0% in Study 2 and to 2.9% in Study three. The practice of mobilisation of patients 
with ETTs clearly did not embed into standard practice at RPH ICU.  
7.3 Baseline practice of mobilisation: Australia and Scotland 
7.3.1 Introduction 
Mobilisation rates for patients admitted to Australian ICUs were measured in Study 
Two and three using different study designs. The point prevalence study measured 
mobilisation events for all patients regardless of whether they had received 
178 
mechanical ventilation. This data was collected for one day and represents the 
prevalence of mobilisation but not incidence. Study Three examined patients in 
intensive care who had received mechanical ventilation at any stage and whose 
whole length of stay was captured during the study period. Capturing patient’s total 
length of stay allows for the reporting of both prevalence and incidence of 
mobilisation.  
Mobilisation practices in Scottish ICUs were observed in Study 3 only.  
7.3.2 Overall mobilisation rates 
Overall, the percentage of patients who mobilised in the 10 Australian ICUs studied 
was 68.9% and in the nine Scottish ICUs studied was 42.5%. The disparity between 
these results could potentially be explained by the difference in diagnostic mix. The 
Australian cohort had a large percentage of patients admitted post cardiothoracic 
surgery. The majority of these patients are routine and are admitted to ICU 
overnight for monitoring and are able to be mobilised the next morning. With just 
under half of the Australian cohort being made up of patients admitted for 
cardiothoracic surgery, the overall mobilisation rate is likely to be positively skewed 
as a result.  
Study Two had a more balanced group in terms of admission diagnoses and APACHE 
II groups. The proportion of patients mobilised on the study day was 39.2%. This 
fraction represents the prevalence of patients mobilised on any one day rather than 
if a patient mobilised at any stage of their total ICU stay. This information alone 
cannot be directly compared with Study One and Three.  
Episodes, activities, activities of weight bearing, minutes and activities on 
mechanical ventilation  
Patients mobilised in Scottish units had higher numbers of median activities (6.3), 
median episodes (3.8) and median minutes (692 minutes) of mobilisation during 
their ICU stay than patients in Australian units (4.2 activities, 2.2 episodes and 362 
minutes). One possible explanation for this is the significantly longer length of stay 
experienced by Scottish patients compared with Australian patients (median 3.8 
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days vs. 2 days p<.001). Interestingly, when looking at activities and episodes per 
patient rather than per patient mobilised, the rates between Australia and Scotland 
cohorts are similar. This infers that workforce efforts are similar but in the Scotland 
cohort these efforts are directed towards fewer patients. This is the first study to 
clearly demonstrate how workforce practices are different in terms of dose of 
mobilisation as a therapy. 
The high proportion of Australian patients who participated in weight bearing 
activities in Study Three may reflect the high proportion of patients admitted for 
cardiothoracic surgery. A high proportion of these patients would ambulate the day 
after surgery. This is re-confirmed in Study Two where 84.2% of surgical patients 
who mobilised participated in weight bearing activities. Literature describing the 
rate of muscle loss in ICU patients after less than one day suggests it may not be 
significant enough to affect functional activities such as standing and walking. 
A longer length of stay potentially provides more opportunity for mobilisation to 
occur. However, a longer length of stay in ICU may also equate to longer periods of 
inactivity, muscle wasting and time on mechanical ventilation. Although length of 
mechanical ventilation data was not collected, longer ventilation time in the 
Scottish cohort seems likely given 34.4% of activities in Scottish ICUs were 
conducted on mechanical ventilation. In contrast only 9.3% of Australian patients 
mobilised on mechanical ventilation at some stage during their stay in Study Three 
and no Australian patients mobilised on mechanical ventilation in Study Two. With 
ten sites in Study Three and 38 sites in Study One, albeit only on one day, it is 
unlikely that Australia’s low rate of mobilisation on mechanical ventilation is a 
random occurrence. More likely an explanation is that patients admitted to 
Australian ICUs rarely mobilise on mechanical ventilation.  
The quantification of these elements of mobilisation can contribute to future 
models of research that examine dose of mobilisation in mechanically ventilated 
adults. Baseline results of episodes, activities and minutes of mobilisation will assist 
in power analysis estimates for sample size and effect size changes.  
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ETTs, RRT and vasopressor infusions 
Results of the questionnaire given to the senior physiotherapist in each unit suggest 
that mobilisation with these therapies is more commonly accepted in Scottish ICUs. 
Eight out of nine Scottish units accepted mobilisation with ETTs and vasopressor 
infusions and six out of nine units accepted mobilisation with RRT in comparison to 
five out of ten Australian units accepting mobilisation with ETTs and vasopressors 
and six out of ten units accepting mobilisation with RRT. As a percentage, more 
patients were admitted to Scottish units where these practices were an option. 
However, rates of mobilisation with ETTs, RRT and vasopressor infusions were lower 
in Scotland than in Australia. There is a discrepancy between agreeing in principle to 
mobilisation with these therapies and actually conducting the practices.  
The percentage of mobilisation episodes where an ETT and mechanical ventilation 
was present was low in both Australian (2.0%) and Scottish (1.1%) cohorts. 
Mobilising with ETTs has been reported in two studies. Bailey et al.(2007) found 
40.9% of the 103 study patients mobilised with an ETT and Thomsen et al.(2008) 
observed 60% of the 10 subjects mobilised with this therapy. The discrepancy 
between previous studies conducted in America and this current program of 
research could be explained by differences in tracheostomy insertion practices. The 
timing of tracheostomy insertion varies depending on clinician preference and 
prediction of a patient’s ICU length of stay. Although a tracheostomy is viewed as a 
more secure airway it is a surgical procedure and not without risk. On close 
examination of the data, patients in the American cohorts continued to have ETTs in 
situ at day 14 (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Thomsen, 
Snow et al. 2008) in comparison to Australian and Scottish data showing ETTs in situ 
commonly for less than 7 days. The lower number of days with an ETT gives less 
opportunity to mobilise with one in situ. Observed practice in Scotland shows a 
large percentage of patients mobilised with mechanical ventilation but not with 
ETTs. Therefore, mobilisation occurred with ventilation delivered via a 
tracheostomy. Overall, mobilisation of patients where an ETT was present was an 
infrequent occurrence in both Australia and Scotland. 
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Mobilisation in the presence of RRT was higher in the Australian cohort at 8.5% but 
remained low in Scottish ICUs at 1.1% of episodes. Study Two also showed high 
prevalence of mobilisation on RRT in an Australian cohort with 22.4% of patients 
receiving RRT undergoing mobilisation. Schweickert et al.(2009) allowed patients 
with RRT to mobilise but did not make specific comment on the percentage of 
episodes where this therapy was being used. Baseline levels of mobilisation with 
RRT are unknown around the world. Study Three is the first study to document the 
prevalence and incidence of mobilisation in the presence of RRT in the Australian 
cohort and benchmark it internationally. Mobilisation of patients receiving RRT is 
common in Australian ICUs and rare in Scottish ICUs. 
Of all three therapies, patients mobilised with vasopressor infusions most 
frequently with 17.1% and 20.4% of episodes of mobilisation being carried out with 
this therapy in situ in the Australian population of Study Three and Study Two 
respectively and 2.8% in the Scottish population. Reporting of mobilisation with 
vasopressor infusions in the literature is poor. No baseline rates have been 
described for any country. Morris et al.’s (2008) study was the only study to 
mention patients had mobilised with vasopressors but did not state a percentage of 
the patients who mobilised with this therapy. The findings in Study Two and Three 
show a high rate of mobilisation in the presence of vasopressor infusions for 
Australian patients admitted to ICU but low in the Scottish equivalents.  
Reporting of comparable dosages of different vasopressor medications is a 
challenge for research in this area (Morris and Herridge 2007; Morris, Goad et al. 
2008). Recording of the type and dose of vasopressors delivered to patients during 
mobilisation did not occur for this study. However, it is likely that the dose of 
vasopressor delivered to a patient at the time of deciding whether or not to 
mobilise the patient will impact upon the decision made. This should be taken into 
consideration for future studies examining the influence of vasopressors on 
mobilisation of patients in the ICU. 
The average rate of mobilisation with ETTs, RRT and vasopressor infusions for each 
country does not reflect practice at the individual unit level. For all three therapies 
182 
there were extremes of scores at individual sites. Commonly an individual ICU 
would record no episodes of mobilisation with a particular therapy and therefore 
the remaining units had above average episodes of mobilisation with that particular 
therapy. If a unit regularly has patients admitted for example post operatively with 
vasopressor infusions, clinicians gain familiarity with this therapy and mobilisation 
of patients on this is accepted and is carried over to medical and trauma patients. 
Units that do not come into regular contact with the therapies may not have the 
same level of confidence and therefore mobilisation never occurs in these 
instances. The prevalence of mobilisation with these three therapies in some units 
gives a positive indication that there is room for increases in both Australian and 
Scottish cohorts. It also highlights the need for education and up skilling of staff for 
future studies attempting to implement these practices. 
Diagnosis (sub group 1) 
Literature examining early mobilisation focuses heavily on patients admitted for 
respiratory illnesses. Results of these studies show between 80% and 100% of 
patients mobilised after the addition of extra staffing (Morris, Goad et al. 2008; 
Schweickert, Pohlman et al. 2009) or changes in process (Bailey, Thomsen et al. 
2007; Thomsen, Snow et al. 2008; Needham and Korupolu 2010). In both the 
Australian and Scottish cohorts of Study three, baseline practice was recorded with 
no additional staff or resources. In both cohorts, the respiratory category recorded 
the highest percentage of patients mobilised (85.7% of Australian and 54.1% of 
Scottish patients). Scottish rates of mobilisation in the respiratory category are at a 
similar level to reported pre-implementation cohorts in Morris et al.’s (2008) study 
(47%) and Needham et al.’s (2010) study (59%). The proportion of respiratory 
patients mobilised in the Australian cohort (Study Three) is comparable with post 
implementation cohorts of patients in previous studies conducted.  
Patients in the neurological and orthotrauma category in both Australian and 
Scottish cohorts recorded low proportions of patients being mobilised and even less 
patients carried out weight bearing activities. With no comparative literature on this 
category of patients, a physiological approach is used to understand mobilisation 
rates in these categories. Given the potential for fractures and lack of innervation to 
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the lower limbs is high in both diagnostic populations, low rates of mobilisation 
would be expected. None of the studies in this thesis collected data that 
documented the physiological contraindications to weight bearing in this or other 
diagnostic specific categories. Rates in the Scottish cohort (neurology: 19.0%; 
orthotrauma 33.3%) were lower than those recorded in the Australian cohorts 
(neurology: 46.3%; orthotrauma: 41.1%) which is consistent with overall 
mobilisation rates of the Scottish cohort. 
Patients in the gastrointestinal category in both Australia and Scotland recorded 
high rates of mobilisation (Australia: 75.8%; Scotland: 51.2%) and weight bearing 
(Australia: 59.3%; Scotland: 46.3%). This category of patient has been neglected in 
the literature and warrants further investigation on the benefits and feasibility of 
mobilisation.  
Patients in the sepsis category in both the Australian and Scottish cohorts recorded 
the highest number of activities per patient of any of the sub groups but the 
proportion of patients mobilised was less than that of the respiratory cohorts. Given 
the severity of illness and increased mortality rate of patients in this category, it is 
not surprising that fewer patients mobilised. However, for those who do mobilise, 
the longer average length of stay these patients experience provides more 
opportunity for mobilisation and hence why these patients experience the highest 
number of activities per patient mobilised. Future research could examine the 
impact of temporally earlier mobilisation in this cohort in a randomised controlled 
trial to determine its influence on outcomes.  
The cardiac category contains patients admitted with both medical and surgical 
cardiac diagnoses. Mobilisation rates in centres heavily weighted with patients 
admitted post cardiothoracic surgery (Australian site 4 and 5) were extremely high 
(78.7% and 92.2%). The overall mobilisation rate of the cardiac category for 
Australia is 75% which is somewhat lower due to the combination of medical and 
surgical admission diagnoses in this category. In the Scottish cohort, no patient was 
admitted post cardiothoracic surgery in the Scottish cohort and therefore had a 
high proportion of patients admitted with medical cardiac problems such as 
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myocardial infarction. Patients admitted for medical cardiac conditions can 
potentially have a more tumultuous course than patients admitted for cardiac 
surgery. Therefore it is not unexpected that the proportion of patients mobilised 
was 38.5% which is considerably lower than the Australian counterpart.  
Classification (sub group 2) 
Mobilisation rates for medical patients have been reported in two papers 
(Schweickert, Pohlman et al. 2009; Needham and Korupolu 2010). Both populations 
were predominantly made up of patients with respiratory illnesses and therefore 
rates may be increased due to admission diagnoses. Rates of 94% and 93% 
respectively were recorded after implementation of changes to process. These rates 
are higher than reported in Australian and Scottish practice (59.6% and 43.1% 
respectively). No mention was made in either paper on the sustainability of this 
increase in activity.  
The surgical population in the Australian cohort is heavily weighted with elective 
post operative cardiothoracic surgery patients. This group is much larger than any 
other of the groups and the proportion of patients mobilised was high at 76.0% in 
comparison with the much smaller Scottish group where 45.2% of patients 
mobilised. The median time to first mobilisation was also markedly different 
between the groups at day 2 (1 to 2) for Australian surgical patients and day 4.5 
(2 to 9.8) for Scottish patients. Disparity between these values does not necessarily 
reflect differences in practice, it may be that there are significant differences in the 
type of surgery performed.  
Patients admitted with trauma injuries have been discussed in previous sections 
(orthotrauma). The low rate of mobilisation in this category of patients is to be 
expected due to the nature of injuries experienced. Low patient numbers in both 
the Australian and Scottish cohorts makes interpretation of this data difficult. 
However, it must be noted that not all patients admitted under trauma need to be 
excluded from mobilisation. Patients must be assessed individually to identify 
potential for mobilisation.  
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Severity of illness (sub group 3) 
The connection between mobilisation and severity of illness has not yet been 
reported for the Australian population. On examination of data in Study three, the 
Australian cohort had similar proportions of patients mobilised in the categories 
from 0 to 24 but steadily decreased in the higher APACHE II categories. Scotland 
does not show the same consistency with the proportion of patients mobilised 
varying between categories. No Scottish patients were mobilised in APACHE II 
categories over 30. The lack of consistency in the Scottish cohort suggests the 
decision to mobilise a patient has little to do with severity of illness and more to do 
with diagnosis or perceived need. This differs from Australian ICUs where there is a 
clear drop in activity for patients who are more severely ill. Given that APACHE II 
scores are not known by physiotherapists at the time of treatment, the score itself 
would not be a factor in mobilisation decisions. Future research into mobilisation in 
ICU should consider illness severity as a stratification variable in any randomisation 
process.  
7.4 Mobilisation and discharge destination 
Discharge destination is used as a surrogate measure of function (Schweickert, 
Pohlman et al. 2009). This measure was chosen due to the lack of availability of a 
valid and reliable measure for the heterogeneous ICU patient population. Discharge 
destination is indicative of what functional level has been attained by the time the 
patient is due to be discharged from hospital. Although this measure is broad in 
nature it is none the less patient focussed.  
The before / after study design used in Study One does not allow for causality to be 
attributed to mobilisation. The intervention delivered in Study One cannot be 
separated from the therapists’ patient selection of who should be mobilised. It is 
likely that both aspects play a role in the discharge location. Despite these 
limitations, associations can be examined. Establishing an association between 
patients who are mobilised and the destination to which they are discharged helps 
establish grounds for future more robust trials.  
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Study One examined discharge destination before and after the implementation of 
an early mobilisation program. The percentage of patients discharged home did rise 
from 37% to 41% but was not significant. Mortality trended down from 21% to 18% 
after implementation but again was not significant. These results are similar to 
those found in Schweickert et al.’s (2009) randomised controlled trial where there 
was a trend towards better discharge locations but significance was not achieved. 
Study One had a large sample size and was not able to detect a significant change. 
Alternative study designs with discharge destination as the primary outcome may 
need to be examined in order to evaluate the impact of early mobilisation on 
outcomes.  
After dividing patients of Phase 2 and 3 into those who mobilised and those who did 
not mobilise there was a clear pattern. Irrespective of what phase of the study 
patients were in, the patients who were mobilised showed better discharge 
destinations. There are many reasons why patients who mobilise are more likely to 
be discharged home and less likely to die. Firstly, the therapists may consciously or 
unconsciously select to mobilise patients who they perceive have the potential to 
be discharged home or at least less likely to die. Alternatively, patients who are 
mobilised may be less severely ill than those who do not. Finally, mobilisation may 
impact on discharge destination.  
Phase 3 saw a 20% increase in the number of patients mobilised and as a group, the 
patients who mobilised achieved the same or better discharge destination. So 
despite there being additional patients in the mobilisation group, the same 
standard of discharge location was maintained. With APACHE II scores remaining 
similar in the mobilised and not mobilised groups, an association can be made that 
patients who were chosen and mobilised in ICU, for whatever reason, are more 
likely to be discharged home and less likely to die.  
Australia and Scotland 
In Study Three, the mortality rate for patients in Australia was similar to the 
national average recorded by ANZICS CORE data. Although mortality rates for 
Scotland appear high, they are not unexpected (Moran and Solomon 2012). The 
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Scottish population had very low percentages of patients admitted for elective 
surgery, who typically have a low mortality rate and results were not adjusted for 
severity of illness. Mortality rates for the Australian cohort are similar to those seen 
in Morris et al.(2008) and Thomsen et al.’s (2008) studies which were conducted in 
the USA. Scottish cohorts are more in line with Schweickert et al.(2009) and Burtin 
et al.’s (2009) studies conducted in USA and Belgium respectively.  
There is a large variation in discharge destinations at each site for both Australia 
and Scotland cohorts. Variation between units can be influenced by the medical 
specialties available in the unit, socioeconomic status of the catchment area and 
practice standards of the area and / or country. The variability seen at individual 
sites and between countries reinforces the need for early mobilisation in ICU to be 
compared with standard practice at each site rather than between sites of different 
demographic makeup.  
The difference in discharge location seen between patients who mobilised and did 
not mobilise is not as stark in the Scottish population as it is in the Australian 
population. While some of this difference must be attributed to the larger amount 
of patients admitted for elective surgery in the Australian cohort, this is unlikely to 
be the only contributor. Mobilisation practices may help to explain these 
differences. In Study three, mobilisation occurred later and in fewer patients in the 
Scottish cohort than the Australian cohort. The effect of this on discharge 
destination requires further investigation.  
The discharge locations for different diagnostic specific categories showed 
respiratory and gastrointestinal patients were more likely to be discharged home 
than patients in the neurology or sepsis categories for both Australia and Scotland. 
Previous data focuses on mortality of these patient groups and shows inverse but 
similar trends. Patients admitted into the cardiac category behave differently in 
Australia and Scotland due to the Australian population being constructed 
predominantly of patients admitted for elective surgery.  
The discharge location of patients who mobilise has had limited investigation. So far 
studies have not been designed or powered to detect differences in this measure 
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(Schweickert, Pohlman et al. 2009). An association has been shown in Study One 
and three between mobilisation and better discharge destination but further 
studies are required to substantiate the link.  
7.5 Safety and feasibility 
Early mobilisation of mechanically ventilated patients as a therapy is being carried 
out at varying intensities in ICUs internationally. Currently, there has not been an 
assessment of the safety of this therapy in a heterogeneous Australian population.  
Baseline adverse event rates were established in Study One at RPH ICU, in Study 
Two at 38 units across ANZ and in Study Three in 10 Australian sites and 
benchmarked with nine Scottish sites.  
7.5.1 Safety 
Safety of early mobilisation was measured in this thesis by the number of adverse 
events experienced. Adverse event rates will vary depending on what criteria are 
used to classify an adverse event. There have not been clear criteria for the 
classification of an adverse event for early mobilisation in ICU. For the studies 
comprising this thesis, there were no serious adverse events. Overall, adverse event 
rates for the three studies were 1.1% (Phase 3 of Study One) 6.4% (Study Two), 
3.2% (Australia, Study three) and 6.2% (Scotland, Study three) respectively. These 
results are comparable or slightly higher than those previously reported for 
mobilisation in ICU which is between 0.96% and 4.2% (Bailey, Thomsen et al. 2007; 
Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; Needham and 
Korupolu 2010).  
The studies in this thesis listed 16 criteria as possible adverse events. The number of 
categories in our studies far exceeded previous studies where no more than five 
criteria were listed (Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Burtin, 
Clerckx et al. 2009; Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; 
Needham and Korupolu 2010). Schweickert et al.(2009) reported 4 criteria (fall to 
knees, ETT removal, SBP >200mmHg or <90 mmHg and SpO2 <80%) and had an 
adverse event rate of 0.2%. However, this was prefaced with the fact that 4% of 
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therapy sessions were discontinued due to instability. What classifies as an adverse 
event in studies in this thesis would have classified as merely instability in another 
study. The definition of an adverse event impacts on the reported rate. The criteria 
in this thesis were perhaps overly conservative in comparison to other studies 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Burtin, Clerckx et al. 2009; 
Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; Needham and 
Korupolu 2010). Despite this, adverse event rates remained low.  
One of the adverse event criteria was: ‘patient withdraws consent to participate 
after mobilisation has commenced’. This had not previously been a criterion in 
other studies but it was felt that in order to be patient focussed, it would be helpful 
to understand what proportion of mobilisation episodes were terminated not due 
to physiological criteria but patient’s wishes. Interestingly, this formed a large 
component of all adverse events in Study One and Three. In Study One it 
contributed to two thirds of the events in Phase 2 and one third of the events in 
Phase 3. The percentage was less in the Scottish cohort (3/18) but remained high in 
the Australian cohort of Study 3 (10/32). The point prevalence study did not have 
this as a criterion. For future studies implementing a change in culture, this criterion 
will continue to be important. It may provide insight into whether patients are in 
fact capable of and should be able to judge the intensity of their mobilisation 
session or it may be that the therapist is not able to explain the benefits of the 
session adequately to the patient due to communication issues on either side. 
However, if studies are evaluating mobilisation only as a technique this may 
increase adverse event rates unnecessarily and should therefore only be 
acknowledged or even abandoned altogether in reporting.  
Study One measured adverse events at RPH ICU in the two prospective phases. The 
recorded adverse event rates were similar at 1.3% prior to implementation and 
1.1% after implementation of the mobility protocol. RPH ICU also participated in 
Study Two and three where the adverse event rate during the point prevalence 
study was zero and in the eight week audit there were five events in 121 episodes 
of mobilisation equating to a 4.1% adverse event rate. Three of the five events were 
a withdrawal of participation by the patient and no event required medical 
190 
intervention. Across the three studies which span three years, adverse event rates 
at RPH ICU were low and consistent with other studies conducted in this area 
(Bailey, Thomsen et al. 2007; Morris, Goad et al. 2008; Burtin, Clerckx et al. 2009; 
Schweickert, Pohlman et al. 2009; Bourdin, Barbier et al. 2010; Needham and 
Korupolu 2010).  
Study Two is the first study to report on adverse events for early mobilisation 
therapy across Australia and New Zealand. The adverse event rate of 6.4% is likely 
to be an overestimation of the true rate as this rate represents events connected 
with both mobilisation and respiratory treatments delivered. Although analyses of 
adverse events for this study were only examined if the patient did mobilise, it is 
still unclear if the adverse event was related to mobilisation or respiratory 
treatment. The majority of the events (54%) were related to blood pressure 
fluctuations. It is unclear as to whether any of these events required medical 
intervention.  
Study Three examined all patients who received mechanical ventilation. Overall, 
Australia had an adverse event rate of 3.2% which was significantly lower than 
Scotland’s rate of 6.2%. Closer analysis of this data shows an uneven distribution of 
events in the Scottish data. One patient at one site experienced six of the nation’s 
18 adverse events, five of which were a reduction in oxygen saturation. The patient 
did not have to return to bed because of the decrease in oxygen saturation in any 
episode. The repeated nature of this event may suggest a misinterpretation of the 
criteria which did allow for an increase in oxygen requirements prior to 
commencement of mobilisation and reporting only when oxygen needed to be 
increased during mobilisation. Alternatively, perhaps oxygen desaturation is not 
seen as an adverse event and does not impact upon subsequent mobilisation 
practices in the same patient.  
The adverse events in the Australian arm of the study occurred earlier in patient’s 
ICU stay than in the Scottish arm. Fifty three percent of the adverse events occurred 
within the first week of admission in the Australian population in comparison to 
11% of Scotland’s events. The timing of events may be due to the slightly earlier 
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timing of mobilisation in the Australian cohort when patients are often experiencing 
more cardiovascular instability. This is plausible given one third of the Australian 
cohort’s adverse events were related to cardiovascular instability.  
Study One examined consecutive patients of all diagnostic specific categories for 
greater than 12 months and showed adverse events were consistent across groups 
and remained low. Study Two recorded adverse events in only three of the eight 
diagnostic specific categories (cardiac, respiratory and gastrointestinal) and again, 
these rates were low.  
In the Australian cohort of Study three, patients in the gastrointestinal category 
recorded the highest adverse event rate at 5.7%. These events were not 
concentrated at any particular site and events were across four criteria suggesting 
this is an accurate representation. In the Scottish cohort, the orthotrauma category 
showed an abnormally high adverse event rate of 20%. This is likely to be due to the 
low number of episodes of mobilisation in this sub group rather than a true 
representation of harm.  
Examination of patients in the classification sub group showed low adverse event 
rates for patients admitted for trauma in all studies. There was minimal difference 
in adverse event rates between medical, surgical and trauma diagnostic specific 
categories. Classification of admission does not appear to influence adverse event 
rates. 
The adverse event rates were higher in the higher APACHE II groupings. With many 
of the adverse events being related to cardiovascular instability, it is not surprising 
that these occurred in patients who were more severely ill and likely had more 
labile cardiovascular stability. Despite this slight increase, rates remained low. 
However, the influence of therapist’s selection of which patients are mobilised 
should not be underestimated in the instance of mobilising patients who are 
severely ill.  
In clinician surveys regarding concerns about or barriers to early mobilisation, 
patient safety was the number one concern (Morris 2007; Winkelman and 
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Peereboom 2010). The studies in this thesis assessed adverse events related to 
early mobilisation of critically ill patients who received mechanical ventilation. 
These studies spanned a number of ICUs over an extended period of time and 
reported no serious adverse events. Adverse event rates in all categories were low. 
From this data, it appears that patient selection and mobilisation carried out by 
physiotherapists within a MDT is safe.  
This program of research is the first to examine adverse event rates associated with 
early mobilisation in a heterogeneous ICU patient population and found the 
therapy, when applied by physiotherapists to chosen patients to be safe.  
7.5.2 Feasibility 
Study One is the first study we are aware of to use a systems change approach to 
early mobilisation in a level III heterogeneous ICU. An across the board increase in 
the percentage of patients mobilised was safely achieved and maintained for a one 
year period. The feasibility of implementing an early mobilisation program focussed 
on three areas: the setting, the workforce and the patient population.  
The culture surrounding early mobilisation at RPH ICU was positive prior to 
implementation of the study. It was a setting receptive to change of policy and 
practice with a MDT already established. The influence of this on the success of the 
program is difficult to measure but felt to be extremely important.  
The majority of previously conducted studies utilised additional staff to achieve 
increases in mobilisation rates (Morris, Goad et al. 2008; Schweickert, Pohlman et 
al. 2009; Needham and Korupolu 2010). This increase in staffing may have been due 
to there being no physical therapist or low physical therapist presence in these units 
prior to the study commencement. The exact staffing ratios prior to 
commencement of data collection in prior studies were not reported. No additional 
staffing was employed to implement the systems change carried out in Study One. 
The increase in mobilisation was achieved by altering policies and improving 
communication opportunities between disciplines and between shift changes. Study 
One shows changes in process can be safely achieved with current staffing levels. 
The cost per day of staying in intensive care is the most expensive of any hospital 
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bed (Williams, Dobb et al. 2005) therefore feasible implementation of a therapy 
utilising existing staffing levels is an attractive concept. It is not yet known if this 
approach can be translated into multiple ICUs internationally. 
Previous studies have examined patients predominantly admitted for respiratory 
conditions only, leaving a gap in the literature on feasibility of early mobilisation in 
all ICU patients. Morris et al.(2008) is the only study to report the feasibility of 
introducing an early mobilisation program for respiratory patients. Study One 
examined all mechanically ventilated patients regardless of diagnosis. Within this 
study, patients in the respiratory category showed high levels of mobilisation both 
pre and post implementation. The percentage of patients mobilised prior to the 
early mobilisation program was at a similar rate to those achieved at the conclusion 
of Morris et al.’s (2008) study. After implementation, the percentage of respiratory 
patients at RPH ICU who mobilised increased (78.3% to 89.2%). This data shows 
even in an ICU that is already positive towards early mobilisation, it is feasible to 
increase rates of mobilisation.  
Feasibility of early mobilisation in all diagnostic specific categories is demonstrated 
by safe increases in the proportion of patients mobilised in each of the categories. 
Significant increases in the proportion of patients mobilised were seen in the 
orthotrauma, surgical and trauma categories with meaningful increases seen in the 
remaining categories. The exception to this was the neurology group who showed a 
decrease which is likely to be explained by the increase in severity of illness of these 
patients in Phase 3 (median APACHE II score rose from 16 to 22). These results show 
that early mobilisation can feasibly and safely achieved with existing staffing and 
resources for patients in all diagnostic specific categories except neurology. 
Mobilisation levels and adverse events for RPH ICU were also assessed in Study 
Three, two years later. Study Three reported the percentage of patients mobilised 
at RPH ICU as 59.5% which was half way between rates recorded in the pre and post 
implementation periods of Study One (53.9%, 64.6%). After two years, there was a 
decrease in the percentage of patients mobilised which was to be expected after 
the decrease in attention early mobilisation was given after completion of the 
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study. However, meaningful change in mobilisation activity was maintained above 
the rate seen pre implementation in Study One.  
The results of Study One and Study Three at RPH ICU show that implementation of 
early mobilisation is feasible for patients with a variety of diagnostic specific 
categories and an increase in rate can be maintained over a two year period. 
7.6 Barriers to mobilisation 
Establishing barriers to mobilisation of patients in intensive care has been 
purported as a key priority for future research in this industry (Adler and Malone 
2012; Needham, Davidson et al. 2012). Patient safety has previously been a large 
concern among clinicians and has been a barrier to mobilisation of patients early in 
their ICU stay (Needham, Korupolu et al. 2010; Winkelman and Peereboom 2010). 
The low adverse event rate associated with early mobilisation at RPH has shown 
this to be a falsely held belief for this cohort.  
In previous research, barriers to mobilisation have been divided into two categories: 
avoidable barriers and unavoidable barriers (Leditschke, Green et al. 2012). These 
formed the basis for categorisation of barriers in Study One. Barriers that were 
deemed to be avoidable or partially modifiable in Study One were: presence of an 
ETT; lack of resources; patients with a craniectomy and no helmet; presence of 
sedation; patient declined to participate; procedures and cardiovascular instability.  
In all studies of this thesis barriers were recorded at the patient’s bedside at the 
end of treatment by the treating physiotherapist. Responses will therefore reflect 
individual clinician’s beliefs regarding why a patient should not mobilise. While 
responses may be subjective in nature, it is an accurate reflection of currently held 
beliefs on what is stopping patients from being mobilised early. This data will assist 
in the design of future studies to understand the challenges required to be 
overcome at the ground level.  
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7.6.1 Barriers to mobilisation in a single centre 
Study One measured barriers to mobilisation prospectively before and after 
implementation of the early mobilisation program. The program targeted a number 
of long standing barriers to mobilisation that were present at RPH ICU. The main 
message of the program was ‘to make mobilisation a priority in every patient’s day’. 
Target changes were: allowing patients with ETTs, RRT and vasoactive infusions to 
mobilise; early communication and coordination of staff to ensure mobilisation was 
not hindered by lack of resources or procedures; early communication with medical 
teams to identify accurate mobilisation restrictions; early ordering of helmets for 
patients who had undergone a craniectomy to ensure this was not a barrier to 
mobilisation and daily planners in patients rooms to establish a routine of activities 
and expectations for both the patient and the staff to prevent patient refusal. 
7.6.1.1 Barriers at baseline 
Prior research conducted prospectively at patients’ bedsides revealed attachments, 
such as ETTs and femorally inserted lines, and procedures were commonly reported 
barriers to mobilisation (Garzon Serrano, Ryan et al. 2011; Leditschke, Green et al. 
2012). For patients in Phase 2 of Study One, the presence of an ETT was the biggest 
barrier to mobilisation and affected 90.2% of the patients. Procedures on the other 
hand were not as prominent a barrier and were experienced by 28.4% of patients.  
The presence of sedation affected 89.2% of patients in Phase 2 which confirms the 
thoughts of surveyed clinicians in prior studies (Needham, Korupolu et al. 2010; 
Winkelman and Peereboom 2010). Cardiovascular stability was the third biggest 
barrier prior to implementation of the early mobilisation program and affected 
60.8% of patients at any one time during their length of stay. The remaining barriers 
were far less frequent but included in descending order, central nervous system 
instability, lack of resources, respiratory instability and orthopaedic orders. Barriers 
that affected less than 10% of patients were: patient declined intervention; the 
presence of a craniectomy without a helmet and the presence of uncontrollable 
diarrhoea.  
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For patients that never mobilised while in RPH ICU, the top five barriers to 
mobilisation remained the same and the proportion of patients affected by each 
also remained similar. The barrier that was more prevalent in this group was 
orthopaedic orders. This rose from 14.7% for the whole group to 21.3% for patients 
that never mobilised. In other words, 10 of the 47 patients who never mobilised had 
injuries that required them to remain in bed for longer than their ICU length of stay. 
Previous studies did not specifically examine patients who never mobilised. For 
future studies in this area it is vital to understand the factors that are limiting 
patients from mobilising. 
7.6.1.2 Barriers after implementation of early mobilisation program 
Of the seven barriers deemed to be avoidable or partially modifiable, four were 
significantly decreased after the implementation of the early mobilisation program, 
two barriers were reduced but not significantly and one increased. The areas of 
improvement correlated with the objectives of the early mobilisation program. 
The most significant barrier to change was the presence of an ETT. Prior to the early 
mobilisation program, an ETT was a barrier to 90.2% of patients at some stage 
during their ICU stay in comparison to only 2.7% of patients after implementation 
(p<.001). In the literature, the patency of lines such as ETTs has been a concern for 
clinicians that has limited mobilisation (Needham, Korupolu et al. 2010; Winkelman 
and Peereboom 2010). Changing clinician’s perceptions of ETTs as being a hindrance 
to mobilisation to being a manageable attachment was a focus area of the study 
and was successfully achieved. 
Communication and coordination of members of the MDT was considered a key 
area for improvement in Study One. The significant reduction in the barrier ‘lack of 
resources’ from 19.6% to 11.6% (p=.049) represents achievement of this goal with 
implementation of systems change and not by increasing staff time or resources. 
Considerable effort from all staff, and particularly senior staff ensured mobilisation 
was a priority and adequate staff and equipment were available to carry this out as 
well as complete all other usual aspects of patient care. Communication between 
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members of the MDT is possible and central to the accomplishment of system 
changes. 
Patients who undergo a craniectomy must have a helmet to mobilise as a matter of 
policy at RPH. Delays in referral for helmets were common prior to the introduction 
of the early mobilisation program. Although this was not an overwhelming issue, 
the reduction in this barrier from 5.9% to 1.9% (p=.017) shows how simple changes 
can impact on the process of care for patients.  
Sedation as a barrier decreased significantly after implementation of the early 
mobilisation program from 89.2% to 79.4% (p=.023). It has been purported in the 
literature that sedation is a barrier to mobilisation and in order to improve 
mobilisation rates, sedation minimisation should occur prior to any mobilisation 
program (Schweickert, Pohlman et al. 2009; Needham and Korupolu 2010; 
Needham, Korupolu et al. 2010; Winkelman and Peereboom 2010). Results of this 
study suggest that early mobilisation of patients in fact influences delivery of 
sedation patterns. What is not clear is whether the sedation was decreased prior to 
mobilisation to ensure maximum participation or if after mobilisation the patient 
required less sedation due to being more settled and physically tired. Sedation was 
not a focus area of this study but may have decreased as a consequence of the early 
mobilisation program. Further research is needed into the interplay between 
mobilisation and sedation 
The barrier ‘declined to participate in mobilisation’ affected only 6.9% of patients in 
Phase 2 but was viewed by investigators prior to commencement of the study to be 
a result of poor planning and communication of the benefits of mobilisation and 
was therefore targeted in the early mobilisation program. This barrier did decrease 
to 3.9% but did not reach statistical significance. The decrease in patients declining 
mobilisation is encouraging but needs further attention in order to limit this as a 
barrier in the future. 
Patients who did not mobilise due to the presence of vasopressor infusions came 
under the barrier ‘cardiovascular instability’. This category also covered patients 
experiencing new or uncontrolled abnormal cardiac rhythms, a haemoglobin level 
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lower than 70 d/L or a systolic blood pressure of less than or equal to 80 mm Hg. 
Due to the array of situations that met this criteria, it is not surprising that a 
statistically significant decrease in the number of patients experiencing this barrier 
was not found. There was a decrease from 60.8% to 51.9% and this may be partly 
attributed to the allowing of patients with vasopressor infusions to mobilise. In 
future the presence of any vasopressor infusions should be separated out as an 
individual barrier to more clearly determine change in practice.  
The higher APACHE II scores seen in Phase 3 could perhaps have equated to 
patients requiring an increased number of procedures. If so, it is reasonable to 
assume that the number of occasions where procedures were a barrier to 
mobilisation would also increase. Procedures as a barrier increased from 28.4% to 
43.0% (p=.007) after implementation of the program. Leditschke et al (2012) found 
the timing of procedures one of the top barriers to mobilisation in their study 
conducted at patient bedsides. For Study One, it was thought that if mobilisation 
was made a priority in the patients’ day that it would still be possible to achieve it 
even when multiple procedures were required. This was perhaps overly ambitious 
given the time and physical effort required of patients to participate in these. As a 
barrier, procedures are not always a modifiable barrier.  
The percentage of patients where respiratory instability was a barrier increased 
from 17.7% to 28.6% in Phase 3. The cause for this rise is unknown but rates are 
consistent with other studies in this field (Garzon Serrano, Ryan et al. 2011; 
Leditschke, Green et al. 2012). The change in policy regarding mobilisation of 
patients with an ETT at RPH may have removed this attachment as a barrier in the 
minds of the clinician and allowed them to look more closely at the respiratory 
system as a whole and therefore the reduction in ETTs as a barrier has equated to a 
rise in respiratory instability being a barrier.  
Central nervous system instability, uncontrollable diarrhoea and orthopaedic orders 
to rest in bed were not focussed on in the early mobilisation program as they were 
thought to be unable to be modified. This is confirmed in the results of the study as 
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the percentage of patients where these criteria were barriers did not change 
significantly between Phase 2 and 3.  
Results of barriers for patients who never mobilised reinforce the achievement of 
systems change with the introduction of the early mobilisation program. The 
presence of an ETT was no longer a major barrier in this population, nor was a 
craniectomy without a helmet. Cardiovascular instability as a barrier decreased at a 
similar rate to the whole population. Orthopaedic orders to rest in bed and 
procedures increased which was to be expected for patients who never mobilised. 
The target areas of the study were achieved in all patients and unavoidable barriers 
remain high for patients who never mobilised. 
7.6.2 Current barriers to mobilisation in Australia and Scotland 
Study Three measured baseline practice for Australia and Scotland. As with Study 
One, barriers were reported by clinicians at the patient bedside. For the Australian 
cohort of Study three, the top five barriers reported were: sedation (61.4%); 
presence of an ETT (36.5%); cardiovascular instability (35.9%); central nervous 
system instability (15.5%) and procedures (12.2%). All other barriers affected less 
than ten percent of the population. The Scottish cohort reported more barriers per 
patient overall (8.5 per patient compared with 5.5 per patient in Australian cohort) 
but the number one barrier for Scotland was common with Australia. Sedation 
affected 75.4% of patients in the Scottish cohort. Endotracheal tubes were not 
reported to be a major barrier in the Scottish cohort despite a very low incidence of 
patients mobilising with an ETT being recorded in the audit.  
The literature on barriers to mobilisation found femorally inserted lines were a 
common barrier (Leditschke, Green et al. 2012). The safety of these lines did not 
feature in the Scottish or Australian cohorts of this study. Procedures were a 
prevalent barrier in the Scottish cohort (33.0%) which may reflect the diagnostic 
make-up of the group being slightly higher in severity of illness and less routine 
surgery patients being present when compared with Australia. Stability of the 
cardiovascular, central nervous system and respiratory systems is mentioned in all 
four previous studies as a barrier to mobilisation (Needham, Korupolu et al. 2010; 
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Winkelman and Peereboom 2010; Garzon Serrano, Ryan et al. 2011; Leditschke, 
Green et al. 2012). Results for both the Australian and Scottish cohorts confirmed 
these as barriers to mobilisation with cardiovascular and central nervous system 
instability being one of the top five barriers in both Australia and Scotland and 
respiratory system instability being a barrier in the Scottish cohort.  
Examination of patients that never mobilised revealed similar results when 
compared with the whole cohort in both Australia and Scotland. Barriers that 
increased were unavoidable barriers that were expected to increase for patients 
that never mobilised. For example, the barrier of imminent death increased from 
1.1% and 3.9% of patients in the mobilised category to 18.1% and 21.4% in the not 
mobilised category for Australia and Scotland. Central nervous system instability 
increased as a barrier from 15.5% to 26.6% for Australian patients which was also 
an unavoidable barrier.  
Barriers that are deemed to be unavoidable contributed to 39.8% of the total 
barriers for Australia and 46.7% of barriers for Scotland. The barriers that increase 
when examining patients who never mobilise are orders to rest in bed, patients in 
whom death is inevitable and patients with central nervous system disturbances. 
These patients are not likely to be able to mobilise in future studies.  
In contrast, barriers that have been deemed avoidable or partially modifiable 
contributed to 60.2% of total barriers for Australia and 53.3% for Scotland. For 
future studies, the barrier requiring most attention is sedation. It has been found to 
be the number one barrier in Study One and Study Three for all cohorts. This 
supports previous studies which surveyed clinician opinions on barriers to 
mobilisation (Needham, Korupolu et al. 2010; Winkelman and Peereboom 2010). 
This program of research did not target sedation reduction but did show a reduction 
in sedation as a barrier in Study One after introduction of an early mobilisation 
program. Sedation as a barrier is not unique to Australian ICUs and was reported 
more frequently in the Scottish cohort in Study Three. Although barriers to early 
mobilisation of mechanically ventilated patients in intensive care will continue to 
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exist, a large proportion of the barriers are able to partially or completely 
overcome. 
7.6.3 Study limitations 
The studies in this thesis have several limitations. Firstly, Study One used a before 
and after study design. This design was chosen to evaluate the incidence and 
prevalence of mobilisation activities across the spectrum of patients admitted to 
the ICU. While study designs such as randomised controlled trials and stepped-
wedge designs may have statistical advantages, they do not allow for change 
management at a single site to adequately occur. Given the aim of the study was to 
change behaviour, the before and after study design was the most appropriate.  
The use of physiotherapists as data collectors for all studies in this thesis may have 
been a source of bias. Feasibly, this represented the best possible way of collecting 
all mobilisation data in a prospective manner.  
The APACHE II scoring system as a measure of severity of illness may be limited in 
its descriptiveness of how the severity of each patient’s illness will present over 
time clinically. However, it is the most widely used and reported risk stratification 
tool used in Australian and Scottish ICUs and widely recognised in the literature.  
The use of discharge destination as a surrogate measure of function is crude and is a 
limitation of the studies in this thesis. At the time of conducting these studies, there 
was no validated and reliable measure of function available for patients in the ICU 
setting. In the absence of a more scientifically robust measure, discharge 
destination was used. Hopefully, development of an appropriate tool for this 
patient population is an area of future research. 
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“With a growing number of patients surviving critical illness, there is an urgent need 
to more fully address the long term consequences of intensive care for survivors and 
their families. This Society of Critical Care Medicine conference focused on improving 
these long term consequences and discussed three major issues in the field” one of 
which is “identifying barriers and solutions for comprehensive post-ICU 
rehabilitation”. (Needham, Davidson et al. 2012) pg 507 - 508 
The program of research in this thesis pre-dates this quote from 2012 by four years. 
This research examined mobilisation and the barriers to it at a local, national and 
international level. 
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Chapter 8 Conclusion and future research 
8.1 Conclusion 
From the thesis outcomes the following conclusions have been drawn: 
 The definition of early mobilisation in ICU has previously lacked clarity. In 
this thesis, the term has been broken down and defined. Activities that 
constitute mobilisation are those that are performed against gravity and 
involve axial loading of the spine and / or long bones which are: sitting 
(either over the edge of the bed or in a chair); using a tilt table; standing and 
ambulation. The timing of mobilisation that classifies it as early involves the 
patient being in the ICU and physiologically ready. Physiological readiness or 
stability is difficult to define and will vary between units as to what 
parameters are acceptable for patients to mobilise with. Consequently, early 
mobilisation should always be discussed in relation to standard practice. 
Given the variability of patient admission diagnosis and therapies that are 
available and practiced, comparison of early mobilisation results between 
countries and units should be made cautiously and only when there is a 
clear definition of standard practice.  
 It is possible to change work practice behaviours in a long term and 
sustainable way in a heterogeneous level III ICU with the implementation of 
an early mobilisation program that changes the focus and goals of the MDT. 
This can be achieved with little increase in resources or staffing. 
 Baseline mobilisation practices vary greatly. This variation can be partly 
explained by workforce practice as well as differences in patient diagnosis, 
classification and severity of illness. To establish generalizable clinical 
pathways for the mobilisation of patients in the ICU, future research should 
take into consideration the large degree of patient variation.  
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 Adult patients who received mechanical ventilation in the ICU and who 
mobilised showed an association with better discharge destination. This 
association requires investigation in more robust trials.  
 Reporting of adverse events related to early mobilisation has not yet been 
standardised. Future research should nominate adverse events as events 
where harm has occurred rather than transient instability. This thesis has 
documented a very low rate of adverse events associated with early 
mobilisation. While this is promising, until the true efficacy of mobilisation 
(both the dose and timing) is validated there will be a continued 
conservative approach to the use of mobilisation in the ICU.  
 Barriers to early mobilisation of mechanically ventilated adults in intensive 
care are multidimensional and often not independent of one another. 
Barriers vary as to how modifiable they are in clinical practice. Some barriers 
have previously been thought to be contraindications to mobilisation such 
as the presence of an ETT. This thesis has shown that therapists are able to 
appropriately select patients who have an ETT in situ for mobilisation and 
that this practice is associated with a low adverse event rate and it is not a 
contraindication to mobilisation. 
 Sedation was consistently reported as the most frequently occurring barrier 
to mobilisation for patients locally, nationally and internationally. 
Modification of sedation delivery and its impact on early mobilisation 
warrants further investigation.  
Early mobilisation of patients in ICU is an area of growing research. This thesis is the 
first to report safety and feasibility of implementing an early mobilisation program 
in a large heterogeneous patient population. This thesis is the first program of 
research to report baseline mobilisation levels at a local, national and international 
level. Barriers to early mobilisation have been identified in Australia and 
benchmarked internationally to guide future systems change studies as well as 
more robust randomised controlled trials focussing on the effect early mobilisation 
has on patient centred outcomes.  
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8.2 Future research 
The aims and objectives of this program of research have been met and answered. 
However, results from this research have also identified further questions that are 
relevant to the field and it is recommended that these be investigated in future 
studies.  
The primary question that remains unanswered in this field of research is - what, if 
any, effect does early mobilisation have on patient centred outcomes. To date this 
has not been established. Several preliminary questions require answering before 
this can be established. Suggestions for future research which aim to resolve this 
primary question have been identified by this thesis. These are outlined below. 
 Early mobilisation should be clearly defined in studies as a relative concept 
that is in comparison to baseline practice. Both the control and intervention 
arms of studies must be clearly defined in terms of activities that constitute 
‘mobilisation’ and the timing that constitutes it as ‘early’.  
 Early mobilisation of all patients in a heterogeneous patient population has 
safely and feasibly been achieved. Future studies investigating early 
mobilisation as a therapy should consider the inclusion of patients of all 
admission diagnoses.  
 The impact of clinician’s attitudes towards mobilisation and their selection 
of who receives mobilisation in ICU has not yet been investigated. The 
impact of this on rates of mobilisation in the ICU requires further 
investigation to allow changes of practice to occur. 
 Patients admitted into the gastrointestinal and sepsis diagnostic categories 
have shown that an increased level of mobilisation is possible and was not 
associated with an increase in the adverse event rate. Patients in these 
categories have previously lacked attention and should be included in future 
research that examines the impact early mobilisation has on patient centred 
outcomes. 
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 Safe increases in mobilisation rates of patients with RRT did not show 
statistical significance in this study. Studies with larger numbers of patients 
receiving this therapy are required to determine if it is clinically viable. 
 The impact of early mobilisation on the patients discharge destination from 
hospital needs to be established in more robust trials.  
 Adverse event criteria related to early mobilisation in the ICU have not been 
agreed upon across studies. A consensus of what constitutes an adverse 
event should be formed and implemented for future research examining 
early mobilisation of mechanically ventilated adults in ICU.  
 The relationship between sedation and early mobilisation has not yet been 
clarified and requires further research.  
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Appendix 1 APACHE II scoring system 
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Appendix 2 Data Dictionary 
Variable Definition 
ETT / NTT An endotracheal or nasotracheal tube is in situ at the time of 
mobilization 
Tracheostomy A tracheostomy is in situ at the time of mobilization 
Mechanically 
ventilated 
The patient is receiving mechanical ventilation at the time of 
mobilization 
RRT in progress The patient is receiving renal replacement therapy (dialysis) 
at the time of mobilization 
Inotropes or 
vasopressors 
The patient is receiving one or more of noradrenaline, 
adrenaline, dobutamine or dopamine intravenously for the 
purpose of supporting blood pressure at the time of 
mobilization. 
SOOB This includes sitting over the edge of the bed or sitting in a 
chair with anything from maximal to no support from others 
Standing Patient is required to weight bear through lower limb/s with 
or without assistance from others +/- the use of an aid for a 
minimum of 2 seconds 
Tilt table Patient has been placed on the tilt table and inclined to 
greater than 40 degree angle 
Ambulation Patient has taken more than 3 steps with or without 
assistance of others +/- the use of an aid. These steps may 
be on the spot or in a forward direction 
Unsuccessful 
mobilisation 
 
Rehab chair Includes chairs that have the ability to be flattened to allow 
patient to be slid across and then passively sat up  
Rocker recliner An arm chair with the ability to elevate legs and recline the 
back rest 
High back chair A solid, supportive chair without moving parts 
Time sat out of bed Using a 24 hour clock, the time the patient was successfully 
and safely seated out of bed or on the edge of the bed 
Time put back to 
bed 
Using a 24 hour clock, the time the patient was successfully 
and safely returned to bed 
Unplanned removal 
art line 
During the process of mobilization the patient’s arterial line 
was dislodged or removed and was then unable to be used 
in its intended capacity 
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Variable Definition 
Unplanned removal 
CVC or Vascath 
During the process of mobilization the patient’s central 
venous catheter or vascath was dislodged or removed and 
was then unable to be used in its intended capacity 
Unplanned removal 
peripheral line 
During the process of mobilization the patient’s peripheral 
line was dislodged or removed and was then unable to be 
used in its intended capacity 
Unplanned removal 
ETT / NTT 
During the process of mobilization the patient’s 
endotracheal tube or nasotracheal tube was dislodged or 
removed and was then unable to be used in its intended 
capacity 
Unplanned removal 
trache 
During the process of mobilization the patient’s 
tracheostomy tube was dislodged or removed and was then 
unable to be used in its intended capacity 
Unplanned removal 
NGT / OGT 
During the process of mobilization the patient’s nasogastric 
or orogastric tube was dislodged or removed and was then 
unable to be used in its intended capacity 
Unplanned removal 
drain 
During the process of mobilization the patient’s drain was 
dislodged or removed and was then unable to be used in its 
intended capacity 
Unplanned removal 
other – please 
specify 
During the process of mobilization, an attachment not 
otherwise stated (e.g. intercostals catheter) was dislodged 
or removed and was then unable to be used in its intended 
capacity 
Fall In an uncontrolled manner, the patient descends to their 
knees or buttocks during a mobilization activity 
Increased oxygen 
requirements (i.e. 
FiO2) 
During the process of mobilization (i.e. not prior to 
commencement), the patients oxygen level drops 
sufficiently to warrant a sustained increase in FiO2 of 0.1 or 
more 
Increased inotropes 
/ vasopressors 
During the process of mobilization the patient’s blood 
pressure falls requiring a sustained increase of vasoactive 
medication intravenously 
CNS unstable During the process of mobilization, there is a drop in 
Glasgow Coma Scale by one or more, or a sustained increase 
in the patient’s intracranial pressure above 20 mmHg 
CVS unstable During the process of mobilization, the patient experiences 
abnormal heart rhythm, heart rate, or blood pressure that 
requires return to bed 
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Variable Definition 
↓SpO2 During the process of mobilization, the patient’s oxygen 
saturation levels drop to 84% or less for greater than 
10 seconds 
Patient refused During the process of mobilization, the patient declines to 
participate in mobilization despite explanation of the 
benefits of mobilization, appropriate pain cover and 
encouragement 
Procedure required Despite best efforts to co-ordinate with all team members, 
the requirement of a procedure must take precedence over 
mobilization 
CNS unstable Patient’s intracranial pressures have been discussed with 
senior medical staff and deemed to be too high or too labile 
to allow safe mobilization 
CVS unstable Patient is requiring high levels of vasoactive medication, is 
having new or uncontrolled abnormal cardiac rhythms, has a 
haemoglobin level lower than 70 or a systolic blood pressure 
of ≤ 80 mm Hg 
Respiratory unstable Patient’s ventilation requirements are deemed to great by 
medical staff to allow mobilization +/- patient is requiring 
nitric oxide. 
Orthopaedic orders Due to orthopaedic restrictions, patient is not allowed to 
mobilize in order to allow healing of bony fractures. 
Sedated Patient is unable to co-operate with staff due to high level of 
sedation – this does NOT include unsedated patients who 
have a low GCS 
Patient refused Prior to the commencement of mobilization the patient 
refuses to participate despite adequate pain cover, 
explanation of the benefits of mobilization and 
encouragement 
Lack of resources Mobilisation is not carried out due to the lack of availability 
of staff or equipment (e.g. chairs, tilt table) 
ETT in situ Mobilisation is not carried out due to the presence of an 
ETT/NTT 
Diarrhoea Mobilisation is unable to be carried out due to patient 
suffering from uncontrolled diarrhoea  
Comatosed Mobilisation is not carried out due to the patient having a 
low GCS. The low GCS must NOT be related to the influence 
of sedatives  
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Variable Definition 
Procedure required Despite best efforts to co-ordinate with all team members, 
the requirement of a procedure must take precedence over 
mobilization 
ETT in situ Mobilisation is not carried out due to the presence of an 
ETT/NTT 
Diarrhoea Mobilisation is unable to be carried out due to patient 
suffering from uncontrolled diarrhoea  
Craniectomy 
without a helmet 
Mobilisation is unable to be carried out due to the lack of  
protective head gear over a craniectomy site 
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Appendix 3 APACHE III diagnostic codes 
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Appendix 4 Questionnaire 
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Appendix 5 Diagnostic breakdown of sub group 1 in Phase 2 and Phase 3 
 
 Phase 2 Phase 3 p-value 
Cardiac 16.5 18.4 0.744 
Respiratory 29.1 28.3 0.889 
Gastrointestinal 15.2 11.3 0.856 
Neurology 7.6 10.9 0.530 
Sepsis 11.4 9.9 0.678 
Orthotrauma 17.7 17.1 0.868 
Metabolic 1.3 3.8 0.437 
Other 1.3 0.3 0.868 
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Appendix 6 Study One: for those who had the opportunity to mobilise the 
proportion of patients who mobilised in each diagnostic specific 
category in Phase 2 and Phase 3 
 
 Phase 2 Phase 3 p 
Cardio 53.85 74.07 .185 
Resp 78.26 89.16 .179 
GI 58.33 84.85 .058 
Neuro 83.33 68.75 .650 
Sepsis 66.67 72.41 1.00 
Orthotrauma 35.71 84.00 .001* 
Metabolic 100 54.55 1.000 
Analysis using Fischer’s exact test  
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Appendix 7 Diagnosis (sub group 1): statistical difference between the 
activities, episodes, minutes, weight bearing activities and activities 
on mechanical ventilation between Phase 2 and Phase 3 
Average number of activities per patient within each diagnostic specific category 
 Phase 2 Phase 3 p 
Cardio 9.14 5.69 .828 
Resp 7.78 10.04 .513 
GI 4.38 6.72 .361 
Neuro 8.17 3.40 .044* 
Sepsis 3.50 7.83 .367 
Orthotrauma 3.88 5.74 .866 
Metabolic 5.00 3.67 .445 
Total 6.47 6.97 .513 
Analysis using Mann Whitney test 
 
The average number of episodes of mobilisation per patient within each 
diagnostic specific category 
 Phase 2 Phase 3 p 
Cardio 4.43 3.62 .529 
Resp 4.61 6.89 .855 
GI 3.38 5.48 .275 
Neuro 6.00 2.52 .235 
Sepsis 2.83 5.65 .271 
Orthotrauma 3.13 4.26 .865 
Metabolic 2.00 1.67 .403 
Total 4.11 4.95 .762 
Analysis using Mann Whitney test 
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Average number of minutes per patient within each diagnostic specific category 
 Phase 2 Phase 3 p 
Cardio 499.43 524.05 .209 
Resp 782.67 960.89 .630 
GI 310.25 815.97 .108 
Neuro 771.17 369.00 .395 
Sepsis 284.50 757.04 .112 
Orthotrauma 182.25 549.31 .069 
Metabolic 330.00 313.67 .617 
Total 531.42 689.38 .172 
Analysis using Mann Whitney test 
 
The average number of weight bearing activities carried out per patient who 
mobilised in each diagnostic specific category. 
 Phase 2 Phase 3 p 
Cardio 5.14 2.55 .460 
Resp 3.72 3.49 .378 
GI 1.13 2.14 .660 
Neuro 2.83 1.04 .095 
Sepsis 0.67 2.57 .310 
Orthotrauma 1.13 1.77 .442 
Metabolic 3.00 2.00 .546 
Total 2.75 2.44 .346 
Analysis using Mann Whitney test 
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Number of activities of mobilisation carried out on mechanical ventilation per 
patient that mobilised within each diagnostic specific category 
 Phase 2 Phase 3 p 
Cardio 5.71 2.36 .622 
Resp 4.06 5.75 .798 
GI 2.38 3.52 .648 
Neuro 3.50 1.12 .819 
Sepsis 1.83 4.91 .535 
Orthotrauma 1.25 2.05 .894 
Metabolic 0 0.50 .533 
Total 3.16 3.44 .596 
Analysis using Mann Whitney test 
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Appendix 8 Classification (sub group 2): statistical difference between the 
percentage of patients mobilised, activities, episodes, minutes, 
weight bearing activities and activities on mechanical ventilation 
between Phase 2 and Phase 3 
Percentage of patients mobilised within each diagnostic specific category 
 Phase 2 Phase 3 p 
Medical 71.43 78.21 .342 
Surgical 55.56 78.38 .048 
Trauma 41.67 90.00 .001 
Analysis using Mann Whitney test 
Average number of activities per patient within each diagnostic specific category 
for those who did mobilise 
 Phase 2 Phase 3 p 
Medical 6.08 7.73 .807 
Surgical 9.25 6.61 .421 
Trauma 3.71 5.30 .902 
Total 6.47 6.97 .513 
Analysis using Mann Whitney test 
The average number of episodes of mobilisation per patient within each 
diagnostic specific category 
 Phase 2 Phase 3 p 
Medical 4.06 5.39 .592 
Surgical 5.00 4.77 .760 
Trauma 2.86 3.94 .785 
Total 4.11 4.95 .762 
Analysis using Mann Whitney test 
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Average number of minutes per patient within each diagnostic specific category 
 Phase 2 Phase 3 p 
Medical 624.19 759.53 .674 
Surgical 497.83 669.48 .501 
Trauma 111.86 514.18 .018 
Total 531.42 689.38 .172 
Analysis using Mann Whitney test 
The average number of weight bearing activities carried out per patient who 
mobilised in each diagnostic specific category. 
 Phase 2 Phase 3 p 
Medical 2.47 2.64 .346 
Surgical 4.42 2.48 .073 
Trauma 1.29 1.68 .402 
Total 2.75 2.44 .346 
Analysis using Mann Whitney test 
Number of activities of mobilisation carried out on mechanical ventilation per 
patient that mobilised within each diagnostic specific category 
 Phase 2 Phase 3 p 
Medical 3.06 4.10 .696 
Surgical 4.75 3.23 .635 
Trauma 1.00 1.82 .861 
Total 3.16 3.44 .596 
Analysis using Mann Whitney test 
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Appendix 9 Severity of illness (sub group 3): statistical differences between 
activities, episodes, minutes, weight bearing activities and activities 
on mechanical ventilation in Phase 2 and Phase 3 
Activities per patient 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0.0  
5-9 20.0 5.0 0.507 
10-14 7.3 4.5 0.209 
15-19 5.0 5.7 0.424 
20-24 6.0 5.9 0.910 
25-29 5.8 8.5 0.849 
30-34 6.4 14.2 1.000 
35-39 1.0 5.9 0.103 
40-44 0 5.3  
45-49 0 1.0  
50-54 0 0.0  
Analysis using Mann Whitney test 
Episodes per patient 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0  
5-9 9.3 2.3 0.369 
10-14 4.9 3.1 0.574 
15-19 3.6 4.0 0.602 
20-24 3.7 4.2 0.691 
25-29 3.2 6.8 0.339 
30-34 5.0 8.5 0.501 
35-39 0 4.3 0.195 
40-44 0 4.3  
45-49 0 1.0  
50-54 0 0  
Analysis using Mann Whitney test 
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Minutes per patient 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0  
5-9 1236.7 286.7 0.513 
10-14 457.9 379.0 0.692 
15-19 473.7 536.9 0.835 
20-24 585.7 592.6 0.230 
25-29 390.9 1039.1 0.215 
30-34 665.2 1143.0 0.211 
35-39 25.0 528.9 0.165 
40-44 0 593.3  
45-49 0 120.0  
50-54 0 0  
Analysis using Mann Whitney test 
Weight bearing activities 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0  
5-9 11.0 2.7 0.767 
10-14 3.4 1.6 0.096 
15-19 1.8 2.0 0.822 
20-24 2.5 2.2 0.674 
25-29 2.7 2.0 0.872 
30-34 1.6 6.2 1.000 
35-39 0 1.9  
40-44 0 1.5  
45-49 0 0  
50-54 0 0  
Analysis using Mann Whitney test 
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Activities on mechanical ventilation 
APACHE group Phase 2 Phase 3 p-value 
0-4    
5-9 66.7 6.7 <.001 
10-14 31.4 36.2 0.609 
15-19 40.0 43.2 0.633 
20-24 57.6 45.6 0.087 
25-29 48.1 59.7 0.087 
30-34 53.1 56.5 0.714 
35-39 0 43.4 1.000 
40-44 0 31.3  
45-49 0 0  
50-54 0 0  
Analysis using Mann Whitney test 
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Appendix 10 Severity of illness (sub group 3): statistical differences between 
number of patients who mobilise with ETTs, RRT or vasopressors in 
Phase 2 and Phase 3 
Percent of patients who mobilise with an ETT 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0  
5-9 0 7.1 0.400 
10-14 0 3.2 0.597 
15-19 0 4.3 0.014 
20-24 1.2 7.3 0.049 
25-29 0 7.0 0.095 
30-34 0 5.9 0.206 
35-39 0 5.0 1.000 
40-44 0 9.7 1.000 
45-49 0 0  
50-54 0 0  
Analysis using Fisher’s exact test 
Percent of patients who mobilise with RTT 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0  
5-9 0 0  
10-14 0 0  
15-19 0 0  
20-24 0 5.2 1.000 
25-29 0 13.2 0.579 
30-34 0 30.8 0.321 
35-39 0 4.5 1.000 
40-44 0 0  
45-49 0 0  
50-54 0 0  
Analysis using Fisher’s exact test 
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Percent of patients who mobilise with vasopressor infusions 
APACHE group Phase 2 Phase 3 p-value 
0-4 0 0  
5-9 0 0  
10-14 0 0  
15-19 0 1.9 0.557 
20-24 0 8.2 0.059 
25-29 0 4.3 1.000 
30-34 0 11.2 0.122 
35-39 0 5.4 1.000 
40-44 0 16.7 1.000 
45-49 0 0  
50-54 0 0  
Analysis using Fisher’s exact test 
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Appendix 11 Point prevalence data collection sheet  
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Appendix 12 Point prevalence study data dictionary 
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Appendix 13 Mobilisation data collection Form 2 
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Appendix 14 Data dictionary for MDCF2 
Variable Definition 
ETT / NTT An endotracheal or nasotracheal tube is in situ at the time 
of mobilization 
Tracheostomy A tracheostomy is in situ at the time of mobilization 
Mechanically 
ventilated 
The patient is receiving mechanical ventilation at the time 
of mobilization 
RRT in progress The patient is receiving renal replacement therapy 
(dialysis) at the time of mobilization 
Inotropes or 
vasopressors 
The patient is receiving one or more of noradrenaline, 
adrenaline, dobutamine or dopamine intravenously for the 
purpose of supporting blood pressure at the time of 
mobilization. 
SOOB This includes sitting over the edge of the bed or sitting in a 
chair with anything from maximal to no support from 
others 
Standing Patient is required to weight bear through lower limb/s 
with or without assistance from others +/- the use of an 
aid for a minimum of 2 seconds 
Tilt table Patient has been placed on the tilt table and inclined to 
greater than 40 degree angle 
Ambulation Patient has taken more than 3 steps with or without 
assistance of others +/- the use of an aid. These steps may 
be on the spot or in a forward direction 
Rehab chair Includes chairs that have the ability to be flattened to 
allow patient to be slid across and then passively sat up  
Rocker recliner An arm chair with the ability to elevate legs and recline the 
back rest 
High back chair A solid, supportive chair without moving parts 
Time sat out of bed Using a 24 hour clock, the time the patient was 
successfully and safely seated out of bed or on the edge of 
the bed 
Time put back to bed Using a 24 hour clock, the time the patient was 
successfully and safely returned to bed 
Unplanned removal 
art line 
During the process of mobilization the patient’s arterial 
line was dislodged or removed and was then unable to be 
used in its intended capacity 
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Variable Definition 
Unplanned removal 
CVC or Vascath 
During the process of mobilization the patient’s central 
venous catheter or vascath was dislodged or removed and 
was then unable to be used in its intended capacity 
Unplanned removal 
peripheral line 
During the process of mobilization the patient’s peripheral 
line was dislodged or removed and was then unable to be 
used in its intended capacity 
Unplanned removal 
ETT / NTT 
During the process of mobilization the patient’s 
endotracheal tube or nasotracheal tube was dislodged or 
removed and was then unable to be used in its intended 
capacity 
Unplanned removal 
trache 
During the process of mobilization the patient’s 
tracheostomy tube was dislodged or removed and was 
then unable to be used in its intended capacity 
Unplanned removal 
NGT / OGT 
During the process of mobilization the patient’s 
nasogastric or orogastric tube was dislodged or removed 
and was then unable to be used in its intended capacity 
Unplanned removal 
drain 
During the process of mobilization the patient’s drain was 
dislodged or removed and was then unable to be used in 
its intended capacity 
Unplanned removal 
other – please specify 
During the process of mobilization, an attachment not 
otherwise stated (e.g. intercostals catheter) was dislodged 
or removed and was then unable to be used in its 
intended capacity 
Fall In an uncontrolled manner, the patient descends to their 
knees or buttocks during a mobilization activity 
Increased oxygen 
requirements (i.e. 
FiO2) 
During the process of mobilization (i.e. not prior to 
commencement), the patients oxygen level drops 
sufficiently to warrant a sustained increase in FiO2 of 0.1 
or more 
Increased inotropes / 
vasopressors 
During the process of mobilization the patient’s blood 
pressure falls requiring a sustained increase of vasoactive 
medication intravenously 
Commencement of 
inotropes / 
vasopressors 
During the process of mobilization the patient’s blood 
pressure falls requiring the commencement of vasoactive 
medication intravenously 
CNS unstable During the process of mobilization, there is a drop in 
Glasgow Coma Scale by one or more, or a sustained 
increase in the patient’s intracranial pressure above 20 
mmHg 
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Variable Definition 
CVS unstable During the process of mobilization, the patient 
experiences abnormal heart rhythm, heart rate, or blood 
pressure that requires return to bed 
SpO2 During the process of mobilization, the patient’s oxygen 
saturation levels drop to 84% or less for greater than 10 
seconds 
Patient refused During the process of mobilization, the patient declines to 
participate in mobilization despite explanation of the 
benefits of mobilization, appropriate pain cover and 
encouragement 
Nil No adverse events occurred during mobilization 
Sedated Patient is unable to co-operate with staff due to high level 
of sedation – this does NOT include unsedated patients 
who have a low GCS 
Comatosed Mobilisation is not carried out due to the patient having a 
low GCS. The low GCS must NOT be related to the 
influence of sedatives  
Procedure required Despite best efforts to co-ordinate with all team members, 
the requirement of a procedure must take precedence 
over mobilization 
ETT in situ Mobilisation is not carried out due to the presence of an 
ETT/NTT 
RRT in progress Mobilisation is not carried out due to the presence of 
renal replacement therapy (dialysis) 
Lack of resources Mobilisation is not carried out due to the lack of 
availability of staff or equipment (e.g. chairs, tilt table) 
 Patient refused Prior to the commencement of mobilization the patient 
refuses to participate despite adequate pain cover, 
explanation of the benefits of mobilization and 
encouragement 
Orthopaedic orders Due to orthopaedic restrictions, patient is not allowed to 
mobilize in order to allow healing of bony fractures. 
Imminent Death Mobilisation is not carried out due to medical staff’s 
prediction that the patient’s condition is not compatible 
with life and death is imminent in the next 48 hours.  
Diarrhoea Mobilisation is unable to be carried out due to patient 
suffering from uncontrolled diarrhoea  
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Variable Definition 
CVS unstable Patient is requiring high levels of vasoactive medication, is 
having new or uncontrolled abnormal cardiac rhythms, has 
a haemoglobin level lower than 70 or a systolic blood 
pressure of ≤ 80 mm Hg 
CNS unstable Patient’s intracranial pressures have been discussed with 
senior medical staff and deemed to be too high or too 
labile to allow safe mobilization 
Respiratory unstable Patient’s ventilation requirements are deemed to great by 
medical staff to allow mobilization +/- patient is requiring 
nitric oxide. 
Other – please specify  
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Appendix 15 Ethics approvals 
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Ethics approval for Royal Hobart Hospital 
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Ethics approval for Royal Perth Hospital 
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Appendix 16 Scotland ethics requirements  
 
Waiver of ethics for Scotland 
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Caldicott guardianship for Aberdeen Royal Infirmary, Aberdeen (NHS Grampian) 
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Caldicott guardianship for Forth Valley Royal Hospital, Larbert (NHS Forth Valley) 
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Caldicott guardianship for Royal Infirmary of Edinburgh – Edinburgh; Western 
General Hospital – Edinburgh; St John’s Hospital – Livingston (NHS Lothian) 
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Caldicott guardianship for Ninewells Hospital – Dundee; Perth Royal Infirmary - 
Perth (NHS Tayside) 
 
272 
Caldicott guardianship for Queen Margaret Hospital – Dunfermline (NHS Fife) 
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Caldicott guardianship for Raigmore Hospital – Inverness (NHS Highland) 
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